Unnamed: 0,title,date,stock,sentiment
190229.0,Boston Scientific Receives Approval for Medicare Transitional Pass-Through Payment for the EXALT Model D Single-Use Duodenoscope,2020-06-08 06:48:00-04:00,BSX,positive
190230.0,Boston Scientific Announces the US Launch of its DIRECTSENSE Tool for Monitoring the Effect of Radiofrequency Energy During Cardiac Ablation Procedures,2020-06-01 06:53:00-04:00,BSX,positive
190231.0,Why Boston Scientific's Stock Is Trading Lower Today,2020-05-21 14:37:00-04:00,BSX,negative
190232.0,Boston Scientific shares are trading lower after the company announced it has commenced concurrent offerings of $750 million shares of its common stock and $750 million of shares of its Series A Mandatory Convertible Preferred Stock.,2020-05-21 11:04:00-04:00,BSX,positive
190233.0,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",2020-05-21 08:01:00-04:00,BSX,neutral
190234.0,5 Stocks Moving In Wednesday's After-Hours Session,2020-05-20 18:06:00-04:00,BSX,neutral
190235.0,"Boston Scientific shares are trading lower after the company announced it has commenced concurrent offerings of $750 million shares of its common stock and $750 million of shares of its Series A Mandatory Convertible Preferred Stock,",2020-05-20 16:38:00-04:00,BSX,positive
190236.0,"Boston Scientific Reports Commencement Of Concurrent $750M Common Stock, $750M Series A Mandatory Convertible Preferred Stock",2020-05-20 16:19:00-04:00,BSX,positive
190237.0,Boston Scientific Files For Potential Stock Shelf Offering; Size Not Disclosed,2020-05-20 16:08:00-04:00,BSX,neutral
190238.0,"Shares of several healthcare companies are trading higher in sympathy with the overall market amid strength in oil, strong earnings from Lowe's and optimism towards a US economic rebound.",2020-05-20 11:19:00-04:00,BSX,positive
190239.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.,2020-05-18 10:23:00-04:00,BSX,positive
190240.0,"The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO",2020-05-15 07:49:00-04:00,BSX,negative
190241.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,BSX,negative
190242.0,"Argus Research Maintains Buy on Boston Scientific, Raises Price Target to $42",2020-05-13 12:16:00-04:00,BSX,neutral
190243.0,Boston Scientific Reports Final Results From UNTOUCHED Study Of EMBLEM Subcutaneous Implantable Defibrillator System Presented At HRS 2020 SCIENCE,2020-05-08 09:03:00-04:00,BSX,neutral
190244.0,"Shares of several healthcare companies are trading higher amid continued economic optimism as some US states ease lockdown restrictions. While jobless claims came in worse than estimates, figures were lower than in prior weeks.",2020-05-07 11:25:00-04:00,BSX,positive
190245.0,Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session.,2020-05-05 12:44:00-04:00,BSX,positive
190246.0,Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions.,2020-05-01 12:35:00-04:00,BSX,positive
190247.0,"Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $41",2020-04-30 11:07:00-04:00,BSX,negative
190248.0,"UBS Maintains Buy on Boston Scientific, Lowers Price Target to $45",2020-04-30 09:57:00-04:00,BSX,negative
190249.0,"Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $42",2020-04-30 09:35:00-04:00,BSX,neutral
190250.0,"Oppenheimer Maintains Perform on Boston Scientific, Lowers Price Target to $41",2020-04-30 09:22:00-04:00,BSX,negative
190251.0,"Credit Suisse Maintains Outperform on Boston Scientific, Raises Price Target to $43",2020-04-30 09:13:00-04:00,BSX,positive
190252.0,"Stifel Maintains Buy on Boston Scientific, Raises Price Target to $45",2020-04-30 08:45:00-04:00,BSX,neutral
190253.0,"Raymond James Maintains Strong Buy on Boston Scientific, Raises Price Target to $43",2020-04-30 07:51:00-04:00,BSX,positive
190254.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,BSX,positive
190255.0,"Boston Scientific Q1 Adj. EPS $0.280 Misses $0.310 Estimate, Sales $2.543B Beat $2.520B Estimate",2020-04-29 06:32:00-04:00,BSX,negative
190256.0,"Earnings Scheduled For April 29, 2020",2020-04-29 04:50:00-04:00,BSX,neutral
190257.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,BSX,negative
190258.0,"UnitedHealth Says Is Collaborating With Boston Scientific, Medtronic And University Of Minnesota To Deploy 3K 'Light' Ventilators",2020-04-23 13:04:00-04:00,BSX,neutral
190259.0,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,2020-04-23 11:27:00-04:00,BSX,positive
190260.0,"SunTrust Robinson Humphrey Maintains Buy on Boston Scientific, Lowers Price Target to $25",2020-04-23 10:39:00-04:00,BSX,negative
190261.0,"Benzinga's Top Upgrades, Downgrades For April 22, 2020",2020-04-22 09:40:00-04:00,BSX,positive
190262.0,SVB Leerink Downgrades Boston Scientific to Market Perform,2020-04-22 07:31:00-04:00,BSX,neutral
190263.0,"Shares of several healthcare companies are trading lower with the overall market on continued downward momentum after oil prices fell to historic lows, partially stemming from weak demand caused by the coronavirus pandemic.",2020-04-21 11:35:00-04:00,BSX,negative
190264.0,Shares of several healthcare companies are trading higher amid optimistic coronavirus outlook following positive drug data from Gilead. This has raised hopes of a sooner return to spending and economic activity.,2020-04-17 10:04:00-04:00,BSX,positive
190265.0,Nanocap Soligenix Rips Higher On Licensing Of COVID-19 Vaccine Adjuvant,2020-04-16 10:41:00-04:00,BSX,neutral
190266.0,"The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant",2020-04-16 08:09:00-04:00,BSX,neutral
190267.0,Soligenix Reports Exclusive License Deal For Novel Vaccine Adjuvant From BTG Specialty,2020-04-16 07:06:00-04:00,BSX,positive
190268.0,Shares of several healthcare companies are trading lower amid overall market weakness caused by the coronavirus which has decreased consumer spending and economic activity.,2020-04-15 10:05:00-04:00,BSX,negative
190269.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,BSX,positive
190270.0,"BioCardia Announces Litigation Financing In Case Captioned Boston Scientific Corp., et al., v. BioCardia Inc.",2020-04-14 08:08:00-04:00,BSX,negative
190271.0,"Shares of several healthcare companies are trading lower amid overall market weakness. Stocks are lower, selling off from last week's gains amid uncertainty surrounding coronavirus outlook and the reopening of the economy.",2020-04-13 12:23:00-04:00,BSX,negative
190272.0,"Nevro Reports Federal Circuit Rules In Its Favor, Upholds Validity Of Co.'s Patent Claims In Litigation Against Boston Scientific",2020-04-09 12:44:00-04:00,BSX,positive
190273.0,Shares of several healthcare companies are trading higher amid overall market strength. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic. UPDATE: Shares of some names in the sector moved higher later in the session following news that US Senator Sanders has suspended his presidential campaign.,2020-04-08 09:34:00-04:00,BSX,positive
190274.0,FDA Says Boston Scientific Is Recalling Imager II 5F Angiographic Catheters Because There Is Potential For Catheter Tip To Detach During Patient Procedure,2020-04-07 09:55:00-04:00,BSX,neutral
190275.0,Shares of several healthcare companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Global slowing cases could raise hopes of a sooner return to spending and economic activity. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-07 07:48:00-04:00,BSX,positive
190276.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,BSX,positive
190277.0,"Needham Maintains Buy on Boston Scientific, Lowers Price Target to $43",2020-04-02 12:21:00-04:00,BSX,negative
190278.0,"The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation",2020-04-02 07:57:00-04:00,BSX,positive
190279.0,"Boston Scientific Outlines Steps To Mitigate Impact Of Coronavirus, Says Sees Q2 Impact From Coronavirus Larger Than Q1 Impact",2020-04-02 06:34:00-04:00,BSX,neutral
190280.0,Boston Scientific Sees Q1 GAAP Sales About Flat To Up Slightly On Year-Over-Year Basis,2020-04-02 06:33:00-04:00,BSX,neutral
190281.0,"Boston Scientific Reports Business Trends For First 2 Months Of Q1 Were Inline With Expectations; In Mar., Coronavirus Impact Caused Procedural Volumes To Decline 'Significantly'",2020-04-02 06:33:00-04:00,BSX,neutral
190282.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,BSX,negative
190283.0,"Shares of several healthcare companies are trading higher amid market strength. NOTE: The coronavirus pandemic has potentially benefited the sector due to demand for medical supplies, testing and treatment candidates",2020-03-31 12:00:00-04:00,BSX,positive
190284.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,BSX,positive
190285.0,"Citigroup Maintains Buy on Boston Scientific, Lowers Price Target to $40",2020-03-27 08:21:00-04:00,BSX,negative
190286.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,BSX,positive
190287.0,"Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $30",2020-03-24 09:05:00-04:00,BSX,negative
190288.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,BSX,negative
190289.0,"Stephens & Co. Maintains Overweight on Boston Scientific, Lowers Price Target to $35",2020-03-23 11:22:00-04:00,BSX,negative
190290.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,BSX,negative
190291.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,BSX,negative
190292.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,BSX,negative
190293.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-11 11:41:00-04:00,BSX,negative
190294.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,BSX,negative
190295.0,"CFRA Upgrades Boston Scientific to Strong Buy, Lowers Price Target to $47",2020-03-09 15:28:00-04:00,BSX,positive
190296.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,BSX,neutral
190297.0,"Credit Suisse Maintains Outperform on Boston Scientific, Lowers Price Target to $46",2020-03-06 10:26:00-05:00,BSX,positive
190298.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,BSX,neutral
190299.0,Shares of several healthcare companies are trading lower. Weakness appears market related as equities across sectors continue to sell off amid coronavirus concerns. NOTE: The sector spiked yesterday following U.S. Democratic primary results.,2020-03-05 10:40:00-05:00,BSX,negative
190300.0,"Hearing Citi Initiates Coverage On J&J, Boston Scientific, Zimmer Biomet, Stryker, Medtronic, Insulet With Buy Ratings",2020-03-04 17:47:00-05:00,BSX,neutral
190301.0,Shares of several healthcare and biotech companies are trading lower amid continued spread of coronavirus including notable upticks in Iran and Italy. NOTE: The virus has raised fear of a global economic slowdown.,2020-02-24 08:37:00-05:00,BSX,negative
190302.0,"Benzinga's Top Upgrades, Downgrades For February 13, 2020",2020-02-13 09:56:00-05:00,BSX,positive
190303.0,"Goldman Sachs Initiates Coverage On Boston Scientific with Neutral Rating, Announces $46 Price Target",2020-02-13 07:41:00-05:00,BSX,neutral
190304.0,"Barron's Picks And Pans: GM, Kraft Heinz, Tesla, Under Armour And More",2020-02-08 11:45:00-05:00,BSX,neutral
190305.0,Boston Scientific Corp Sees A Reduction In Volume For All Non Emergency Medical Device Procedures In February And March In China Due To Negative Impact From Coronavirus,2020-02-05 08:40:00-05:00,BSX,negative
190306.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,BSX,neutral
190307.0,"Boston Scientific Sees Q1 Adj. EPS $0.37-$0.40 vs $0.41 Est., Sees FY20 Adj. EPS $1.74-$1.79 vs $1.78 Est.",2020-02-05 06:31:00-05:00,BSX,neutral
190308.0,"Boston Scientific Q4 Adj. EPS $0.46 Beats $0.44 Estimate, Sales $2.905B Miss $2.93B Estimate",2020-02-05 06:30:00-05:00,BSX,negative
190309.0,"Boston Scientific ays Settled Dispute With Channel Resulting in Termination of Agreement, Payment by Co of Undisclosed Sum",2020-02-05 06:10:00-05:00,BSX,positive
190310.0,"10 Stocks To Watch For February 5, 2020",2020-02-05 05:28:00-05:00,BSX,neutral
190311.0,"Earnings Scheduled For February 5, 2020",2020-02-05 04:26:00-05:00,BSX,neutral
190312.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,BSX,neutral
190313.0,ï»¿Shares of several healthcare companies are trading lower as fears of the coronavirus' potential impact on the global economy intensifies. The death toll continues to rise and the U.K. and Russia confirmed their first cases.,2020-01-31 11:41:00-05:00,BSX,negative
190314.0,Boston Scientific shares are trading lower after the company issued Q4 and FY19 sales guidance below analyst estimates.,2020-01-14 07:43:00-05:00,BSX,neutral
190315.0,"Boston Scientific Sees Prelim. Q4 Sales $2.90B vs $2.93B Est., FY19 Sales $10.74B vs $10.76B Est.",2020-01-14 06:31:00-05:00,BSX,neutral
190316.0,10 Biggest Price Target Changes For Monday,2019-12-30 08:58:00-05:00,BSX,neutral
190317.0,"Cowen & Co. Maintains Outperform on Boston Scientific, Raises Price Target to $52",2019-12-30 06:21:00-05:00,BSX,neutral
190318.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,BSX,neutral
190319.0,"JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $55",2019-12-20 09:22:00-05:00,BSX,neutral
190320.0,"Benzinga's Top Upgrades, Downgrades For December 19, 2019",2019-12-19 09:51:00-05:00,BSX,positive
190321.0,Needham Downgrades Boston Scientific to Buy,2019-12-19 06:55:00-05:00,BSX,neutral
190322.0,"Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $51",2019-12-17 09:00:00-05:00,BSX,negative
190323.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,BSX,positive
190324.0,Stocks That Hit 52-Week Highs On Monday,2019-12-16 10:16:00-05:00,BSX,neutral
190325.0,10 Biggest Price Target Changes For Monday,2019-12-16 08:26:00-05:00,BSX,neutral
190326.0,"Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $52",2019-12-16 07:36:00-05:00,BSX,negative
190327.0,"Boston Scientific Receives FDA Clearance For World's First Single-Use Duodenoscope, EXALT Model D",2019-12-13 13:31:00-05:00,BSX,neutral
190328.0,Stocks That Hit 52-Week Highs On Friday,2019-12-13 11:19:00-05:00,BSX,neutral
190329.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,BSX,positive
190330.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-12 10:21:00-05:00,BSX,neutral
190331.0,"Cramer Advises His Viewers On GW Pharma, Enphase And More",2019-12-11 11:12:00-05:00,BSX,neutral
190332.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-10 14:27:00-05:00,BSX,neutral
190333.0,15 Highest-Rated Analyst Stock Picks In The S&P 500,2019-11-26 13:32:00-05:00,BSX,neutral
190334.0,"CVS, Incyte And More 'Fast Money Halftime Report' Picks From Nov. 13",2019-11-13 16:56:00-05:00,BSX,neutral
190335.0,Large Option Traders Betting Boston Scientific Has Run Out Of Steam,2019-11-13 13:50:00-05:00,BSX,neutral
190336.0,Boston Scientific Option Alert: Nov 29 $42.5 Calls Sweep (19) near the Ask: 620 @ $0.409 vs 143 OI; Ref=$41.38,2019-11-13 10:17:00-05:00,BSX,positive
190337.0,Boston Scientific shares are trading higher on seemingly no company-specific news,2019-11-12 15:43:00-05:00,BSX,neutral
190338.0,Boston Scientific Option Alert: Nov 22 $40.5 Calls at the Ask: 1607 @ $0.58 vs 125 OI; Ref=$40.32,2019-11-11 11:03:00-05:00,BSX,positive
190339.0,Boston Scientific Announces Data For Ranger Drug-Coated Balloon And Eluvia Drug-Eluting Vascular Stent At VIVA19,2019-11-05 13:24:00-05:00,BSX,neutral
190340.0,33 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-23 08:48:00-04:00,BSX,neutral
190341.0,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data",2019-10-23 07:54:00-04:00,BSX,negative
190342.0,Boston Scientific shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.,2019-10-23 07:15:00-04:00,BSX,positive
190343.0,"Boston Scientific Sees Q4 Adj. EPS $0.42-$0.45 vs $0.44 Est., Sees FY19 Adj. EPS $1.55-$1.58 vs $1.56 Est.",2019-10-23 06:34:00-04:00,BSX,neutral
190344.0,"Boston Scientific Q3 EPS $0.39 Beats $0.38 Estimate, Sales $2.71B Beat $2.65B Estimate",2019-10-23 06:33:00-04:00,BSX,neutral
190345.0,"Earnings Scheduled For October 23, 2019",2019-10-23 04:15:00-04:00,BSX,neutral
190346.0,Boston Scientific Option Alert: Fri $39.5 Calls at the Ask: 2761 @ $0.641 vs 127 OI; Earnings 10/23 Before Open Ref=$38.87,2019-10-22 09:56:00-04:00,BSX,positive
190347.0,Earnings Season Kicks Into Full Gear In Round 3 Of The WeTrader Competition,2019-10-21 11:16:00-04:00,BSX,neutral
190348.0,"Raymond James Maintains Strong Buy on Boston Scientific, Lowers Price Target to $48",2019-10-14 08:20:00-04:00,BSX,positive
190349.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,BSX,positive
190350.0,Shares of several healthcare companies are trading higher after multiple reports suggesting China is open to a partial trade deal surfaced. The reports renewed optimism in the upcoming U.S.-China trade talks.,2019-10-09 11:10:00-04:00,BSX,positive
190351.0,Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.,2019-10-08 10:36:00-04:00,BSX,positive
190352.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.,2019-10-02 10:33:00-04:00,BSX,negative
190353.0,Boston Scientific shares are trading lower. NOTE: The company presented data from the EVOLVE Short DAPT clinical trial yesterday before the close.,2019-09-27 11:19:00-04:00,BSX,neutral
190354.0,Boston Scientific Announces Announces Presentation Of Data From EVOLVE Short DAPT,2019-09-26 15:17:00-04:00,BSX,neutral
190355.0,"Shares of companies in the medical devices space are trading lower. Despite no company or sector-specific news for these stocks, other spaces in the healthcare sector including diagnostics and pharmaceuticals have seen weakness today.",2019-09-10 12:12:00-04:00,BSX,negative
190356.0,Shares of several diagnostics/medical device companies trading lower with broader market. DexCom shares leading the group lower following comments from Morgan Stanley about pressure on the company's Q3 comps.,2019-09-09 12:48:00-04:00,BSX,negative
190357.0,Boston Scientific shares are trading higher after Stifel raised the price target from $46 to $47.,2019-09-06 14:05:00-04:00,BSX,positive
190358.0,"Barclays Reinstates Overweight on Boston Scientific, Announces $48 Price Target",2019-09-03 06:33:00-04:00,BSX,negative
190359.0,Shares of several healthcare companies are trading lower on escalated trade tensions after China announced it plans to impose a 5% to 10% tariff rate on $75 billion worth of U.S. goods. Trump announced he will respond to China's tariffs this afternoon.,2019-08-23 12:40:00-04:00,BSX,negative
190360.0,Boston Scientific Announces FDA Approval Of ImageReady MRI For Vercise Gevia Deep Brain Stimulation System,2019-08-19 17:41:00-04:00,BSX,positive
190361.0,Boston Scientific Issues Response To FDA Guidance On Use Of Peripheral Paclitaxel Devices For Treatment Of PAD,2019-08-07 12:26:00-04:00,BSX,neutral
190362.0,FTC Says Boston Scientific Has Agreed To Divest Certain Assets To Varian Medical,2019-08-07 10:55:00-04:00,BSX,positive
190363.0,"Boston Scientific Shares Unaffected As Hearing FTC To Require Divestitures, Has Imposed Other Conditions On Co.'s Purchase Of BTG",2019-08-07 10:51:00-04:00,BSX,positive
190364.0,Shares of several drug/pharma/medical equipment companies trading lower given weakness in broader stock market following concerns with China trade tensions.,2019-08-05 12:43:00-04:00,BSX,negative
190365.0,"Raymond James Maintains Strong Buy on Boston Scientific, Raises Price Target to $50",2019-07-25 07:32:00-04:00,BSX,positive
190366.0,From Boston Scientific Q2 Earnings Conference Call: Co. Has Capacity To Make Tuck-In Acquisitions In 2019,2019-07-24 08:40:00-04:00,BSX,neutral
190367.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,BSX,neutral
190368.0,Boston Scientific Reaffirms FY19 Guidance: Adj. EPS $1.54-$1.58 vs $1.56 Estimate; Sees Q3 Adj. EPS $0.37-$0.39 vs $0.39 Est.,2019-07-24 06:36:00-04:00,BSX,neutral
190369.0,"Boston Scientific Q2 Adj. EPS $0.39 Beats $0.38 Estimate, Sales $2.631B Miss $2.64B Estimate",2019-07-24 06:35:00-04:00,BSX,negative
190370.0,"Earnings Scheduled For July 24, 2019",2019-07-24 04:00:00-04:00,BSX,neutral
190371.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,BSX,neutral
190372.0,Varian Will Acquire Embolic Bead Asset From Boston Scientific,2019-07-02 12:51:00-04:00,BSX,positive
190373.0,Varian to Acquire Embolic Bead Asset from Boston Scientific; Terms Not Disclosed,2019-07-02 04:21:00-04:00,BSX,positive
190374.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Friday, June 28, 2019",2019-06-28 16:30:00-04:00,BSX,positive
190375.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Fri., June 28, 2019",2019-06-28 13:42:00-04:00,BSX,positive
190376.0,"Canaccord Genuity Maintains Buy on Boston Scientific, Raises Price Target to $46",2019-06-27 09:42:00-04:00,BSX,neutral
190377.0,UPDATE: Boston Scientific Sees Double-Digit Adj. EPS Growth Through 2019-2022 Period,2019-06-26 10:20:00-04:00,BSX,positive
190378.0,"Boston Scientific, At Investor Day Wed., Will Highlight Plans To Launch ~75 New Products By 2022, Sees Moderate-, High-Growth Markets Reaching ~80% Of Sales By 2022, Sees Compound Annual Growth Rate Through 2022 6-9%",2019-06-26 10:18:00-04:00,BSX,positive
190379.0,"Wells Fargo Maintains Outperform on Boston Scientific, Raises Price Target to $45",2019-06-18 09:29:00-04:00,BSX,positive
190380.0,Many US-traded stocks are trading higher as recent economic signals have raised the potential for a Federal Reserve rate cut.,2019-06-07 12:31:00-04:00,BSX,negative
190381.0,"BMO Adds Boston Scientific To Top Picks, Sees Catalysts Ahead",2019-05-30 13:27:00-04:00,BSX,positive
190382.0,"Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",2019-05-17 09:21:00-04:00,BSX,neutral
190383.0,"13F From Loeb's Third Point Shows New Stakes In Netflix, Boston Scientific, United Technologies, Marathon Petroleum, Microsoft, Sony",2019-05-15 17:12:00-04:00,BSX,positive
190384.0,"13F For JANA Shows Liquidated Stakes In Apple, Adobe, Anthem, Autodesk, Boston Scientific, Mastercard, Microsoft, Teva, Tiffany",2019-05-15 09:37:00-04:00,BSX,neutral
190385.0,"Shares of several healthcare companies are trading higher as the US market rebounds from recent weakness, driven by renewed cautious optimism surrounding US-China trade talks.",2019-05-14 13:32:00-04:00,BSX,positive
190386.0,"Benzinga's Top Upgrades, Downgrades For May 13, 2019",2019-05-13 09:18:00-04:00,BSX,positive
190387.0,Evercore ISI Group Upgrades Boston Scientific Corporation Common Stock to Outperform,2019-05-13 07:57:00-04:00,BSX,neutral
190388.0,Shares of several healthcare companies are trading lower in sympathy with the overall market. The S&P 500 is trading lower 1%,2019-05-10 13:09:00-04:00,BSX,positive
190389.0,"Boston Scientific shares are trading lower, giving up Thursday's gains following news the company agreed to acquire Vertiflex for $465 million. The healthcare group as a whole is underperforming the S&P 500 Friday.",2019-05-10 12:05:00-04:00,BSX,positive
190390.0,"Boston Scientific Reports Purchase Of Vertiflex For $465M In Upfront Cash, Added Payments Contingent On Commercial Milestones Over Next 3 Years",2019-05-09 06:48:00-04:00,BSX,neutral
190391.0,Boston Scientific Reports Receive FDA Approval For VICI VENOUS STENT System,2019-05-06 06:46:00-04:00,BSX,positive
190392.0,Boston Scientific Announces Scheduled Presentations at Heart Rhythm 2019 May 8-11,2019-05-01 17:13:00-04:00,BSX,neutral
190393.0,"Canaccord Maintains Buy, $43 Tgt On Boston Scientific As Firm Would Buy Stock Ahead Of Near-Term Events Like The HRS Meeting In May, Digestive Disease Week Update In Mid May, EuroPCR In Late May, Close Of BTG Acquisition In Mid '19, Analyst Day In June",2019-04-25 12:14:00-04:00,BSX,positive
190394.0,Analysts Shrug Off Softness In Edwards Lifesciences' Heart Value Replacement System,2019-04-24 11:22:00-04:00,BSX,positive
190395.0,From Boston Scientific Corp Conference Call; Co. Says Mesh Market Withdrawal Represents A 30 Basis Point Drag To Q1 And FY19 Organic Growth; Says Peripheral Interventions Business Felt Impact Of Paclitaxel-Related Concerns In Second Half Of Q1,2019-04-24 08:21:00-04:00,BSX,positive
190396.0,"The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova",2019-04-24 08:09:00-04:00,BSX,neutral
190397.0,Boston Scientific Sees Q2 Adj. EPS $0.37-$0.39 vs $0.39 Estimate,2019-04-24 06:34:00-04:00,BSX,neutral
190398.0,"Boston Scientific Narrows, Raises Low End Of FY19 Adj. EPS Guidance From $1.53-$1.58 To $1.54-$1.58 vs $1.56 Estimate, Sales Growth From 7-9% Year Over Year To 7-8%",2019-04-24 06:33:00-04:00,BSX,positive
190399.0,"Boston Scientific Q1 Adj. EPS $0.35 Misses $0.36 Estimate, Sales $2.493B Miss $2.54B Estimate",2019-04-24 06:32:00-04:00,BSX,negative
190400.0,"Earnings Scheduled For April 24, 2019",2019-04-24 04:18:00-04:00,BSX,neutral
190401.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,BSX,positive
190402.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,BSX,neutral
190403.0,Boston Scientific shares are trading lower after the FDA ordered manufacturers of urogynecologic surgical mesh implants to stop selling their products. Shares are also down with the overall medical device sector.,2019-04-17 12:55:00-04:00,BSX,neutral
190404.0,"Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $43",2019-04-17 10:20:00-04:00,BSX,negative
190405.0,Boston Scientific Says Anticipates $25M Negative Impact To 2019 Revenue After The FDA Ordered Manufacturers To Stop Selling Surgical Mesh Products For Transvaginal Repair Of Pelvic Organ Prolapse,2019-04-17 06:34:00-04:00,BSX,negative
190406.0,"FDA Determines Boston Scientific Hasn't Showed Reasonable Assurance Of Safety, Effectiveness For Surgical Meshes",2019-04-16 14:27:00-04:00,BSX,positive
190407.0,"Piper Jaffray Says FDA Surgical Mesh Removal Likely To Have 'Relatively Minor' Revenue Impact On Boston Scientific, Recommends Buying Dip",2019-04-16 14:15:00-04:00,BSX,positive
190408.0,"Boston Scientific Responds To FDA Decision On Premarket Approval Applications: Says Is Disappointed, Will Work Closely With FDA To Understand Direction, Determine Next Steps",2019-04-16 12:32:00-04:00,BSX,neutral
190409.0,"Boston Scientific shares are trading lower after the FDA ordered manufacturers of urogynecologic surgical mesh implants to stop selling their products, as they have not demonstrated reasonable assurance of safety and effectiveness.",2019-04-16 12:24:00-04:00,BSX,negative
190410.0,"FDA Determined Boston Scientific, Coloplast Have Not Showed Reasonable Assurance Of Safety, Effectiveness For Devices",2019-04-16 11:54:00-04:00,BSX,positive
190411.0,"Port Report: Year After First Salvo, U.S.-China Trade War In Ceasefire, But New Ones Are Starting",2019-04-09 10:34:00-04:00,BSX,negative
190412.0,24 Stocks Moving In Friday's Pre-Market Session,2019-04-05 08:05:00-04:00,BSX,neutral
190413.0,"BofA Lowers Boston Scientific Revenue Estimates On FDA Warning, But Keeps Buy Rating",2019-03-18 15:04:00-04:00,BSX,negative
190414.0,Shares of several pharmaceutical companies are trading lower after the FDA issued a note Friday which said there is a signal of increased long-term mortality in people treated with paclitaxel-coated balloons.,2019-03-18 11:29:00-04:00,BSX,positive
190415.0,Boston Scientific Announces Late-breaking Clinical Trial Highlights Positive Safety and Efficacy Data for the LUMINIZE RF Balloon Catheter @#EHRA2019,2019-03-17 18:04:00-04:00,BSX,positive
190416.0,Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX Left Atrial Appendage Closure Device,2019-03-13 07:10:00-04:00,BSX,neutral
190417.0,"The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering",2019-02-13 07:49:00-05:00,BSX,negative
190418.0,"The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",2019-02-12 08:04:00-05:00,BSX,negative
190419.0,Boston Scientific shares are trading higher after the company reported Q4 EPS of $0.39 beating the $0.37 estimate and reported sales of $2.56 billion inline with estimates.,2019-02-06 12:56:00-05:00,BSX,negative
190420.0,"The Daily Biotech Pulse: Paratek Launches Antibiotic In US, Eli Lilly Earnings, Catabasis Offering",2019-02-06 08:23:00-05:00,BSX,neutral
190421.0,"Boston Scientific Q4 Adj. EPS $0.39 Beats $0.37 Estimate, Sales $2.56B Inline",2019-02-06 06:54:00-05:00,BSX,neutral
190422.0,"Earnings Scheduled For February 6, 2019",2019-02-06 04:10:00-05:00,BSX,neutral
190423.0,"The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs",2019-02-03 10:09:00-05:00,BSX,neutral
190424.0,Boston Scientific Highlights Launch Of Spectra WaveWriter Spinal Cord Stimulator System In Europe,2019-01-31 07:11:00-05:00,BSX,neutral
190425.0,Boston Scientific Reports Data From Randomized Clinical Trial Of Rezum Water Vapor Therapy Published In 'Urology' Showed 'durable results and preserves sexual function four years after treatment',2019-01-25 06:46:00-05:00,BSX,neutral
190426.0,Boston Scientific Reports Results From VIRTUS Study Showing VICI Venous Stent Met Its Primary Effectiveness And Safety Endpoints In Re-establishing Blood Flow At Twelve Months,2019-01-22 06:15:00-05:00,BSX,positive
190427.0,Hearing Dealreporter Says JNJ May Be 'Gearing Up' For A Takeover Of Boston Scientific,2019-01-15 09:37:00-05:00,BSX,neutral
190428.0,UPDATE: Edwards Has Made 1-Time Payment Of $180M To Boston Scientific,2019-01-15 06:56:00-05:00,BSX,neutral
190429.0,"Boston Scientific, Edwards Lifesciences Report Global Litigation Settlement",2019-01-15 06:55:00-05:00,BSX,negative
190430.0,"Boston Scientific Sees Q4 Sales $2.56B vs $2.56B Est., FY18 Sales $9.82B vs $9.82B Est.",2019-01-08 06:32:00-05:00,BSX,neutral
190431.0,Hearing Medtronic CFO Parkhill Mentioned Co. Expects FY20 EPS Below Trend From Tax And FX Headwinds,2019-01-07 13:07:00-05:00,BSX,neutral
190432.0,RBC Capital Reiterates Boston Scientific As Top Pick Going Into 2019; Believes '2019 guidance will reflect another year of strong revenue and EPS growth',2019-01-03 09:10:00-05:00,BSX,positive
190433.0,Mid-Afternoon Market Update: Dow Down Over 500 Points; Crude Oil Falls 3.5%,2018-12-27 14:43:00-05:00,BSX,negative
190434.0,Mid-Day Market Update: CSP Drops After Q4 Results; BioXcel Therapeutics Shares Gain,2018-12-27 12:59:00-05:00,BSX,positive
190435.0,Mid-Morning Market Update: Markets Open Lower; Boston Scientific To Buy Out Millipede,2018-12-27 10:43:00-05:00,BSX,negative
190436.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,BSX,neutral
190437.0,A Peek Into The Markets: US Stock Futures Down; Dow Futures Fall Over 300 Points,2018-12-27 07:02:00-05:00,BSX,neutral
190438.0,Boston Scientific Reports Deal To Buy Remaining Stake In Millipede,2018-12-27 06:46:00-05:00,BSX,neutral
190439.0,Barron's Article Highlights Concerns About Overuse Of Stents,2018-12-26 11:50:00-05:00,BSX,neutral
190440.0,"Credit Suisse Initiates Coverage On Boston Scientific with Outperform Rating, Announces $42 Price Target",2018-12-18 07:18:00-05:00,BSX,positive
190441.0,"The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel",2018-12-12 08:07:00-05:00,BSX,positive
190442.0,Edwards Comments On U.S. Court Decision,2018-12-12 04:24:00-05:00,BSX,neutral
190443.0,Shares of Boston Scientific are trading up 3.4% after UBS initiated coverage on the stock with a Buy rating and $45 price target.,2018-11-28 15:12:00-05:00,BSX,positive
190444.0,"UBS Initiates Coverage On Boston Scientific with Buy Rating, Announces $45 Price Target",2018-11-28 07:58:00-05:00,BSX,neutral
190445.0,"Jim Cramer Gives His Opinion On Boston Scientific, MongoDB And More",2018-11-28 07:23:00-05:00,BSX,neutral
190446.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,BSX,positive
190447.0,26 Stocks Moving In Tuesday's Pre-Market Session,2018-11-20 08:00:00-05:00,BSX,neutral
190448.0,Boston Scientific Announces Recommended Offer to Acquire BTG plc for ~$4.2B,2018-11-20 04:19:00-05:00,BSX,positive
190449.0,Boston Scientific Option Alert: Feb 15 $39 Calls at the Ask: 2250 @ $0.98 vs 3382 OI; Ref=$35.5972,2018-11-19 12:19:00-05:00,BSX,positive
190450.0,Boston Scientific shares are trading up 2.6% after the company announced a new global restructuring program that is expected to cut up to $150 million of annual pre-tax expenses.,2018-11-16 11:30:00-05:00,BSX,neutral
190451.0,Boston Scientific Approves New Global Restructuring Program Expected To Reduce Gross Annual Pre-Tax Expenses By $100M-$150M,2018-11-15 16:57:00-05:00,BSX,negative
190452.0,"Guggenheim Reiterates Boston Scientific As A Best Idea, Raises Price Target From $43 To $45; Believes Investors Are Underestimating 'how strong the company's fundamentals are'",2018-11-15 08:23:00-05:00,BSX,positive
190453.0,13F For Appaloosa Shows Cut Stake In Boston Scientific From ~2.5M Shares To ~850K Shares.,2018-11-14 16:16:00-05:00,BSX,positive
190454.0,"Canaccord Genuity Maintains Buy on Boston Scientific, Raises Price Target to $42",2018-10-25 10:03:00-04:00,BSX,neutral
190455.0,"The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",2018-10-24 07:48:00-04:00,BSX,positive
190456.0,"Boston Scientific Narrows FY18 Adj. EPS From $1.37-$1.41 To $1.38-$1.40 vs $1.40 Estimate, Cuts Sales Guidance From $9.8B-$9.88B To $9.787B-$9.827B vs $9.85B Est.",2018-10-24 06:33:00-04:00,BSX,negative
190457.0,"Boston Scientific Sees Q4 Adj. EPS $0.30-$0.32 vs $0.36 Estimate, Sales $2.525B-$2.565B vs $2.58B Estimate",2018-10-24 06:32:00-04:00,BSX,neutral
190458.0,"Boston Scientific Q3 EPS $0.35 Beats $0.34 Estimate, Sales $2.393B Miss $2.4B Estimate",2018-10-24 06:32:00-04:00,BSX,negative
190459.0,"Earnings Scheduled For October 24, 2018",2018-10-24 04:05:00-04:00,BSX,neutral
190460.0,"Boston Scientific Prevails In German Edwards Lifesciences litigation; Court Rules Edwards' Next-Generation Valve Infringes On Co.'s Patent, Grants Right To Enjoin Sales In Germany",2018-10-23 06:52:00-04:00,BSX,neutral
190461.0,Watching Boston Scientific As Traders Circulate Speculation From Dealreporter J&J Could Be Interested In Co.,2018-10-17 09:41:00-04:00,BSX,positive
190462.0,Boston Scientific shares are trading up 4.6% after analysts at Barclays earlier initiated coverage on the stock with an Overweight rating and $43 price target.,2018-10-16 14:06:00-04:00,BSX,negative
190463.0,Surverying The Q3 Earnings Heat Map,2018-10-16 13:30:00-04:00,BSX,neutral
190464.0,"Barclays Initiates Coverage On Boston Scientific with Overweight Rating, Announces $43 Price Target",2018-10-16 07:10:00-04:00,BSX,negative
190465.0,3 Screens That Hint At Which Stocks May Outperform In Q4,2018-10-05 11:57:00-04:00,BSX,neutral
190466.0,"Stocks Which Set New 52-Week High Yesterday, October 2nd",2018-10-03 12:59:00-04:00,BSX,neutral
190467.0,"The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",2018-10-03 07:54:00-04:00,BSX,positive
190468.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,BSX,neutral
190469.0,"Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $48",2018-10-02 07:20:00-04:00,BSX,negative
190470.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,BSX,neutral
190471.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,BSX,neutral
190472.0,"Stocks That Made New 52-Week Highs So Far Today Include: Becton Dickinson, PerkinElmer, TJX Companies, Medtronic, Danaher, Mastercard, Visa, Illumina, Motorola Solutions, Salesforce, Ross Stores, Edward Lifesciences, and Boston Scientific",2018-09-26 12:58:00-04:00,BSX,positive
190473.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,BSX,neutral
190474.0,"Stocks That Made New 52-Week Highs So Far Today Include: Textron, Fiserv, Intuitive Surgical, Mosaic, Paychex, Juniper Networks, F5 Networks, Gartner, Cooper Companies, Edwards Lifesciences, Boston Scientific, Illumina, Yum Brands, and Align Technology",2018-09-25 13:02:00-04:00,BSX,neutral
190475.0,"Stocks Which Set New 52-Week High Yesterday, September 24th",2018-09-25 09:06:00-04:00,BSX,neutral
190476.0,"The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering",2018-09-25 08:30:00-04:00,BSX,negative
190477.0,"Stocks That Made New 52-Week Highs So Far Today Include: Amgen, Ross Stores, Marathon Petroleum, Marathon Oil, Medtronic, Humana, Pfizer, Boston Scientific, Edward Lifesciences, and Abbott Labs",2018-09-24 13:13:00-04:00,BSX,neutral
190478.0,Boston Scientific Earlier Gave an Update on its IMPERIAL Trial,2018-09-24 08:23:00-04:00,BSX,neutral
190479.0,Boston Scientific Receives FDA Approval for the Eluvia Drug-Eluting Vascular Stent System,2018-09-24 06:46:00-04:00,BSX,positive
190480.0,Boston Scientific Announces Eluvia Drug-Eluting Stent Demonstrates Superior Results in IMPERIAL Trial,2018-09-22 13:38:00-04:00,BSX,positive
190481.0,"Stocks Which Set New 52-Week High Yesterday, September 20th",2018-09-21 08:16:00-04:00,BSX,neutral
190482.0,Boston Scientific Launches LithoVue Empower Retrieval Deployment Device,2018-09-21 04:08:00-04:00,BSX,neutral
190483.0,"Stocks That Made New 52-Week Highs So Far Today Include: Corning, Visa, Pfizer, ADP, Anthem, Microsoft, Nike, Sherwin-Williams, Lowe's, Honeywell, Yum Brands, Medtronic, ConocoPhillips, Amgen, Cooper Companies, and Boston Scientific",2018-09-20 12:04:00-04:00,BSX,neutral
190484.0,"The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering",2018-09-19 08:47:00-04:00,BSX,negative
190485.0,"Stocks That Made New 52-Week Highs So Far Today Include: Allegion, Boston Scientific, Arthur J. Gallagher, United Technologies, Waste Management, Qualcomm, Pfizer, Mastercard, Nike, Lowe's, Union Pacific, Norfolk Southern, and Aetna",2018-09-18 14:21:00-04:00,BSX,neutral
190486.0,"Wells Fargo Maintains Outperform on Boston Scientific, Raises Price Target to $42",2018-09-17 09:30:00-04:00,BSX,positive
190487.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,BSX,neutral
190488.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,BSX,neutral
190489.0,"Stocks That Made New 52-Week Highs So Far Today Include: NiSource, Pfizer, United Continental, UDR, Kellogg, Arthur J. Gallagher, PerkinElmer, Paypal, Thermo Fisher, Honeywell, Visa, American Express, Nike, Intuit, Boston Scientific, Microsoft, and AMD",2018-09-13 11:43:00-04:00,BSX,positive
190490.0,"The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Wallet, Advaxis Offering",2018-09-07 07:55:00-04:00,BSX,neutral
190491.0,"Boston Scientific To Acquire Augmenix For $500M Cash Upfront, Up to $100M in Milestone Payments",2018-09-06 16:45:00-04:00,BSX,neutral
190492.0,10 Biggest Price Target Changes For Tuesday,2018-09-04 09:45:00-04:00,BSX,neutral
190493.0,"Benzinga's Top Upgrades, Downgrades For September 4, 2018",2018-09-04 09:17:00-04:00,BSX,positive
190494.0,"Jefferies Upgrades Boston Scientific to Buy, Raises Price Target to $42",2018-09-04 08:37:00-04:00,BSX,neutral
190495.0,"Raymond James Maintains Strong Buy on Boston Scientific, Raises Price Target to $41",2018-09-04 07:59:00-04:00,BSX,positive
190496.0,Jefferies Upgrades Boston Scientific to Buy from Hold; Raises Price Target to $42 from $34,2018-09-04 05:08:00-04:00,BSX,neutral
190497.0,Jana Partners 13F Shows Reduced Stake In Boston Scientific From ~4.72M Shares To ~3.14M Shares,2018-08-14 09:48:00-04:00,BSX,positive
190498.0,"Boston Scientific Announces Agreement to Acquire VENITI, Inc. For $108M In Cash Up Front And $52M In Payments Contingent On FDA Approval Of VICI Stent System",2018-08-08 06:47:00-04:00,BSX,positive
190499.0,"Nevro Reports Co., Boston Scientific Have Filed To Dismiss Remaining Claims; Boston Scientific Represents It Has No Plans to Launch High Frequency Products",2018-07-30 08:34:00-04:00,BSX,negative
190500.0,Buying The Dip In Nevro Pays Off For Investors After Court Ruling,2018-07-25 15:22:00-04:00,BSX,neutral
190501.0,22 Stocks Moving In Wednesday's Pre-Market Session,2018-07-25 08:01:00-04:00,BSX,neutral
190502.0,A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings,2018-07-25 06:50:00-04:00,BSX,neutral
190503.0,"Boston Scientific Narrows FY18 Guidance From $9.75-$9.90B To $9.80-$9.88B, Sees Adj EPS $1.37-$1.41 vs $1.39 Est.",2018-07-25 06:32:00-04:00,BSX,neutral
190504.0,"Boston Scientific Q2 EPS $0.41 Beats $0.34 Estimate, Sales $2.49B Beat $2.47B Estimate",2018-07-25 06:31:00-04:00,BSX,neutral
190505.0,"Earnings Scheduled For July 25, 2018",2018-07-25 04:23:00-04:00,BSX,neutral
190506.0,Nevro Announces Patent Litigation Update; Says Court Found that Boston Scientific is Not Currently Infringing Six Upheld Method Claims,2018-07-25 03:48:00-04:00,BSX,negative
190507.0,Boston Scientific Reports Recommendation For Shareholders to Reject Mini Tender Offer By TRC Capital,2018-07-24 16:45:00-04:00,BSX,negative
190508.0,"UPDATE: US District Court Doc Related To Boston Scientific, Nevro Shows 'Motions To Strike Filed By Both Parties Are Denied As Moot'",2018-07-24 15:49:00-04:00,BSX,negative
190509.0,"Boston Scientific Reports Purchase Of Claret Medical For $220M In Upfront Cash, Potential Reimbursement-Based Milestone Payment Of Up To $50M",2018-07-20 06:45:00-04:00,BSX,neutral
190510.0,Nevro Shares Down 16.2%; Price Action May Or May Not Be Related To Traders Passing Media Report Out Yesterday Highlighting Action Last Week In The Co.'s Patent Suit With Boston Scientific,2018-07-10 14:56:00-04:00,BSX,positive
190511.0,"Boston Scientific to Acquire Remaining 65% Of Cryterion Medical, Inc. For $202M Cash",2018-07-05 08:35:00-04:00,BSX,neutral
190512.0,"Bernstein Initiates Coverage On Boston Scientific with Outperform Rating, Announces $38 Price Target",2018-06-27 07:59:00-04:00,BSX,neutral
190513.0,Stryker 8-K Shows Co. 'not in discussions with Boston Scientific Corporation regarding a potential acquisition',2018-06-13 08:06:00-04:00,BSX,neutral
190514.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Jun. 12, 2018",2018-06-12 12:31:00-04:00,BSX,positive
190515.0,Benzinga Pro's 5 Stocks To Watch Today,2018-06-12 09:23:00-04:00,BSX,neutral
190516.0,44 Biggest Movers From Yesterday,2018-06-12 04:49:00-04:00,BSX,neutral
190517.0,"Boston Scientific 8K Indicates Co. Is Aware Of Reports Speculating That It Has Been Approached By Stryker, Says Co. Does Not Comment On Market Rumors Or Speculation",2018-06-11 14:56:00-04:00,BSX,neutral
190518.0,Boston Scientific Halted On Stryker Takeover Approach,2018-06-11 14:43:00-04:00,BSX,neutral
190519.0,Boston Scientific Shares Halted News Pending,2018-06-11 12:56:00-04:00,BSX,positive
190520.0,Hearing Stifel Analyst On Boston Scientific Said Any Bid For Co. Would Have To Be Above $40/Share,2018-06-11 12:34:00-04:00,BSX,neutral
190521.0,32 Stocks Moving In Monday's Mid-Day Session,2018-06-11 12:25:00-04:00,BSX,neutral
190522.0,Hearing Wells Fargo Analyst Has Said Boston Scientific Could Be Valued At $42/Share Based On Becton Dickinson/CR Bard Deal,2018-06-11 12:00:00-04:00,BSX,positive
190523.0,Boston Scientific Option Alert: Jun 29 $33 Calls Sweep (6) near the Ask: 500 @ $2.0 vs 1000 OI; Earnings 7/26 Before Open [est] Ref=$34.955,2018-06-11 10:44:00-04:00,BSX,positive
190524.0,"Boston Scientific Shares Resume Trade, Continue Higher, Now Up 9.6% For Session",2018-06-11 10:39:00-04:00,BSX,positive
190525.0,Boston Scientific Shares Expected To Resume Trade At 10:35:19 a.m. EDT,2018-06-11 10:34:00-04:00,BSX,positive
190526.0,"Stryker Shares Fall To Session Low, Now Down 1.8%, Following Report Co. Approached Boston Scientific Related To Takeover",2018-06-11 10:32:00-04:00,BSX,neutral
190527.0,"Boston Scientific Shares Spike 6% Higher, Halted On Circuit Breaker; Stryker Made Takeover Approach To Co.",2018-06-11 10:31:00-04:00,BSX,positive
190528.0,"Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs",2018-06-08 09:20:00-04:00,BSX,positive
190529.0,"Bernstein Strategic Decisions Conference Continues Today, Presenters Include: American Express, Home Depot, Wells Fargo, 3M, Danaher, Kimberly Clark, ConocoPhillips, Tupperware, Occidental Petroleum, Boston Scientific, Boeing, Wendy's, and Mondolez",2018-05-31 08:35:00-04:00,BSX,positive
190530.0,UPDATE: Boston Scientific Sees Added Net Interest Of $305M Through Expected Date Of Payment,2018-05-31 07:14:00-04:00,BSX,positive
190531.0,UPDATE: Boston Scientific Says Final Recalculations Of Tax Liabilities Including Added Items Will Result In Net Tax Payments For Tax Court And Appeals Periods Of $303M,2018-05-31 07:14:00-04:00,BSX,negative
190532.0,"Boston Scientific 8-K Shows Final Condition Contained In Stipulations Of Settled Issues With IRS Were Satisfied, Parties Filed Final Stipulated Decisions To Be Entered In Tax Court Concluding All Disputes",2018-05-31 07:13:00-04:00,BSX,positive
190533.0,20 Stocks Moving In Wednesday's Pre-Market Session,2018-05-23 08:36:00-04:00,BSX,neutral
190534.0,"Benzinga's Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict",2018-05-22 08:05:00-04:00,BSX,positive
190535.0,"Stocks That Made New 52-Week Highs Today Include: Moody's, Macy's, Zions Bancorp, T. Rowe Price, VeriSign, ADP, Boston Scientific, Expeditors International",2018-05-21 11:53:00-04:00,BSX,neutral
190536.0,"Jim Cramer Gives His Opinion On Boston Scientific, Lennar And Discover Financial",2018-05-17 07:22:00-04:00,BSX,neutral
190537.0,13F From David Tepper's Appaloosa Shows Decreased Stake In Boston Scientific From 4.78M Shares To 3.91M Shares,2018-05-15 16:31:00-04:00,BSX,positive
190538.0,26 Stocks Moving In Monday's Pre-Market Session,2018-05-14 08:18:00-04:00,BSX,neutral
190539.0,"Boston Scientific Says There's No New Developments With Transvaginal Mesh Issue, Expects 60 Minutes Will Cover Information That Is Already Publicly Available",2018-05-11 11:30:00-04:00,BSX,negative
190540.0,Canaccord: Buy The Dip In Nevro After Disappointing Quarterly Report,2018-05-08 14:24:00-04:00,BSX,negative
190541.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,BSX,neutral
190542.0,"Stocks That Made New 52-Week Highs Today Include: IHS Markit, E*TRADE, Boston Scientific, Red Hat, Sysco, Illumina, Mastercard, Anadarko Petroleum, and Citrix Systems",2018-05-07 15:51:00-04:00,BSX,neutral
190543.0,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street,2018-04-25 07:23:00-04:00,BSX,negative
190544.0,"Boston Scientific Sees Q2 Adj. EPS $0.33 to $0.35 vs $0.35 Est., Sales $2.45B to $2.50B vs $2.44B Est.",2018-04-25 06:34:00-04:00,BSX,neutral
190545.0,"Boston Scientific Raises FY18 Adj. EPS Guidance From $1.35-$1.39 to $1.37-$1.41 vs $1.37 Est., Raises FY 18 Sales Guidance From $9.65B-$9.80B to $9.75B-$9.90B vs $9.75B Est.",2018-04-25 06:33:00-04:00,BSX,neutral
190546.0,"Boston Scientific Reports Q1 Adj. EPS $0.33 Beats $0.32 Est., Sales $2.38B Beats $2.34B Est.",2018-04-25 06:32:00-04:00,BSX,neutral
190547.0,"Earnings Scheduled For April 25, 2018",2018-04-25 04:25:00-04:00,BSX,neutral
190548.0,"Boston Scientific Offers 1-Year Data From INTERPID Study For Parkinson's In US: Study Evaluated 292 Patients In 23 Sites And Successfully Met Primary, Secondary Endpoints",2018-04-24 06:34:00-04:00,BSX,positive
190549.0,"Boston Scientific Announces It Has Successfully Opposed Edwards Lifesciences In European Patent Dispute, Says European Patent Office Revokes Edward Lifescience's '550 Patent",2018-04-16 16:46:00-04:00,BSX,positive
190550.0,Boston Scientific Reports Purchase Of nVision Medical For Upfront Payment Of $150M Plus Added Milestones Of Up To $125M,2018-04-16 06:31:00-04:00,BSX,neutral
190551.0,"Benzinga's Top Analyst Calls From April 5, 2018",2018-04-05 14:43:00-04:00,BSX,positive
190552.0,"Boston Scientific Acquires Remaining Stake Of Securus Medical Group At $40M, With Up To $10M In Contingent Payments",2018-04-03 07:03:00-04:00,BSX,neutral
190553.0,Edwards Lifescience Announces It Has Prevailed In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid,2018-03-23 16:51:00-04:00,BSX,neutral
190554.0,Boston Scientific Reports Deal To Buy NxThera For Upfront Cash Payment Of $306M And Up To Added $100M In Potential Commercial Milestone Payments,2018-03-21 06:46:00-04:00,BSX,neutral
190555.0,"Boston Scientific Reports Trial Data Further Showed Safety, Effectiveness Of RHYTHMIA Mapping System",2018-03-20 07:02:00-04:00,BSX,positive
190556.0,"Boston Scientific Announces Acquisition of EMcision, Terms Not Disclosed",2018-03-05 06:30:00-05:00,BSX,neutral
190557.0,13F From David Tepper's Appaloosa Shows Raised Stake In Boston Scientific,2018-02-14 17:03:00-05:00,BSX,neutral
190558.0,Traders Circulating Chatroom Rumor of Activist Interest In Boston Scientific,2018-02-05 09:54:00-05:00,BSX,positive
190559.0,"Watch Shares of Boston Scientific, Hearing Jana Took an Activist Stake in the Stock",2018-02-05 09:50:00-05:00,BSX,positive
190560.0,"Boston Scientific Sees FY18 Adj. EPS $1.35-$1.39 vs $1.38 Est., Sales $9.65B-$9.8B vs $9.61B Est.",2018-02-01 06:31:00-05:00,BSX,neutral
190561.0,"Boston Scientific Sees Q1 Adj. EPS $0.30-$0.32 vs $0.32 Est., Sales $2.32B-$2.35B Vs $2.32B Est.",2018-02-01 06:31:00-05:00,BSX,neutral
190562.0,"Boston Scientific Reports Q4 Adj. EPS $0.34, Inline, Sales $2.408B vs $2.38B Est.",2018-02-01 06:30:00-05:00,BSX,neutral
190563.0,"Earnings Scheduled For February 1, 2018",2018-02-01 04:39:00-05:00,BSX,neutral
190564.0,Boston Scientific's Millipede Deal To Aid MR Business,2018-01-26 11:17:00-05:00,BSX,neutral
190565.0,"Boston Scientific Reports Investment, Acquisition Option Deal With Millipede For Total Consideration Of $90M; Completion Of Acquisition Would Results In Added $325M Payment By Boston Scientific At Closing, Further $125M Upon Milestones",2018-01-24 07:32:00-05:00,BSX,neutral
190566.0,The Top 10 Value Stocks In The S&P 500,2018-01-19 13:12:00-05:00,BSX,positive
190567.0,Boston Scientific Fortifies Pain Therapy Arm With FDA Nod,2018-01-16 10:58:00-05:00,BSX,negative
190568.0,"Boston Scientific Announces Positive Results from WHISPER Spinal Cord Stimulation Study, Says Trail Shows Effectiveness Of Long-Term Treatment With Sub-Perception Spinal Cord Stimulation",2018-01-12 10:37:00-05:00,BSX,positive
190569.0,Boston Scientific Announces FDA Approval for Spectra WaveWriter Spinal Cord Stimulator,2018-01-11 06:33:00-05:00,BSX,positive
190570.0,Boston Scientific Raises Q4 Sales Guidance from $2.35B-2.38B to $2.41B vs $2.35B Est,2018-01-09 06:32:00-05:00,BSX,neutral
190571.0,"No Fundamental Reason For Boston Scientific Shares' Underperformance, RBC Upgrades Stock",2018-01-05 16:57:00-05:00,BSX,neutral
190572.0,"Benzinga's Top Upgrades, Downgrades For January 5, 2018",2018-01-05 09:11:00-05:00,BSX,positive
190573.0,RBC Capital Upgrades Boston Scientific to Top Pick,2018-01-05 08:23:00-05:00,BSX,positive
190574.0,"Goldman Sachs Healthcare CEOs Unscripted Conference Taking Place Today; Presenters Include Agilent, Bluebird Bio, Boston Scientific, Alexion, Eli Lilly, and Alnylam",2018-01-04 06:54:00-05:00,BSX,neutral
190575.0,"Evercore ISI Group Initiates Coverage On Boston Scientific with In-Line Rating, Announces $27.00 Price Target",2018-01-03 08:12:00-05:00,BSX,neutral
190576.0,Stephens' Analysts Present Their Best Ideas For 2018,2018-01-02 14:19:00-05:00,BSX,positive
190577.0,Boston Scientific Receives FDA Approval For Vercise,2017-12-11 17:04:00-05:00,BSX,positive
190578.0,6 Reasons Why Needham Upgraded Boston Scientific,2017-12-08 16:33:00-05:00,BSX,neutral
190579.0,Boston Scientific Option Alert: Dec 29 $25.5 Calls at the Ask: 1000 @ $0.641 vs 28 OI; Ref=$25.62,2017-12-08 15:21:00-05:00,BSX,positive
190580.0,Boston Scientific Option Alert: Dec 29 $25.5 Calls at the Ask: 1000 @ $0.641 vs 28 OI; Ref=$25.62,2017-12-08 15:21:00-05:00,BSX,positive
190581.0,Boston Scientific Option Alert: Dec 29 $25.5 Calls at the Ask: 1000 @ $0.641 vs 28 OI; Ref=$25.62,2017-12-08 15:21:00-05:00,BSX,positive
190582.0,"Benzinga's Top Upgrades, Downgrades For December 8, 2017",2017-12-08 09:07:00-05:00,BSX,positive
190583.0,Needham Upgrades Boston Scientific to Strong Buy,2017-12-08 07:23:00-05:00,BSX,positive
190584.0,"Lightning Round: Jim Cramer Weighs In On Boston Scientific, Masco, ADP And More",2017-12-01 07:48:00-05:00,BSX,neutral
190585.0,UPDATE: BTIG Earlier Upgrade Boston Scientific Shares To Buy; Analyst Sean Lavin Noted His Concerns Related To Lotus Are Now 'essentially out of the picture',2017-11-30 15:59:00-05:00,BSX,positive
190586.0,"Benzinga's Top Upgrades, Downgrades For November 30, 2017",2017-11-30 09:04:00-05:00,BSX,positive
190587.0,BTIG Research Upgrades Boston Scientific to Buy,2017-11-30 07:00:00-05:00,BSX,neutral
190588.0,JPMorgan: Buy The Boston Scientific Dip,2017-11-29 12:16:00-05:00,BSX,neutral
190589.0,"Boston Scientific Announces Delay to Previously Communicated Timelines for Commercialization of LOTUS Edge Aortic Valve System in Europe, U.S.",2017-11-29 04:20:00-05:00,BSX,negative
190590.0,"Hearing Wells Fargo Out Positive On Boston Scientific, Says There Checks Say There Are No New Issues With Lotus, Recommends To Buy Weakness",2017-11-28 14:02:00-05:00,BSX,positive
190591.0,"Boston Scientific, Abbott Shares Fall As Traders Circulate NY Times Article ''Unbelievable': Heart Stents Fail to Ease Chest Pain'",2017-11-02 13:46:00-04:00,BSX,negative
190592.0,Amazon Pharmacy Rumors Heating Up Again: Here's What We Know,2017-10-30 13:45:00-04:00,BSX,positive
190593.0,"Boston Scientific Raises FY17 Adj. EPS Outlook From $1.23-$1.27 to $1.24-$1.27 vs $1.26 Est., Sales $8.985B-$9.015B vs $8.95B Est.",2017-10-26 16:07:00-04:00,BSX,neutral
190594.0,"Boston Scientific Sees Q4 Adj. EPS $0.32-$0.35 vs $0.34 Est., Sales $2.345B-$2.375B vs $2.33B Est.",2017-10-26 16:06:00-04:00,BSX,neutral
190595.0,"Boston Scientific Reports Q3 Adj. EPS $0.31 In-line With Est., Sales $2.22B vs $2.21B Est.",2017-10-26 16:05:00-04:00,BSX,neutral
190596.0,"Boston Scientific Narrows FY17 Adj. EPS Outlook From $1.23-$1.27 To $1.24-$1.27 vs $1.26 Est., Sales $8.985B-$9.015B vs $8.95B Est.",2017-10-26 06:34:00-04:00,BSX,neutral
190597.0,"Boston Scientific Sees Q4 Adj. EPS $0.32-$0.35 vs $0.34 Est., Sales $2.345B-$2.375B vs $2.33B Est.",2017-10-26 06:33:00-04:00,BSX,neutral
190598.0,"Boston Scientific Reports Q3 Adj. EPS $0.31, Inline, Sales $2.222B vs $2.21B Est.",2017-10-26 06:33:00-04:00,BSX,neutral
190599.0,"Earnings Scheduled For October 26, 2017",2017-10-26 04:20:00-04:00,BSX,neutral
190600.0,Boston Scientific May Now Have The Strongest Pipeline In Company History,2017-10-24 12:04:00-04:00,BSX,positive
190601.0,"Benzinga's Top Upgrades, Downgrades For October 24, 2017",2017-10-24 09:20:00-04:00,BSX,positive
190602.0,"Canaccord Genuity Initiates Coverage On Boston Scientific with Buy Rating, Announces $36.00 Price Target",2017-10-24 07:53:00-04:00,BSX,neutral
190603.0,Benzinga's Option Alert Recap From October 20,2017-10-20 16:55:00-04:00,BSX,positive
190604.0,Boston Scientific Option Alert: Nov 17 $29 Puts at the Ask: 4915 @ $0.531 vs 830 OI; Ref=$29.59,2017-10-20 11:25:00-04:00,BSX,positive
190605.0,"Boston Scientific Reports Deal To Buy Apama Medical For $175M In Cash Upfront, Maximum $125M In Continent Payments",2017-10-02 16:19:00-04:00,BSX,neutral
190606.0,A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Fed Speakers,2017-09-25 07:33:00-04:00,BSX,negative
190607.0,Boston Scientific Announces FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate Devices,2017-09-25 07:09:00-04:00,BSX,positive
190608.0,"Lightning Round: Jim Cramer Gives His Opinion On Blue Apron, Philip Morris And More",2017-08-08 06:57:00-04:00,BSX,neutral
190609.0,"Boston Scientific Reports Q2 Adj. EPS $0.32 vs $0.31 Est., Sales $2.257B vs $2.21B Est.",2017-07-27 06:33:00-04:00,BSX,neutral
190610.0,"Earnings Scheduled For July 27, 2017",2017-07-27 05:07:00-04:00,BSX,neutral
190611.0,FDA's 60-Day Extension For Medical Device Defects Not Likely Obstructive To Public Health,2017-07-14 08:26:00-04:00,BSX,negative
190612.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-07-12 08:06:00-04:00,BSX,neutral
190613.0,5 Biggest Price Target Changes For Wednesday,2017-06-28 10:32:00-04:00,BSX,neutral
190614.0,"Companies Holding Analyst/Investor Days Today Include Diplomat Pharmacy, Allianz, Louisiana-Pacific, Akebia Therapeutics, and Boston Scientific",2017-06-27 09:19:00-04:00,BSX,neutral
190615.0,Boston Scientific Sees Global Markets Addressed By Co. Products Growing From $40B Today To $50B+ By 2020,2017-06-27 07:37:00-04:00,BSX,positive
190616.0,Non-Horrible Bosses: Meet The Best CEOs Of 2017,2017-06-21 07:06:00-04:00,BSX,positive
190617.0,U.S. Lawmakers Urge India to Reconsider Price Cap on Heart Stents -Reuters,2017-06-19 04:29:00-04:00,BSX,neutral
190618.0,India Regulator Seeks Four Additional Medical Devices to be Added to Price Control List -Reuters,2017-06-07 04:52:00-04:00,BSX,neutral
190619.0,Boston Scientific Reports Co. Received CE Mark for Vercise Gevia Deep Brain Stimulation System,2017-06-06 06:31:00-04:00,BSX,neutral
190620.0,"Seeing Notable Block Trade In Boston Scientific: 944,910 Shares At $27.10",2017-05-31 12:12:00-04:00,BSX,negative
190621.0,"Boston Scientific Publishes Data From Bornchial Thermoplasty Study In Severe Persistent Asthma, Says Percentage Of Study Participants Who Had At Least One Severe Asthma Exacerbation Decreased 77.8% In Prior Year To 50.4% In Next Year and 46% In Year Two",2017-05-24 09:17:00-04:00,BSX,negative
190622.0,"Bank Of America Health Care Conference Concludes Today; Presenters Include Boston Scientific, Humana, Universal Health, Chemed, Community Health, Eagle Pharma, Alnylam, Gilead, & Illumina",2017-05-18 08:53:00-04:00,BSX,positive
190623.0,"Goldman Sachs Initiates Coverage On Boston Scientific with Neutral Rating, Announces $28.00 Price Target",2017-05-16 07:21:00-04:00,BSX,neutral
190624.0,Boston Scientific Announces Positive European Registry Results For WATCHMAN Left Atrial Appendage Closure Device,2017-05-12 12:26:00-04:00,BSX,positive
190625.0,Boston Scientific Announces Results From U.S. Post-Market Approval Study Of Patients With S-ICD System Implants,2017-05-11 13:07:00-04:00,BSX,positive
190626.0,Seeing Notable Block Trade In Boston Scientific: ~ 813K Shares At $26.40,2017-05-11 09:38:00-04:00,BSX,negative
190627.0,Boston Scientific Reports Received FDA Approval for Resonate Family,2017-05-09 06:38:00-04:00,BSX,positive
190628.0,"Companies Holding Shareholder Meetings Today Include; Capitala Finance, Gildan Activewear, UPS, Alaska Air, Allergan, Boston Scientific, & Verizon",2017-05-04 08:31:00-04:00,BSX,neutral
190629.0,"Seeing Notable Block Trade In Boston Scientific; 1,377,621 Shares Traded at $26.10",2017-04-27 14:51:00-04:00,BSX,negative
190630.0,UPDATE: Boston Scientific Raises FY17 Sales from $8.675B-$8.875B to $8.8B-$8.9B vs $8.78B Est.,2017-04-27 06:34:00-04:00,BSX,neutral
190631.0,Boston Scientific Raises FY Outlook,2017-04-27 06:33:00-04:00,BSX,neutral
190632.0,"Boston Scientific Sees Q2 Adj. EPS $0.30-$0.32 vs $0.31 Est., Sales $2.185B-$2.215B vs $2.21B Est.",2017-04-27 06:32:00-04:00,BSX,neutral
190633.0,"Boston Scientific Reports Q1 Adj. EPS $0.29 vs $0.30 Est., Sales $2.16B vs $2.08B Est.",2017-04-27 06:32:00-04:00,BSX,neutral
190634.0,"Earnings Scheduled For April 27, 2017",2017-04-27 06:30:00-04:00,BSX,neutral
190635.0,Global Market For Medical Implants To Hit Nearly $27 Billion In 5 Years,2017-04-25 15:59:00-04:00,BSX,neutral
190636.0,Boston Scientific Reports Initiation of Global Study to Assess Sudden Cardiac Arrest Prevention Therapy in Patients With Diabetes Who Have Previously Experienced A Heart Attack,2017-04-18 16:19:00-04:00,BSX,negative
190637.0,Neovasc Shares Indicated ~11% Higher; Hearing JMP Has Suggested Co. Could be Purchased by Boston Scientific,2017-03-31 09:18:00-04:00,BSX,positive
190638.0,Boston Scientific Announces Agreement to Acquire Symetis for $435M in Cash Upfront,2017-03-30 06:03:00-04:00,BSX,positive
190639.0,Boston Scientific Anno8unces NICE Recommends CRT-D Devices Powered By EnduraLife Battery Technology for Treatment of Heart Failure,2017-03-17 04:17:00-04:00,BSX,positive
190640.0,Edwards Lifesciences Announces German Court Boston Scientifc's Lotus Valve Infringes One Patent,2017-03-09 06:47:00-05:00,BSX,neutral
190641.0,Boston Scientific Announces Favorable Rulings In Edwards Lifesciences Litigation,2017-03-09 05:59:00-05:00,BSX,positive
190642.0,Edwards Lifesciences Says it Will Appeal a UK Court's Decision That One Patent Asserted by Boston Scientific Against SAPIEN 3 is Valid and One is Invalid,2017-03-03 06:54:00-05:00,BSX,neutral
190643.0,Boston Scientific Says They Expect To Bring Lotus Valve Platform Back To European Markets In Q4 2017,2017-02-23 08:16:00-05:00,BSX,neutral
190644.0,Option Alert: Boston Scientific May $28 Call; 2000 @Bid @$0.40,2017-02-21 10:55:00-05:00,BSX,positive
190645.0,U.S. Supreme Court Rejects Boston Scientific Appeal Of $308M Patent Licensing Dispute Verdict,2017-02-21 09:32:00-05:00,BSX,negative
190646.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-02-07 08:15:00-05:00,BSX,neutral
190647.0,"The Market In 5 Minutes: Facebook Beats, Trump Tweets",2017-02-02 09:27:00-05:00,BSX,neutral
190648.0,"Boston Scientific Sees FY17 Adj. EPS $1.22-$1.26 vs $1.25 Est., Sales $8.675B-$8.875B vs $8.78B Est.",2017-02-02 06:33:00-05:00,BSX,neutral
190649.0,"Boston Scientific Sees Q1 Adj. EPS $0.29-$0.31 vs $0.29 Est., Sales $2.05B-$2.1B vs $2.07B Est.",2017-02-02 06:33:00-05:00,BSX,neutral
190650.0,"Boston Scientific Reports Q4 Adj. EPS $0.30 vs $0.29 Est., Sales $2.191B vs $2.16B Est.",2017-02-02 06:32:00-05:00,BSX,neutral
190651.0,Watch These 7 Huge Put Purchases In Monday Trade,2017-01-23 04:27:00-05:00,BSX,positive
190652.0,Option Alert: Boston Scientific May 23.0 Puts Sweep: 501 @  ASK  $1.02: 957 traded vs 91 OI:  Earnings 2/2 Before Open  $23.77 Ref,2017-01-20 10:29:00-05:00,BSX,positive
190653.0,"JP Morgan Maintains Boston Scientific as a Top Pick, Reiterates Overweight; Highlights 'Upbeat' Comments from Co. Chair, CEO Mahoney During JP Morgan Healthcare Conference Presentation",2017-01-10 12:00:00-05:00,BSX,positive
190654.0,The MedTech Group: 2017 Top Picks And Catalysts,2017-01-06 10:35:00-05:00,BSX,positive
190655.0,15 Stocks Moving In Tuesday's Pre-Market Session,2016-12-27 08:24:00-05:00,BSX,neutral
190656.0,Boston Scientific Reports 15% Passive Stake in Neovasc in 13G,2016-12-16 06:14:00-05:00,BSX,positive
190657.0,18 Biggest Mid-Day Losers For Wednesday,2016-12-14 12:56:00-05:00,BSX,negative
190658.0,Mid-Afternoon Market Update: Dow Rises Over 100 Points; Proteon Therapeutics Shares Slide,2016-12-13 14:33:00-05:00,BSX,positive
190659.0,10 Biggest Mid-Day Gainers For Tuesday,2016-12-13 12:42:00-05:00,BSX,neutral
190660.0,Mid-Day Market Update: Inovalon Drops After Lowered Outlook; Achaogen Shares Surge,2016-12-13 12:26:00-05:00,BSX,positive
190661.0,Mid-Morning Market Update: Markets Open Higher; VeriFone Issues Weak Forecast,2016-12-13 09:51:00-05:00,BSX,negative
190662.0,20 Stocks Moving In Tuesday's Pre-Market Session,2016-12-13 08:30:00-05:00,BSX,neutral
190663.0,Boston Scientific to Acquire Certain Neovasc Assets and 15% Equity for $75M,2016-12-13 07:09:00-05:00,BSX,positive
190664.0,Watch These 10 Huge Call Purchases In Monday Trade,2016-12-12 01:55:00-05:00,BSX,positive
190665.0,Boston Scientific Files Patent Lawsuit Against Nevro,2016-12-09 17:24:00-05:00,BSX,negative
190666.0,Option Alert: BSX Feb17 19.0 Calls Sweep: 652 @  ASK  $2.279: 1006 traded vs 73 OI:  Earnings 2/2 Before Open (est)  $20.80 Ref,2016-12-09 15:53:00-05:00,BSX,positive
190667.0,Wonderful Wearables Get Their Own ETF,2016-12-09 15:07:00-05:00,BSX,positive
190668.0,Edwards Lifesciences Paints A Picture Of A Compelling Future,2016-12-09 13:41:00-05:00,BSX,positive
190669.0,Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data,2016-12-07 11:43:00-05:00,BSX,negative
190670.0,Mid-Afternoon Market Update: Crude Oil Up 1%; Five Below Shares Rise On Earnings Beat,2016-12-02 14:26:00-05:00,BSX,negative
190671.0,15 Biggest Mid-Day Gainers For Friday,2016-12-02 12:41:00-05:00,BSX,neutral
190672.0,Mid-Day Market Update: Smith & Wesson Declines On Weak Forecast; Envision Healthcare Shares Spike Higher,2016-12-02 12:15:00-05:00,BSX,negative
190673.0,Mid-Morning Market Update: Markets Mixed; Big Lots Earnings Beat Estimates,2016-12-02 09:50:00-05:00,BSX,neutral
190674.0,25 Stocks Moving In Friday's Pre-Market Session,2016-12-02 08:26:00-05:00,BSX,neutral
190675.0,Neovasc Shares Rise 100% Following Announcement of Agreement with Boston Scientific,2016-12-02 07:40:00-05:00,BSX,positive
190676.0,Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities For $75M In Cash; Includes 15% Equity Investment In Neovasc,2016-12-02 07:01:00-05:00,BSX,positive
190677.0,Boston Scientific Announces Positive Results Of Heartlogic Heart Failure Diagnostic Service,2016-11-16 13:41:00-05:00,BSX,positive
190678.0,Stifel Healthcare Conference Today,2016-11-15 10:53:00-05:00,BSX,neutral
190679.0,"Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access, Terms Not Disclosed",2016-11-15 06:32:00-05:00,BSX,neutral
190680.0,"13F from Paulson & Co. Shows New Stakes in eBay, HP Enterprises, Infblox, Carmike, Increased Stake in Facebook, Boston Scientific, Reduced Stake in J&J, Liquidated Stakes in EMC, B/E Aerospace",2016-11-14 17:46:00-05:00,BSX,positive
190681.0,"Boston Scientific Reports PLATINUM Diversity Study for Promus PREMIER Stent System Showed 'no significant outcome differences between white men and women or minorities for the composite primary endpoint of death, MI or TVR'",2016-11-01 13:16:00-04:00,BSX,negative
190682.0,"Boston Scientific Sees Q4 EPS $0.27 to $0.29 vs $0.29 est, Revenue $2.14B to $2.19B vs $2.15B est",2016-10-26 06:37:00-04:00,BSX,neutral
190683.0,"Boston Scientific Q3 EPS $0.27 vs $0.27 est, Revenue $2.11B vs $2.07B est",2016-10-26 06:36:00-04:00,BSX,neutral
190684.0,Can You Guess This Chart?,2016-10-19 07:42:00-04:00,BSX,neutral
190685.0,Watch These 7 Huge Call Purchases In Tuesday Trade,2016-10-11 02:48:00-04:00,BSX,positive
190686.0,Option Alert: BSX Feb17 25.0 Calls: 2590 @  Above Ask!  $0.95: 3081 traded vs 185 OI:  Earnings 10/26 Before Open  $23.77 Ref,2016-10-10 11:10:00-04:00,BSX,positive
190687.0,Option Alert: BSX Feb17 25.0 Calls: 2590 @  Above Ask!  $0.95: 3081 traded vs 185 OI:  Earnings 10/26 Before Open  $23.77 Ref,2016-10-10 11:10:00-04:00,BSX,positive
190688.0,"Benzinga's M&A Chatter for Tuesday September 27, 2016",2016-09-27 21:01:00-04:00,BSX,neutral
190689.0,Mid-Afternoon Market Update: Dow Rises Over 100 Points; SYNNEX Shares Climb On Earnings Beat,2016-09-27 14:38:00-04:00,BSX,positive
190690.0,15 Biggest Mid-Day Gainers For Tuesday,2016-09-27 12:41:00-04:00,BSX,neutral
190691.0,Mid-Day Market Update: Crude Oil Down 3.5%; EndoChoice Shares Jump Following Boston Scientific Deal,2016-09-27 12:02:00-04:00,BSX,negative
190692.0,Mid-Morning Market Update: Markets Open Higher; FactSet Misses Q4 Views,2016-09-27 10:13:00-04:00,BSX,negative
190693.0,15 Stocks Moving In Tuesday's Pre-Market Session,2016-09-27 08:25:00-04:00,BSX,neutral
190694.0,A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Economic Data,2016-09-27 07:55:00-04:00,BSX,positive
190695.0,EndoChoice to Be Acquired by Boston Scientific for $8/Share Cash,2016-09-27 06:31:00-04:00,BSX,neutral
190696.0,"Argus Upgrades Boston Scientific, Sees Market Share Gains And Strong Growth Ahead",2016-09-01 10:27:00-04:00,BSX,positive
190697.0,Benzinga's Top Upgrades,2016-09-01 08:47:00-04:00,BSX,positive
190698.0,"Argus Research Upgrades Boston Scientific to Buy, Announces $33.00 PT",2016-09-01 07:40:00-04:00,BSX,neutral
190699.0,The Most Popular Stocks This 13F Season,2016-08-16 12:07:00-04:00,BSX,positive
190700.0,"13F from Paulson & Co. Shows Increased Stakes in Boston Scientific, Rite Aid, Office Depot, Facebook",2016-08-15 17:29:00-04:00,BSX,positive
190701.0,Barclays Says Investors Underestimate St. Jude Medical 's Potential,2016-08-12 12:41:00-04:00,BSX,negative
190702.0,Boston Scientific Adds EMBLEM MRI S-ICD System To Its Growing ImageReady MR-Conditional Devices,2016-08-09 07:41:00-04:00,BSX,positive
190703.0,Boston Scientific Announces FDA Approval of Emblem MRI S-ICD System,2016-08-09 07:08:00-04:00,BSX,positive
190704.0,A Peek Into The Markets: U.S. Stock Futures Mostly Flat; Ford Earnings Miss Views,2016-07-28 07:57:00-04:00,BSX,negative
190705.0,"Boston Scientific Q2 Revenue Beats Guidance, Fueled By Deep Portfolio",2016-07-28 07:45:00-04:00,BSX,neutral
190706.0,"Boston Scientific Raises FY16 Adj. EPS from $1.06-$1.10 to $1.07-$1.11, Sales from $8.075B-$8.225B to $8.27B-$8.37B",2016-07-28 06:32:00-04:00,BSX,neutral
190707.0,"Boston Scientific Sees Q3 Adj. EPS $0.25-$0.27, Sales $2.035B-$2.085B",2016-07-28 06:32:00-04:00,BSX,neutral
190708.0,"Boston Scientific Reports Q2 Adj. EPS $0.27 vs $0.22 in Same Qtr. Last Year, Sales $2.126B",2016-07-28 06:31:00-04:00,BSX,neutral
190709.0,"Alphabet, Whole Foods And More: Fast Money Picks For July 28",2016-07-28 06:20:00-04:00,BSX,neutral
190710.0,"Earnings Scheduled For July 28, 2016",2016-07-28 04:03:00-04:00,BSX,neutral
190711.0,Boston Scientific Buys Cosman Medical To Expand Therapeutic Options,2016-07-27 09:50:00-04:00,BSX,positive
190712.0,"Boston Scientific Reports Purchase of Cosman Medical, No Terms Disclosed",2016-07-27 09:01:00-04:00,BSX,negative
190713.0,Option Alert: BSX Aug16 24.0 Puts Sweep: 784 @  ASK  $0.84: 1019 traded vs 697 OI:  Earnings 7/28 Before Open  $23.73 Ref,2016-07-25 15:24:00-04:00,BSX,positive
190714.0,Boston Scientific Settled Issues with IRS Intended to Resolve All Disputes Related to Previously Disclosed Transfer Pricing Issues for Guidant Corporation -8K,2016-07-20 06:39:00-04:00,BSX,positive
190715.0,Option Alert: BSX Aug16 26.0 Calls Sweep: 652 @  ASK  $0.12: 2008 traded vs 322 OI:  Earnings 7/28 Before Open  $23.61 Ref,2016-07-15 11:53:00-04:00,BSX,positive
190716.0,"Barron's Picks And Pans: Arista Networks, Northern Trust, 1-800-Flowers And More",2016-07-09 15:48:00-04:00,BSX,positive
190717.0,Watch These 7 Huge Put Purchases In Friday Trade,2016-07-08 03:01:00-04:00,BSX,positive
190718.0,Option Alert: BSX Jul16 24.0 Puts Sweep: 681 @  ASK  $0.51: 820 traded vs 27 OI:  Earnings 7/28 Before Open  $23.67 Ref,2016-07-07 12:11:00-04:00,BSX,positive
190719.0,Benzinga's Top Initiations,2016-06-09 09:18:00-04:00,BSX,positive
190720.0,Guggenheim Securities Initiates Coverage on Boston Scientific at Buy,2016-06-09 06:19:00-04:00,BSX,positive
190721.0,"Boston Scientific Sees Q2 EPS $0.25 to $0.27 vs $0.27 est, FY EPS $1.06 to $1.10 vs $1.09 est",2016-06-09 06:10:00-04:00,BSX,neutral
190722.0,Boston Scientific Announces Restructuring Program,2016-06-08 19:28:00-04:00,BSX,neutral
190723.0,"Charman Mahoney Sells 100,000 Shares of Boston Scientific @$22.69/Share -Form 4",2016-06-03 07:59:00-04:00,BSX,positive
190724.0,Benzinga's Top Downgrades,2016-05-23 09:22:00-04:00,BSX,positive
190725.0,The Market In 5 Minutes: Merger Monday Mania,2016-05-23 08:58:00-04:00,BSX,neutral
190726.0,BTIG Research Downgrades Boston Scientific to Neutral,2016-05-23 07:17:00-04:00,BSX,neutral
190727.0,Boston Scientific Gets FDA Approval For Precision Montage MRI Spinal Cord Stimulator System,2016-05-19 09:25:00-04:00,BSX,positive
190728.0,RBC Confident That Boston Scientific Is A Multi-Year Revenue Growth Story,2016-05-12 10:11:00-04:00,BSX,positive
190729.0,"Global X Adds To Thematic Lineup With Longevity, Health & Wellness ETFs",2016-05-11 10:08:00-04:00,BSX,positive
190730.0,Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters,2016-05-03 16:41:00-04:00,BSX,positive
190731.0,Stocks Hitting 52-Week Highs,2016-04-27 10:01:00-04:00,BSX,neutral
190732.0,"Boston Scientific Sees Q2 EPS $0.25 to $0.27 vs $0.26 est, Revenue $2.01B to $2.06B vs $2.01B est",2016-04-27 06:33:00-04:00,BSX,neutral
190733.0,"Boston Scientific Raises Guidance; Sees FY 2016 EPS $1.06 to $1.10 vs $1.05 est, Revenue $808B to $8.23B vs $8.02B est",2016-04-27 06:32:00-04:00,BSX,neutral
190734.0,"Boston Scientific Q1 EPS $0.28 vs $0.24 est, Revenue $1.96B vs $1.91B est",2016-04-27 06:31:00-04:00,BSX,neutral
190735.0,"Earnings Scheduled For April 27, 2016",2016-04-27 04:01:00-04:00,BSX,neutral
190736.0,Boston Scientific Reports FDA Approval for ImageReady MR-Conditional Pacing System,2016-04-25 16:30:00-04:00,BSX,positive
190737.0,Boston Scientific Reports CE Mark for MRI Labeling of Emblem S-ICD Systems,2016-04-20 07:01:00-04:00,BSX,neutral
190738.0,Boston Scientific: RBC's Channel Checks Point To Upside Not Baked In Stock Price,2016-04-12 09:55:00-04:00,BSX,neutral
190739.0,Boston Scientific Announces Voluntary Recall of Fetch 2 Aspiration Catheter,2016-04-08 16:30:00-04:00,BSX,neutral
190740.0,"Citigroup Positive On Boston Scientific's 2017 Outlook, Sees Upside For Co's Facility Volumes, Maintains Buy And $23 PT",2016-03-29 06:05:00-04:00,BSX,positive
190741.0,BofA's Favorite MedTech Picks Right Now,2016-03-24 08:40:00-04:00,BSX,positive
190742.0,"Boston Scientific Reports Launch of AXIOS Stent, Electrocautery Enhanced Delivery System",2016-03-22 08:32:00-04:00,BSX,neutral
190743.0,Benzinga's Top Initiations,2016-03-18 09:12:00-04:00,BSX,positive
190744.0,"Nomura Starts MedTech Group: STJ, BSX, ZBH, EW, MDT, SYK At Buy, BCR At Neutral",2016-03-17 10:04:00-04:00,BSX,neutral
190745.0,Benzinga's Top Initiations,2016-03-17 09:19:00-04:00,BSX,positive
190746.0,"Nomura Initiates Coverage on Boston Scientific at Buy, Announces $22.00 PT",2016-03-17 04:15:00-04:00,BSX,neutral
190747.0,"Boston Scientific, May Clinic Partner To Speed Medical Device Development",2016-03-16 16:34:00-04:00,BSX,neutral
190748.0,Boston Scientific Receives U.S. FDA Approval For Blazer Open-Irrigated Catheter,2016-03-10 16:35:00-05:00,BSX,positive
190749.0,Benzinga's Top Initiations,2016-02-25 09:35:00-05:00,BSX,positive
190750.0,Corindus Vascular Robotics Hires Ex-Boston Scientific Executive As CEO,2016-02-25 07:43:00-05:00,BSX,neutral
190751.0,SunTrust Robinson Humphrey Initiates Coverage on Boston Scientific at Buy,2016-02-25 06:49:00-05:00,BSX,neutral
190752.0,Boston Scientific Says Chairman Pete Nicholas to Retire; President and CEO Mike Mahoney to Become Chairman,2016-02-25 06:33:00-05:00,BSX,neutral
190753.0,"Boston Scientific Reports FDA Approval for Quadripolar Leads, Reports Initiation of Global Trial to Expand MRI Labeling to US, Asia",2016-02-23 07:05:00-05:00,BSX,positive
190754.0,"Boston Scientific Reports Received CE Mark for Eluvia Stent, Initiates New Clinical Trial",2016-02-22 08:06:00-05:00,BSX,neutral
190755.0,Boston Scientific +2.5% After-Hours; May be Attributed to CMS Decision Memo for Percutaneous Left Atrial Appendage Closure Therapy,2016-02-08 17:19:00-05:00,BSX,neutral
190756.0,Earnings Recap For February 4,2016-02-04 16:59:00-05:00,BSX,neutral
190757.0,"Boston Scientific Sees FY 2016 EPS $1.03 to $1.07 vs $1.05 est, Revenue $7.9B to $8.1B vs $8.1B est",2016-02-04 06:33:00-05:00,BSX,neutral
190758.0,"Boston Scientific Q4 EPS $0.26 vs $0.25 est, Revenue $1.98B vs $1.99B est",2016-02-04 06:32:00-05:00,BSX,neutral
190759.0,"10 Stocks To Watch For February 4, 2016",2016-02-04 04:31:00-05:00,BSX,neutral
190760.0,"Earnings Scheduled For February 4, 2016",2016-02-04 04:13:00-05:00,BSX,neutral
190761.0,Option Alert: BSX Feb16 18.0 Calls Sweep: 2634 @  ASK  $0.21: 2634 traded vs 2569 OI:  Earnings 2/4 Before Open  $16.93 Ref,2016-01-28 14:24:00-05:00,BSX,positive
190762.0,The Medical Device Sector Is Alive,2016-01-19 09:41:00-05:00,BSX,positive
190763.0,Boston Scientific Launches The LithoVue Single-Use Digital Flexible Ureteroscope In U.S. And Europe,2016-01-12 08:33:00-05:00,BSX,positive
190764.0,Butcofski: The Replacement Parts Are Holding Up Well In Boston Scientific,2015-12-29 11:21:00-05:00,BSX,positive
190765.0,Boston Scientific Reports Voluntary Recall of Chariot Guiding Sheath,2015-12-09 16:31:00-05:00,BSX,neutral
190766.0,"Nevro Announces USPTO Denies Boston Scientific Petitions for Inter Partes Review of U.S. Patent No. 8,359,102",2015-12-01 04:15:00-05:00,BSX,negative
190767.0,Boston Scientific Receives FDA Approval And CE Mark For AngioJet ZelanteDVT Thrombectomy Catheter,2015-11-30 16:15:00-05:00,BSX,positive
190768.0,"Early Global News: Judge Dismisses Yelp Lawsuit, Boston Scientific Recall, Brazil Suing BHP & Vale",2015-11-28 11:42:00-05:00,BSX,negative
190769.0,Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLXâ¢ Left Atrial Appendage Closure Device,2015-11-19 16:30:00-05:00,BSX,neutral
190770.0,Benzinga's Top Initiations,2015-11-12 10:08:00-05:00,BSX,positive
190771.0,"Citigroup Initiates Coverage on Boston Scientific at Buy, Announces $23.00 PT",2015-11-12 06:33:00-05:00,BSX,neutral
190772.0,Boston Scientific Sharply Lower After Watchman Insurance Concerns Surface,2015-11-11 11:17:00-05:00,BSX,negative
190773.0,"Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences, Upfront Payment Of $70M Plus Additional Regulatory/Sales Milestone Payments",2015-11-10 08:33:00-05:00,BSX,neutral
190774.0,"Boston Scientific Raises FY EPS $0.90-$0.92 Vs Est $0.91, Had Seen $0.88-$0.92; Sales $7.47B-$7.51B Vs Est $7.48B",2015-10-28 06:39:00-04:00,BSX,neutral
190775.0,"Boston Scientific Sees Q4 EPS $0.23-$0.25 Vs Est $0.26, Revs $1.97B-$2.010B Vs Est $2.00B",2015-10-28 06:34:00-04:00,BSX,neutral
190776.0,"Boston Scientific Reports QQ3 EPS $0.24 Vs Est $0.23, Sales $1.888B vs Est $1.86B",2015-10-28 06:31:00-04:00,BSX,neutral
190777.0,"Earnings Scheduled For October 28, 2015",2015-10-28 04:56:00-04:00,BSX,neutral
190778.0,13 Stocks To Watch In The Healthcare Space,2015-10-27 14:38:00-04:00,BSX,neutral
190779.0,US Stock Futures Down Ahead Of Fed Minutes,2015-10-08 06:50:00-04:00,BSX,neutral
190780.0,Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies,2015-10-08 06:30:00-04:00,BSX,neutral
190781.0,Morning Market Gainers,2015-10-05 09:47:00-04:00,BSX,neutral
190782.0,Benzinga's Top Downgrades,2015-10-05 09:28:00-04:00,BSX,positive
190783.0,Benzinga's Top #PreMarket Gainers,2015-10-05 08:13:00-04:00,BSX,positive
190784.0,"Raymond James Downgrades Boston Scientific to Strong Buy, Maintains $21.00 PT",2015-10-05 07:53:00-04:00,BSX,positive
190785.0,US Stock Futures Rise Ahead Of Economic Data,2015-10-05 07:11:00-04:00,BSX,neutral
190786.0,Boston Scientific Receives FDA Approval For SYNERGYâ¢ Bioabsorbable Polymer Drug-Eluting Stent System,2015-10-05 06:30:00-04:00,BSX,positive
190787.0,Barron's Recap: The Volatility Lovers,2015-10-04 17:50:00-04:00,BSX,positive
190788.0,Needham Upgrades Boston Scientific to Buy,2015-09-28 08:00:00-04:00,BSX,neutral
190789.0,Boston Scientific Announces Vascular Stent System Demonstrates 12-month Primary Patency Of 96.1 Percent,2015-09-28 06:04:00-04:00,BSX,neutral
190790.0,UBS Initiates Coverage on Boston Scientific at Buy,2015-09-22 09:26:00-04:00,BSX,neutral
190791.0,Benzinga's Top Upgrades,2015-08-27 09:11:00-04:00,BSX,positive
190792.0,"Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff",2015-08-27 08:40:00-04:00,BSX,positive
190793.0,"UPDATE: Goldman Sees New Opportunities In MedTech Amidst Sell-Off, Upgrades Boston Scientific, CR Bard to Buy, Sees 32+% Upside in Zeltiq",2015-08-27 06:24:00-04:00,BSX,positive
190794.0,"Goldman Sachs Upgrades Boston Scientific to Buy, Raises PT to $20.00",2015-08-27 05:49:00-04:00,BSX,neutral
190795.0,"Boston Scientific Reports CE Mark for MRI Compatible Labeling for ICD, CRT-D Systems",2015-08-24 16:30:00-04:00,BSX,neutral
190796.0,"Insider Buying Heats Up In Tesla, Boston Scientific, Freeport-McMoRan & Others",2015-08-23 18:19:00-04:00,BSX,neutral
190797.0,Boston Scientific Announces FDA Approval of Innova Vascular Self-Expanding Stent System,2015-08-19 16:45:00-04:00,BSX,positive
190798.0,"Boston Scientfic Reports Equity Investment, Sales Cooperation Deal with Preventice Solutions",2015-08-03 16:40:00-04:00,BSX,positive
190799.0,"UPDATE: Boston Scientific Cuts GAAP EPS Outlook from $0.32-$0.38 to $0.28-$0.34 vs $0.23 Est., Adj. EPS $0.88-$0.92 vs $0.90 Est.",2015-07-23 07:08:00-04:00,BSX,negative
190800.0,"Boston Scientific Sees Q3 Adj. EPS $0.21-$0.23 vs $0.23 Est., Sales $1.79B-$1.84B vs $1.84B Est.; Narrows FY15 Sales Guidance from $7.225B-$7.375B to $7.275B-$7.375B vs $7.34B Est.",2015-07-23 07:07:00-04:00,BSX,neutral
190801.0,"Boston Scientific Reports Q2 EPS $0.22 vs. Est. $0.21, Rev. $1.843B vs. Est. $1.83B",2015-07-23 07:00:00-04:00,BSX,neutral
190802.0,"Earnings Scheduled For July 23, 2015",2015-07-23 04:46:00-04:00,BSX,neutral
190803.0,Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology,2015-07-20 09:02:00-04:00,BSX,neutral
190804.0,Benzinga's Top Initiations,2015-07-07 09:49:00-04:00,BSX,positive
190805.0,Stephens & Co. Initiates Boston Scientific With Overweight,2015-07-07 08:28:00-04:00,BSX,negative
190806.0,"Stephens & Co. Initiates Coverage on Boston Scientific at Overweight, Announces $21.00 PT",2015-07-07 07:08:00-04:00,BSX,negative
190807.0,Boston Scientific Initiates Global Study To Assess EMBLEM Subcutaneous Implantable Defibrillator In Primary Prevention Patients With Low Ejection Fraction,2015-06-22 09:03:00-04:00,BSX,negative
190808.0,New Data Demonstrate Greater Pain Relief With Boston Scientific Precision Spectraâ¢ Spinal Cord Stimulator System,2015-06-10 09:02:00-04:00,BSX,positive
190809.0,Jury Orders Boston Scientific to Pay $100M in Transvaginal Mesh Trial; Including $75M in Punitive Damages -Reuters,2015-05-28 12:17:00-04:00,BSX,negative
190810.0,Boston Scientific Shares Quiet Over Last Few Mins as Bloomberg Reporting Co. to Pay $100M in Vaginal Mesh Case,2015-05-28 11:42:00-04:00,BSX,positive
190811.0,Study Evaluating Boston Scientific Lotus Valve System Demonstrates Extremely Low Rate of Leakage,2015-05-20 03:47:00-04:00,BSX,negative
190812.0,Recent Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY Bioabsorbable Polymer Stent System Across Four Years,2015-05-19 07:54:00-04:00,BSX,positive
190813.0,"Boston Scientific Completes $1.85/B Sr. Offering, Sees Charges Of $0.02/Share On Redemptions",2015-05-12 10:55:00-04:00,BSX,negative
190814.0,"Nevro Announces Boston Scientific Unit Files Petitions for Inter Partes Review of U.S. Patent No. 8,359,102",2015-05-12 04:55:00-04:00,BSX,negative
190815.0,"8-K from Boston Scientific Shows Co. Expecting FY17 Organic Sales Growth 3-6%, '18-'19 Organic Sales Growth 4-7%",2015-05-06 17:33:00-04:00,BSX,positive
190816.0,"8-K from Boston Scientific Shows Co. Expecting FY16 Organic Sales Growth in 3-6% Range, FY17 Organic Sales Growth 3-5%, FY18-19 Sales Growth 3-7%",2015-05-01 08:09:00-04:00,BSX,positive
190817.0,"Boston Scientific, MedAxiom And TogetherMD Partner To Bring Value Based Solutions To Healthcare Systems",2015-04-30 08:36:00-04:00,BSX,positive
190818.0,Needham Calls Boston Scientific's Results Just 'Decent',2015-04-29 10:49:00-04:00,BSX,neutral
190819.0,"Boston Scientific Posts In-Line Q1 Earnings, Issues Weak Outlook",2015-04-28 08:20:00-04:00,BSX,negative
190820.0,Boston Scientific Sees Cuts FY15 Sales Guidance from $7.3B-$7.5B to $7.23B-$7.38B vs $7.39B Est.,2015-04-28 07:05:00-04:00,BSX,negative
190821.0,"Boston Scientific Reports Q1 Adj. EPS $0.21, Inline, Sales $1.77B vs $1.78B Est.; Sees Q2 Adj. EPS $0.20-$0.22 vs $0.22 Est.",2015-04-28 07:00:00-04:00,BSX,neutral
190822.0,Boston Scientific's Eluvia Drug-Eluting Vascular Stent System Demonstrate 94.4% Primary Patency Rate at Nine Months,2015-04-28 04:38:00-04:00,BSX,neutral
190823.0,"Earnings Scheduled For April 28, 2015",2015-04-28 04:35:00-04:00,BSX,neutral
190824.0,Boston Scientific to Collaborate With Brainlab AG,2015-04-27 16:16:00-04:00,BSX,neutral
190825.0,Boston Scientific Announces Enrollment of Patient in Vessix Study,2015-04-16 16:12:00-04:00,BSX,neutral
190826.0,"Boston Scientific, Frankenman Medical Equipment Company Sign Strategic Alliance",2015-04-14 09:01:00-04:00,BSX,neutral
190827.0,"Benzinga's M&A Chatter for Wednesday April 1, 2015",2015-04-01 17:22:00-04:00,BSX,neutral
190828.0,"Boston Scientific Announces Purchase of Xlumena for Upfront Payment of $62.5M, Added Payment of $12.5M Upon FDA Clearnace of HOT AXIOS",2015-04-01 16:02:00-04:00,BSX,neutral
190829.0,"Growth Is Already Factored In At Boston Scientific, Analyst Says",2015-03-30 16:18:00-04:00,BSX,positive
190830.0,Oppenheimer: 3 Healthcare Stocks And 2 Energy Stocks To Buy Now,2015-03-28 11:39:00-04:00,BSX,positive
190831.0,InterVene Announces Closing of $5.9M Series A Funding Led by Boston Scientific,2015-03-23 16:21:00-04:00,BSX,neutral
190832.0,Boston Scientific Is 'Riding The Wave Of Business Improvement',2015-03-20 12:17:00-04:00,BSX,positive
190833.0,"Raymond James Initiates Coverage on Boston Scientific at Outperform, Announces $21.00 PT",2015-03-19 16:49:00-04:00,BSX,neutral
190834.0,"Morgan Stanley Reiterates Overweight, Raises PT On Boston Scientific On Path To 2017",2015-03-18 08:50:00-04:00,BSX,negative
190835.0,Oppenheimer: Bullish Technical Analysis Of 5 Healthcare Names,2015-03-18 08:10:00-04:00,BSX,neutral
190836.0,"Boston Scientific Announces FDA, CE Mark Approval of The EMBLEM S-ICD System",2015-03-17 16:03:00-04:00,BSX,positive
190837.0,Boston Scientific Surges Following Watchman News,2015-03-16 10:54:00-04:00,BSX,neutral
190838.0,Morning Market Gainers,2015-03-16 09:40:00-04:00,BSX,neutral
190839.0,Benzinga's Top #PreMarket Gainers,2015-03-16 08:06:00-04:00,BSX,positive
190840.0,Boston Scientific Shares Up 3.5% Premarket; Several Sell-Side Firms Discussing WATCHMAN LAA Closure Device Approval,2015-03-16 07:51:00-04:00,BSX,positive
190841.0,Analyst: Boston Scientific's Acquisition Is 'Strategically Sound',2015-03-03 16:10:00-05:00,BSX,neutral
190842.0,"Benzinga's M&A Chatter for Monday March 2, 2015",2015-03-02 19:29:00-05:00,BSX,neutral
190843.0,"'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In Total Deals",2015-03-02 13:19:00-05:00,BSX,neutral
190844.0,UPDATE: Endo Tops Q4 Views,2015-03-02 08:44:00-05:00,BSX,positive
190845.0,CORRECTION: Endo Health Reports Q4 Adj. EPS $1.16 vs $1.12 Est.,2015-03-02 07:21:00-05:00,BSX,neutral
190846.0,Boston Scientific To Buy Endo Unit For ~$1.65B,2015-03-02 07:03:00-05:00,BSX,neutral
190847.0,Endo Announces Divestiture of American Medical Systems' Men's And Prostate Health Businesses to Boston Scientific for Up to $1.65B,2015-03-02 07:02:00-05:00,BSX,neutral
190848.0,"Benzinga's M&A Chatter for Tuesday February 24, 2015",2015-02-24 18:03:00-05:00,BSX,neutral
190850.0,"Boston Scientific Near Deal to Acquire Endo's AMS Medical Device Unit, According to Sources -Reuters",2015-02-24 12:14:00-05:00,BSX,neutral
190851.0,3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis,2015-02-23 13:57:00-05:00,BSX,neutral
190852.0,Sterne Agee To Investors: Caution! Boston Scientific Priced To Perfection,2015-02-20 09:08:00-05:00,BSX,positive
190853.0,Boston Scientific Closes Up 12%,2015-02-18 16:44:00-05:00,BSX,neutral
190854.0,Boston Scientific Soars 11% After Settling Dispute With Johnson & Johnson,2015-02-18 14:42:00-05:00,BSX,negative
190855.0,Stifel Boosts Price Targets For These 5 Stocks,2015-02-18 12:56:00-05:00,BSX,positive
190856.0,Mid-Day Market Update: Angie's List Jumps On Upbeat Earnings; MedAssets Shares Tumble,2015-02-18 12:51:00-05:00,BSX,positive
190857.0,Sterne Agree Weighs In On Boston Scientific-Johnson & Johnson Litigation Settlement,2015-02-18 10:24:00-05:00,BSX,positive
190858.0,Stocks Hitting 52-Week Highs,2015-02-18 10:05:00-05:00,BSX,neutral
190859.0,Morning Market Gainers,2015-02-18 09:38:00-05:00,BSX,neutral
190860.0,Benzinga's Top #PreMarket Gainers,2015-02-18 08:11:00-05:00,BSX,positive
190861.0,Boston Scientific Shares Rise 12% After-Hours on JNJ Settlement News,2015-02-17 17:28:00-05:00,BSX,positive
190862.0,Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation; BSX Will Pay $600M,2015-02-17 16:07:00-05:00,BSX,positive
190863.0,"Boston Scientific Reports Deal with J&J for Resolution of Guidant Litigation, Will Make $600M in Payments, Sees Pretax Charge $600M",2015-02-17 16:06:00-05:00,BSX,negative
190864.0,JMP Securities Covers Mostly Good News From Pharma Pending More Visibility,2015-02-11 07:54:00-05:00,BSX,positive
190865.0,"Boston Scientific, CR Bard Report Distribution Deal for Lutonix Drug-Coated Ballon, Terms Not Disclosed",2015-02-09 09:05:00-05:00,BSX,neutral
190866.0,JMP Bullish On Boston Scientific: 'Strong Execution and Improved Results in Core Businesses' Will Continue To Drive Growth,2015-02-05 10:58:00-05:00,BSX,positive
190867.0,"Wedbush Securities Reiterates Neutral Rating, Raises Price Target On Boston Scientific On 4Q Recap",2015-02-05 08:01:00-05:00,BSX,negative
190868.0,"UPDATE: Boston Scientific Posts In-Line Q4 Earnings, Issues Weak Forecast",2015-02-04 07:35:00-05:00,BSX,negative
190869.0,"Boston Scientific Sees Q1 Adj. EPS $0.19-$0.21 vs $0.22 Est., Sales $1.74B-$1.8B vs $1.83B Est. Sees FY15 Adj. EPS $0.88-$0.92, Sales $7.3B-$7.5B Est.",2015-02-04 07:10:00-05:00,BSX,neutral
190870.0,"Boston Scientific Reports In-Line Q4 Adj EPS $0.22, Sales $1.89B Vs Est $1.90B",2015-02-04 07:04:00-05:00,BSX,neutral
190871.0,"Earnings Scheduled For February 4, 2015",2015-02-04 05:08:00-05:00,BSX,neutral
190872.0,"Keep an Eye on These 10 Stocks for February 4, 2015",2015-02-04 04:08:00-05:00,BSX,neutral
190873.0,Benzinga's Top Upgrades,2015-01-30 09:00:00-05:00,BSX,positive
190874.0,BMO Capital Upgrades Boston Scientific To Outperform,2015-01-30 08:41:00-05:00,BSX,neutral
190875.0,"BMO Capital Upgrades Boston Scientific to Outperform, Raises PT to $18.00",2015-01-30 05:53:00-05:00,BSX,neutral
190876.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2,2015-01-12 11:03:00-05:00,BSX,neutral
190877.0,Opinion: Here Are 10 Trends (And 11 Investments) To Watch In 2015,2015-01-11 19:52:00-05:00,BSX,neutral
190878.0,Benzinga's Top Upgrades,2015-01-08 09:09:00-05:00,BSX,positive
190879.0,Leerink Swann Upgrades Boston Scientific To Outperform,2015-01-08 08:48:00-05:00,BSX,neutral
190880.0,"Leerink Swann Upgrades Boston Scientific to Outperform, Raises PT to $18.00",2015-01-08 05:56:00-05:00,BSX,neutral
190881.0,"Boston Scientific CEO Currently Speaking at Goldman's CEOs Unscripted Healthcare Conference: Expecting Similar Market Growth in '15 as Last Year, Remains Committed to Goal for Margin Improvement",2015-01-06 09:51:00-05:00,BSX,positive
190882.0,"Option Alert: Boston Scientific Jan $14 Call; 1,160 Contract Trade at Ask @$0.11; Currently $13.23",2014-12-29 15:20:00-05:00,BSX,positive
190883.0,Volcano Up 55% On Acquisition News,2014-12-17 10:36:00-05:00,BSX,neutral
190884.0,How To Profit From An Aging Population,2014-12-05 10:46:00-05:00,BSX,positive
190885.0,How Technology Will Fill The Gaps In Healthcare Delivery In The U.S.,2014-12-03 17:32:00-05:00,BSX,neutral
190886.0,"S&P 500 Stocks With Most Active Options Today: PWR, XEL, NSc, BSX, LLTC, JNJ",2014-12-01 13:19:00-05:00,BSX,positive
190887.0,Boston Scientific Loses Second Surgical Mesh Trial,2014-11-20 12:50:00-05:00,BSX,negative
190888.0,Boston Scientific Ordered To Pay $14.5M In Damages,2014-11-20 12:48:00-05:00,BSX,negative
190889.0,Boston Scientific Announces New Data From Evolve Clinical Program Demonstrate SYNERGYâ¢ Bioabsobable Polymer Stent Meets Key Performance Endpoints,2014-11-19 12:11:00-05:00,BSX,neutral
190890.0,Boston Scientific Says It's Synergy Unit Stent Meets Primary Endpoint,2014-11-19 11:47:00-05:00,BSX,neutral
190891.0,"13F from Cooperman's Omega Shows Liquidated Positions in Freeport-McMoRan, Boston Scientific, Qualcomm, Reduced Stake in Sirius XM, New ~2.63M Share Stake in Melco Crown",2014-11-14 12:42:00-05:00,BSX,positive
190892.0,"Boston Scientific Reports Subcutaneous Implantable Defibrillator Received Favorable Coding, Payment Designations for '15",2014-11-13 17:15:00-05:00,BSX,positive
190893.0,"Boston Scientific Case Related to Vaginal Implants Currently Ongoing: Lawyer Arguing Co. Sacrificed Patients' Safety, Did Not Properly Test Devices",2014-11-13 14:10:00-05:00,BSX,negative
190894.0,Benzinga's Top Upgrades,2014-10-23 08:45:00-04:00,BSX,positive
190895.0,Goldman Sachs Upgrades Boston Scientific To Neutral,2014-10-23 06:48:00-04:00,BSX,neutral
190896.0,"Goldman Sachs Upgrades Boston Scientific Corporation to Neutral, Raises PT to $13.00",2014-10-23 05:41:00-04:00,BSX,neutral
190897.0,Morgan Stanley Reviews Boston Scientific Q3 Results,2014-10-22 10:36:00-04:00,BSX,neutral
190898.0,"UPDATE: Boston Scientific Posts In-Line Q3 Profit, Raises Forecast",2014-10-22 09:10:00-04:00,BSX,positive
190899.0,Boston Scientific Corporation Sees Q4 EPS $0.20-0.22; Sees Sales $1.88B-1.93B,2014-10-22 07:13:00-04:00,BSX,neutral
190900.0,Boston Scientific Corporation Raises FY2014 EPS Guidance from $0.79-0.83 to $0.81-0.83; Sees Sales $7.37B-7.42B,2014-10-22 07:12:00-04:00,BSX,neutral
190901.0,"Boston Scientific Corporation Reports Q3 EPS of $0.20, Inline; Revenue of $1.85B vs $1.82B Est",2014-10-22 07:11:00-04:00,BSX,neutral
190902.0,"Earnings Scheduled For October 22, 2014",2014-10-22 05:16:00-04:00,BSX,neutral
190903.0,"Keep an Eye on These 7 Stocks for October 22, 2014",2014-10-22 04:04:00-04:00,BSX,neutral
190904.0,"Boston Scientific Reports FDA, CE Mark Approval for New CoverEdge Surgical Leads",2014-10-21 09:00:00-04:00,BSX,positive
190905.0,Boston Scientific Reports Initiation of Study for Promus PREMIER Coronary Stent System in Underserved Patient Populations,2014-10-20 08:09:00-04:00,BSX,neutral
190906.0,Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging,2014-10-16 16:33:00-04:00,BSX,neutral
190907.0,Boston Scientific Announces FDA Panel Votes in Favor of WATCHMAN Left Atrial Appendage Closure Device ,2014-10-08 22:02:00-04:00,BSX,positive
190908.0,"8-K from Boston Scientific Shows Exec VP, Global Operations, Quality, Technology Kenneth Pucel to Leave, Effective Nov. 28th",2014-10-03 08:59:00-04:00,BSX,positive
190909.0,"UPDATE: Needham Initiates Coverage On St. Jude Medical, Inc.",2014-09-30 16:17:00-04:00,BSX,neutral
190910.0,Needham Initiates Coverage on Boston Scientific Corporation at Hold,2014-09-30 06:51:00-04:00,BSX,neutral
190911.0,"8-K from Boston Scientific Shows Montgomery County Circuit Court Entered Judgment Co. Breached License Deal with Mirowski Family Ventures, Awarded Damages of $308M",2014-09-24 16:37:00-04:00,BSX,negative
190912.0,Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus Valve System,2014-09-23 16:07:00-04:00,BSX,neutral
190913.0,Boston Scientific Receives CE Mark for Vercise DBS System for Treating Patients With Tremor ,2014-09-17 05:13:00-04:00,BSX,neutral
190914.0,"Boston Scientific Has Said REPRISE II Trial Confirmed Safety, Effectiveness Out to One Year, Saw No Cases of Moderate, Severe Leaking",2014-09-15 15:56:00-04:00,BSX,negative
190915.0,Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Revenue,2014-09-11 04:17:00-04:00,BSX,positive
190916.0,Boston Scientific Ordered to Pay $73M Related to Mesh Implant - Bloomberg,2014-09-09 09:50:00-04:00,BSX,negative
190917.0,"Boston Scientific Expecting Bayer Unit Deal Immaterial to Adj. EPS in FY14, Adding $0.01 to Adj. EPS in FY15",2014-09-02 08:10:00-04:00,BSX,neutral
190918.0,Boston Scientific NECTAR-HF Clinical Trial did Not Meet Endpoint ,2014-08-30 12:57:00-04:00,BSX,neutral
190919.0,Boston Scientific Has Won Second Vaginal Mesh Trial in Massachusetts Court - Bloomberg,2014-08-29 12:42:00-04:00,BSX,positive
190920.0,"Boston Scientific, ASAHI INTECC Announce Joint Development and Manufacturing Programs ",2014-08-19 03:43:00-04:00,BSX,neutral
190921.0,10-Q from Boston Scientific Shows Subpoena from US Attorney in NJ Related to Bridgepoint Medical Purchase - Bloomberg,2014-08-06 17:58:00-04:00,BSX,neutral
190922.0,"Vascular Solutions Reports Settlement of Patent Suit with Boston Scientific, Terms Confidential",2014-07-30 17:30:00-04:00,BSX,positive
190923.0,Benzinga's Top Initiations,2014-07-29 09:14:00-04:00,BSX,positive
190924.0,Sterne Agee Initiates Boston Scientific At Neutral,2014-07-29 07:59:00-04:00,BSX,neutral
190925.0,UPDATE: Sterne Agee Initiates Coverage On Boston Scientific,2014-07-29 07:39:00-04:00,BSX,neutral
190926.0,"Sterne Agee Initiates Coverage on Boston Scientific Corporation at Neutral, Announces $13.50 PT",2014-07-29 06:47:00-04:00,BSX,neutral
190927.0,Boston Scientific Corporation Raises FY2014 EPS Guidance from $0.77-0.82 to $0.79-0.83 vs $0.80 Est,2014-07-24 07:12:00-04:00,BSX,neutral
190928.0,Boston Scientific Corporation Sees Q3 EPS $0.18-0.20 vs $0.19 Est,2014-07-24 07:11:00-04:00,BSX,neutral
190929.0,Boston Scientific Corporation Reports Q2 EPS of $0.21 vs $0.19 Est; Revenue of $1.87B vs $1.87B Est,2014-07-24 07:02:00-04:00,BSX,neutral
190930.0,"Earnings Scheduled For July 24, 2014",2014-07-24 05:31:00-04:00,BSX,neutral
190931.0,Boston Scientific Receives CE Mark For Agent(TM) Drug-Coated Balloon - DJ Reports,2014-07-23 17:01:00-04:00,BSX,neutral
190932.0,Boston Scientific Announces FDA Approval for REBEL Platinum Chromium Coronary Stent,2014-07-21 16:32:00-04:00,BSX,positive
190933.0,Boston Scientific Reports CE Mark for Ranger Drug-Coated Balloon,2014-07-14 09:00:00-04:00,BSX,neutral
190934.0,"CRT Capital Initiates Coverage on Boston Scientific Corporation at Buy, Announces $16.00 PT",2014-07-07 18:22:00-04:00,BSX,neutral
190935.0,~2M Share Block Trade in Boston Scientific @$12.60 at 11:13 AM ET,2014-06-17 11:15:00-04:00,BSX,negative
190936.0,Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson,2014-06-16 16:29:00-04:00,BSX,positive
190937.0,"#PreMarket Primer: Monday, June 16: Rebels Seize Another Iraqi City",2014-06-16 07:22:00-04:00,BSX,negative
190938.0,800K Share Block Trade in Boston Scientific at 10:55 AM ET,2014-06-12 10:57:00-04:00,BSX,negative
190939.0,"#PreMarket Primer: Wednesday, June 11: PBOC Looking For Stable Monetary Policy",2014-06-11 07:30:00-04:00,BSX,positive
190940.0,Boston Scientific Reports Clinical Study Results of Vercise DBS System Shows Terapeutic Advantages,2014-06-10 18:10:00-04:00,BSX,positive
190941.0,UPDATE: Morgan Stanley Reiterates On Boston Scientific On Three Key Debates,2014-06-10 08:55:00-04:00,BSX,neutral
190942.0,Boston Scientific Initiates ESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus Valve System ,2014-06-05 05:31:00-04:00,BSX,neutral
190943.0,Boston Scientific Announces Strong Performance Data for SYNERGY Stent,2014-05-21 08:06:00-04:00,BSX,positive
190944.0,"Boston Scientific Reports Strong Performance Data for SYNERGY Stent System, Shows Target Lesion Revascularization Remains Low",2014-05-21 08:04:00-04:00,BSX,positive
190945.0,Market Wrap For May 15: Bears Return In Full-Force As Dow Suffers Triple-Digit Point Loss,2014-05-15 16:41:00-04:00,BSX,negative
190946.0,"US Stock Futures Flat Ahead Of Economic Data, Wal-Mart Earnings",2014-05-15 07:15:00-04:00,BSX,neutral
190947.0,UPDATE: Boston Scientific to Acquire Interventional Division of Bayer AG For $415M,2014-05-15 07:07:00-04:00,BSX,neutral
190948.0,"UPDATE: Boston Scientific Expecting Deal with Bayer Adding Immediately to Adj. EPS in FY14, Adding ~$0.01/Share in FY15",2014-05-15 07:07:00-04:00,BSX,neutral
190949.0,Boston Scientific to Acquire Interventional Division of Bayer AG For $415M,2014-05-15 07:03:00-04:00,BSX,neutral
190950.0,Boston Scientific Latitude Remote Patient Management System Demonstrates Significant Reduction In Mortality And Hospitalization ,2014-05-10 18:45:00-04:00,BSX,positive
190951.0,CNBC Newsroom Tweets 'Boston Scientific discloses it has been subpoenaed by the Dept. of Health & Human Services in regards to certain defibrillator devices. $BSX',2014-05-08 16:56:00-04:00,BSX,positive
190952.0,Boston Scientific Announces Purchase of IoGyn for $65M,2014-05-06 17:27:00-04:00,BSX,neutral
190953.0,Boston Scientific Launches Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan ,2014-05-01 05:28:00-04:00,BSX,neutral
190954.0,Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine Tension and Upcoming Fed Meeting ,2014-04-29 16:43:00-04:00,BSX,positive
190955.0,Boston Scientific Corporation Raises FY2014 EPS Guidance from $0.75-0.80 to $0.77-0.82 vs $0.78 Est,2014-04-29 07:03:00-04:00,BSX,neutral
190956.0,Boston Scientific Corporation Sees Q2 EPS $0.18-0.20 vs $0.20 Est,2014-04-29 07:03:00-04:00,BSX,neutral
190957.0,Boston Scientific Corporation Reports Q1 EPS of $0.20 vs $0.18 Est; Revenue of $1.77B vs $1.80B Est,2014-04-29 07:02:00-04:00,BSX,neutral
190958.0,"Earnings Scheduled For April 29, 2014",2014-04-29 05:16:00-04:00,BSX,neutral
190959.0,Boston Scientific Begins Clinical Trial of ACUITY X4 LV Pacing Leads and RELIANCE 4-FRONT ICD Leads ,2014-04-22 09:31:00-04:00,BSX,neutral
190960.0,"Wednesday IPO Review & Sneak-Peek For Thursday, April 17",2014-04-17 07:39:00-04:00,BSX,neutral
190961.0,"UPDATE: Boston Scientific Reports FDA Approval for Latest Generation of Defib., Heart Failure Devices",2014-04-15 16:52:00-04:00,BSX,negative
190962.0,"Boston Scientific Reports FDA Approval for Latest Generation of Defib., Heart Failure Devices, Including DYNAGEN Mini, X4 INOGEN Mini ICDs, X4 CRT-Ds",2014-04-15 16:46:00-04:00,BSX,negative
190963.0,Vascular Solutions Announces Prelim. Injunction Against Boston Scientific's Guidezilla Catheter Vacated by Federal Circuit,2014-04-15 11:52:00-04:00,BSX,positive
190964.0,"US Appeals Court Throws Out Preliminary Injunction Against Boston Scientific, Rules Against Vascular Solutions -Reuters",2014-04-15 11:15:00-04:00,BSX,positive
190965.0,UPDATE: Bank of America Upgrades Boston Scientific on Multiple Positive Factors,2014-04-14 10:14:00-04:00,BSX,positive
190966.0,Morning Market Movers ,2014-04-14 09:38:00-04:00,BSX,neutral
190967.0,Benzinga's Top #PreMarket Gainers,2014-04-14 08:12:00-04:00,BSX,positive
190968.0,Benzinga's Top Upgrades,2014-04-14 07:58:00-04:00,BSX,positive
190969.0,"Bank of America Upgrades Boston Scientific Corporation to Buy, Raises PO to $16.00",2014-04-14 06:39:00-04:00,BSX,negative
190970.0,"Boston Scientific, Amos Gazit Report New Distribution Deal in Israel",2014-04-08 09:53:00-04:00,BSX,neutral
190971.0,Boston Scientific Begins Expansion of S-ICD System in Asia ,2014-04-07 19:51:00-04:00,BSX,neutral
190972.0,"Boston Scientific Receives FDA Clearance, CE Mark for Expect Slimline Needle ",2014-04-07 19:20:00-04:00,BSX,neutral
190973.0,US Stock Futures Edge Higher Ahead Of ADP Report,2014-04-02 07:32:00-04:00,BSX,neutral
190974.0,"Boston Scientific Reports Favorable Results in Studies Related to CRT, TAVR, Platinum Chromium Stent Platforms",2014-04-02 05:45:00-04:00,BSX,positive
190975.0,Boston Scientific Data Shows Patients with Mild Heart Failure had Lower Mortality Rates with Co's CRT Defibrillators,2014-03-30 17:17:00-04:00,BSX,negative
190976.0,Benzinga's Top Upgrades,2014-03-24 07:51:00-04:00,BSX,positive
190977.0,"Bernstein Upgrades Boston Scientific Corporation to Outperform, Raises PT to $15.00",2014-03-24 07:37:00-04:00,BSX,neutral
190978.0,"Boston Scientific Announces CE Mark Approval, First Implants of Ingevity MRI Pacing Leads ",2014-03-14 10:19:00-04:00,BSX,positive
190979.0,Boston Scientific Reports CE Mark Approval for INGEVITY Family,2014-03-14 10:18:00-04:00,BSX,positive
190980.0,Boston Scientific Gets CE Mark Approval for Rebel Stent System,2014-03-12 18:42:00-04:00,BSX,positive
190981.0,CAFC Document Shows Medtronic Has Won Ruling in Boston Scientific Defibrillator Case,2014-03-11 11:18:00-04:00,BSX,positive
190982.0,Boston Scientific Increases Board Size from 11 to 12; Names Edward J. Ludwig to Board,2014-03-03 16:49:00-05:00,BSX,neutral
190983.0,Boston Scientific WallFlex Esophageal Stent Gains CE Mark for Treatment Of Refractory Benign Esophageal Strictures ,2014-02-14 13:01:00-05:00,BSX,positive
190984.0,Morgan Stanley Sees Positive Outlook Ahead for Boston Scientific,2014-02-05 09:30:00-05:00,BSX,positive
190985.0,"Option Alert: Boston Scientific Feb $13/$15 Call Spread; 7,500 Spread Trade; Currently $12.68",2014-02-04 10:10:00-05:00,BSX,positive
190986.0,UPDATE: Boston Scientific Posts Higher Q4 Profit,2014-02-04 08:26:00-05:00,BSX,positive
190987.0,Boston Scientific Corporation Sees FY2014 EPS $0.47-0.52 vs $0.52 Est,2014-02-04 07:12:00-05:00,BSX,neutral
190988.0,Boston Scientific Corporation Sees Q1 EPS $0.16-0.18 vs $0.12 Est; Sees Sales $1.75B-1.80B vs $1.80B Est,2014-02-04 07:02:00-05:00,BSX,neutral
190989.0,Boston Scientific Reports Q4 Adjusted EPS of $0.21 vs $0.09 Est; Revenue of $1.84B vs $1.73B Est,2014-02-04 07:02:00-05:00,BSX,neutral
190990.0,"Earnings Scheduled For February 4, 2014",2014-02-04 04:14:00-05:00,BSX,neutral
190991.0,"Stocks To Watch For February 4, 2014",2014-02-04 04:09:00-05:00,BSX,neutral
190992.0,"Stifel Nicolaus Maintains Buy on Boston Scientific Corporation, Raises PT to $15.00",2014-01-29 07:26:00-05:00,BSX,neutral
190993.0,Benzinga's Top Upgrades,2014-01-21 08:36:00-05:00,BSX,positive
190994.0,"Piper Jaffray Upgrades Boston Scientific Corporation to Overweight, Raises PT to $18.00",2014-01-21 08:24:00-05:00,BSX,negative
190995.0,"#PreMarket Primer: Tuesday, January 21: China's Central Bank Adds Record Amount Of Cash To Markets",2014-01-21 07:09:00-05:00,BSX,neutral
190996.0,Bloomberg Reporting Boston Scientific CEO Has Said Co. Will Pause Start of Hypertension Study,2014-01-16 14:12:00-05:00,BSX,neutral
190997.0,FDA Issues Class 2 Recall on Boston Scientific Twister,2014-01-16 10:33:00-05:00,BSX,neutral
190998.0,Amaranth Medical Announces Investment from Boston Scientific ,2014-01-14 09:16:00-05:00,BSX,neutral
190999.0,Vascular Solutions Reports Prelim. Injunction Against Boston Scientific's Guidezilla Catheter Now Effective,2014-01-13 09:05:00-05:00,BSX,positive
191000.0,"BTIG Research Initiates Coverage on Boston Scientific Corporation at Buy, Announces $15.00 PT",2014-01-08 08:55:00-05:00,BSX,neutral
191001.0,Morgan Stanley Upgrades Boston Scientific on Pipeline Acceleration ,2014-01-06 14:01:00-05:00,BSX,neutral
191002.0,"Option Alert; Boston Scientific January $13 Call; 13,528 Contract Trade at Bid @$0.08; Currently $12.40",2014-01-06 09:41:00-05:00,BSX,positive
191003.0,"#PreMarket Primer: Monday, January 6: Asia Plunges",2014-01-06 07:17:00-05:00,BSX,neutral
191004.0,"Morgan Stanley Upgrades Boston Scientific Corporation to Overweight, Announces $15.00 PT",2014-01-06 06:54:00-05:00,BSX,negative
191005.0,"Boston Scientific Plans China Expansion, Considering Acquisitions ",2013-12-23 09:46:00-05:00,BSX,neutral
191006.0,Slideshow: The Top 10 'Highs & Dives' Of S&P 500 Stocks In 2013,2013-12-17 09:38:00-05:00,BSX,positive
191007.0,Boston Scientific Receives CE Mark Approval for X4 Quadripolar CRT-D Systems ,2013-12-17 08:05:00-05:00,BSX,positive
191008.0,Market Wrap For December 12: Dow Suffers Second Consecutive Day of Triple Point Loss,2013-12-12 16:41:00-05:00,BSX,negative
191009.0,"Option Alert: Boston Scientific February $13 Call; 10,000 Contract Trade Between Bid and Ask @$0.26; Currently $11.54",2013-12-12 15:29:00-05:00,BSX,positive
191010.0,Benzinga's Top #PreMarket Gainers,2013-12-12 08:09:00-05:00,BSX,positive
191011.0,UPDATE: FDA Advisory Panel Votes 13-1 on Benefits of Boston Scientific WATCHMAN Left Atrial Appendage Closure Device ,2013-12-11 21:03:00-05:00,BSX,positive
191012.0,FDA Advisory Panel Votes 13-1 Benefits of Boston Scientific's Watchman Outweigh Risks,2013-12-11 17:59:00-05:00,BSX,positive
191013.0,Vascular Solutions Wins Prelim. Injunction Versus Boston Scientific's Guidezilla Catheter,2013-12-09 18:04:00-05:00,BSX,positive
191014.0,Cowen & Company Upgrades Boston Scientific Corporation to Outperform,2013-12-06 08:44:00-05:00,BSX,neutral
191015.0,"Boston Scientific, The Medicines Co. Announces Deal for PROMUS Premier Stent System in the US",2013-12-06 07:02:00-05:00,BSX,neutral
191016.0,"Benchmark Initiates Coverage on Boston Scientific Corporation at Hold, Announces $12.00 PT",2013-12-05 07:50:00-05:00,BSX,neutral
191017.0,"Option Alert: Boston Scientific January $13 Call; 10,000 Contract Trade Between Bid and Ask @$0.06; Currently $11.25",2013-12-04 13:33:00-05:00,BSX,positive
191018.0,10 Stocks To Be Thankful For This Thanksgiving,2013-11-27 11:12:00-05:00,BSX,positive
191019.0,Boston Scientific Receives FDA Approval For Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System ,2013-11-25 09:02:00-05:00,BSX,positive
191020.0,"Boston Scientific Receives FDA Clearance, CE Mark Approval for Direxion Torqueable Microcatheter ",2013-11-19 18:46:00-05:00,BSX,positive
191021.0,Boston Scientific Vercise Deep Brain Stimulation System Receives CE Mark Approval ,2013-11-19 05:51:00-05:00,BSX,positive
191022.0,Boston Scientific Says Lotus Meets Co-Primary Endpoints,2013-11-15 10:59:00-05:00,BSX,neutral
191023.0,Boston Scientific Says Lotus Valve System Meets Primary Endpoint,2013-10-31 17:41:00-04:00,BSX,neutral
191024.0,"Boston Scientific Vessix Renal Denervation System Data Show Significant and Sustained Reduction in Blood Pressure,",2013-10-28 21:54:00-04:00,BSX,negative
191025.0,Boston Scientific Receives CE Mark for Lotus Valve System,2013-10-28 09:12:00-04:00,BSX,neutral
191026.0,Boston Scientific Corporation Narrows Q4 Sales Guidance from $7.05B-7.17B to $7.08B-7.13B vs $7.14B Est,2013-10-24 07:09:00-04:00,BSX,neutral
191027.0,Boston Scientific Corporation Reports Q3 EPS of $0.17 Which May Not Compare $0.09 Est; Revenue of $1.74B Which May Not Compare $1.73B Est,2013-10-24 07:08:00-04:00,BSX,neutral
191028.0,"Form 8-K from Boston Scientific Shows Co. Board Has Approved 2014 Restructuring Program, Expecting to Cut 1,110-1,500 Jobs, Sees Pre-Tax Charge $175-225M",2013-10-23 16:49:00-04:00,BSX,positive
191029.0,"Option Alert; Boston Scientific November 11 Put; 2,000 Contracts Traded @$0.11; Currently $12.19",2013-10-21 11:45:00-04:00,BSX,positive
191030.0,"Bloomberg Reporting Boston Scientific, Units Will Pay $30M Related to Sale of Defective Heart Devices",2013-10-17 13:04:00-04:00,BSX,negative
191031.0,Boston Scientific Launches Clinical Trial Of Innova Peripheral Vascular Drug-Eluting Stent System ,2013-10-09 20:23:00-04:00,BSX,neutral
191032.0,Boston Scientific Announces Positive Clinical Trial Results for OffRoad Re-Entry Catheter System ,2013-10-08 15:07:00-04:00,BSX,positive
191033.0,"Stocks to Watch for October 01, 2013",2013-10-01 13:55:00-04:00,BSX,neutral
191034.0,Boston Scientific Opens China Branch of Institute For Advancing Science,2013-09-17 06:08:00-04:00,BSX,neutral
191035.0,"OrbusNeich, Boston Scientific Settle All Stent-Related Patent Litigation ",2013-09-17 05:51:00-04:00,BSX,negative
191036.0,Boston Scientific Reports Favorable Six-Month Results From Lotus Valve System Clinical Trial ,2013-09-17 05:50:00-04:00,BSX,positive
191037.0,CL King Downgrades Boston Scientific Corporation to Neutral,2013-09-10 11:12:00-04:00,BSX,neutral
191038.0,"Boston Scientific Wins FDA Approval for IntellaTip MiFi XP Ablation Catheter, 510(k) Clearance of Zurpaz 8.5F Sheath",2013-08-21 09:05:00-04:00,BSX,positive
191039.0,Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova,2013-08-19 21:05:00-04:00,BSX,neutral
191040.0,"Boston Scientific Closes $1.05B Senior Notes Offering, Expecting $0.03/Share Charge in Q3",2013-08-13 14:32:00-04:00,BSX,neutral
191041.0,"BMO Capital Maintains Market Perform on Boston Scientific Corporation, Raises PT to $9.80",2013-07-26 09:08:00-04:00,BSX,neutral
191042.0,"Benzinga Market Primer: Friday, July 26: Futures Flat On Mixed Global Stocks Overnight",2013-07-26 06:41:00-04:00,BSX,neutral
191043.0,Mid-Afternoon Market Update: Sequenom Plummets as ONEOK Rises on News That it Will Spin Off Natural Gas Unit,2013-07-25 15:37:00-04:00,BSX,positive
191044.0,"Mid-Day Market Update: Facebook Shares Rise On Strong Results, Crocs Falls",2013-07-25 12:28:00-04:00,BSX,positive
191045.0,"Mid-Morning Market Update: Markets Mostly Lower, GM Posts Upbeat Profit",2013-07-25 11:29:00-04:00,BSX,positive
191046.0,Boston Scientific Corporation Sees Q3 EPS $0.14-0.16 vs $0.07 Est; Sees Sales $1.70B-1.76B vs $1.71B Est; Raises FY Outlook,2013-07-25 07:02:00-04:00,BSX,neutral
191047.0,Boston Scientific Corporation Reports Q2 EPS of $0.18 vs $0.09 Est; Revenue of $1.81B vs $1.78B Est,2013-07-25 07:01:00-04:00,BSX,neutral
191048.0,"Benzinga Market Primer: Thursday, July 25: Futures Lower After Technical Breakdown",2013-07-25 06:31:00-04:00,BSX,negative
191049.0,Boston Scientific Receives FDA 510(k) Clearance for the Rhythmia Mapping System ,2013-07-24 21:39:00-04:00,BSX,neutral
191050.0,"Boston Scientific Launches OptiCrossâ¢ Coronary Imaging Catheter in U.S., Europe and Japan ",2013-07-24 09:07:00-04:00,BSX,neutral
191051.0,"Recent Insider Buying at Navistar, Walgreen (NAV, OPK, WAG)",2013-07-20 12:16:00-04:00,BSX,neutral
191052.0,"Citigroup Downgrades Boston Scientific Corporation to Neutral, Raises PT to $9.30",2013-07-08 07:55:00-04:00,BSX,neutral
191053.0,"Form 8-K from Boston Scientific Shows Co. Entered Reduced Credit Pact for $300M, Had Been for $350M, Pact Extended by Two Years",2013-07-01 16:51:00-04:00,BSX,positive
191054.0,Spectrum Pharmaceuticals Elects Two New Healthcare Industry Veterans to the Board of Directors ,2013-07-01 07:11:00-04:00,BSX,neutral
191055.0,"Chesapeake Energy, Weyerhaeuser and Other Stocks Insiders Are Buying (CHK, WY)",2013-06-30 20:34:00-04:00,BSX,positive
191056.0,S&P Capital IQ Upgrades Boston Scientific Corporation to Buy,2013-06-28 12:01:00-04:00,BSX,neutral
191057.0,UPDATE: Boston Scientific the Buyer of Bard Assets,2013-06-28 08:32:00-04:00,BSX,positive
191058.0,"Boston Scientific to Buy CR Bard for $275 Million, Sees Deal Adding to Earnings in 2014",2013-06-28 08:32:00-04:00,BSX,neutral
191059.0,Two Nifty New Dividend ETFs,2013-06-26 16:31:00-04:00,BSX,positive
191060.0,Boston Scientific Vercise DBS System Demonstrates Improveed Motor Function in Parkinson's Patients,2013-06-18 06:13:00-04:00,BSX,neutral
191061.0,UPDATE: Boston Scientific Announces Collaboration with Pelvic Floor Disorders Network to Study Treatment Strategies for Uterine Prolapse,2013-06-03 09:02:00-04:00,BSX,neutral
191062.0,Boston Scientific Announces Collaboration with Pelvic Floor Disorders Network to Study Treatment Strategies for Uterine Prolapse,2013-06-03 09:01:00-04:00,BSX,neutral
191063.0,UPDATE: Wedbush Initiates Boston Scientific at Neutral on Continued Turnaround Story,2013-05-31 10:20:00-04:00,BSX,neutral
191064.0,"Wedbush Initiates Coverage on Boston Scientific Corporation at Neutral, Announces $10.00 PT",2013-05-31 06:32:00-04:00,BSX,neutral
191065.0,Boston Scientific Files Debt Securities Shelf,2013-05-29 16:35:00-04:00,BSX,negative
191066.0,Boston Scientific Receives CE Mark for GUIDE DBS System ,2013-05-27 19:24:00-04:00,BSX,neutral
191067.0,"Boston Scientific Announces Results from Promus Premier, Synergy Drug-Eluting Stent",2013-05-22 09:18:00-04:00,BSX,neutral
191068.0,OrbusNeich Seizes 190 Boston Scientific Stents in Germany in Patent Infringement Suit,2013-05-21 05:54:00-04:00,BSX,negative
191069.0,Vascular Solutions Issues Patent Infringement Complaint Against Boston Scientific,2013-05-16 16:19:00-04:00,BSX,negative
191070.0,Vascular Solutions Files Patent Infringement Complaint Against Boston Scientific,2013-05-16 16:07:00-04:00,BSX,negative
191071.0,"UPDATE: Stifel Nicolaus Raises PT on Boston Scientific Following HRS Meeting, Management Q&A",2013-05-16 09:03:00-04:00,BSX,neutral
191072.0,"Stifel Nicolaus Maintains Buy on Boston Scientific Corporation, Raises PT to $11.00",2013-05-16 08:08:00-04:00,BSX,neutral
191073.0,UPDATE: JP Morgan Raises PT on Boston Scientific on Recent FX Movements and 1Q Result,2013-05-15 14:27:00-04:00,BSX,positive
191074.0,OrbusNeich Obtains Second Preliminary Injunction in Germany Against Boston Scientific Importing Certain Stent Systems,2013-05-14 05:59:00-04:00,BSX,positive
191075.0,Wells Fargo Upgraded Boston Scientific Corporation to Outperform,2013-05-10 10:38:00-04:00,BSX,positive
191076.0,Boston Scientific Wins CE Mark Approval for Rhythmia Mapping System,2013-05-10 09:04:00-04:00,BSX,positive
191077.0,UPDATE: Credit Suisse Upgrades Boston Scientific to Outperform on Expected Positive Sales Growth,2013-04-26 12:03:00-04:00,BSX,positive
191078.0,"Credit Suisse Upgrades Boston Scientific Corporation to Outperform, Raises PT to $8.75",2013-04-26 08:01:00-04:00,BSX,positive
191079.0,UPDATE: Boston Scientific Corporation Raises FY2013 EPS Guidance from $0.64-0.70 to $0.65-0.70; Lowers FY2013 Sales Guidance from $7.05B-7.35B to $6.95B-7.15B vs $7.18B Est,2013-04-25 08:58:00-04:00,BSX,negative
191080.0,Boston Scientific Corporation Reports Q1 EPS of $0.16 vs $0.09 Est; Revenue of $1.76B vs $1.79B Est,2013-04-25 08:34:00-04:00,BSX,neutral
191081.0,"Earnings Scheduled For April 25, 2013",2013-04-25 05:12:00-04:00,BSX,neutral
191082.0,Boston Scientific Launches Precision Spectraâ¢ Spinal Cord Stimulator System in US,2013-04-12 09:05:00-04:00,BSX,neutral
191083.0,Boston Scientific Says FDA Approves SCS System in US,2013-04-12 09:05:00-04:00,BSX,positive
191084.0,"Deutsche Bank Maintains Hold on Boston Scientific Corporation, Raises PT to $7.90",2013-04-12 07:33:00-04:00,BSX,neutral
191085.0,These Are the 100 Highest-Paid CEOs in Business Today,2013-04-08 16:30:00-04:00,BSX,neutral
191086.0,UPDATE: Credit Suisse Downgrades Boston Scientific Corporation to Neutral on Valuation,2013-04-03 13:34:00-04:00,BSX,positive
191087.0,Credit Suisse Downgrades Boston Scientific Corporation to Neutral,2013-04-03 07:42:00-04:00,BSX,positive
191088.0,"FIG Partners Initiates Coverage on BancorpSouth at Market Perform, Announces $17.00 PT",2013-03-12 06:28:00-04:00,BSX,neutral
191089.0,"Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying",2013-03-09 14:55:00-05:00,BSX,neutral
191090.0,A Peek Into The Market Before The Trading Starts,2013-03-08 07:13:00-05:00,BSX,neutral
191091.0,OrbusNeich Files Suit in Ireland Against Boston Scientific Claiming Patent Infringement,2013-03-08 06:44:00-05:00,BSX,negative
191092.0,Boston Scientific Updates PREVAIL Late-Breaking Clinical Trials Presentation,2013-03-06 16:38:00-05:00,BSX,neutral
191093.0,Boston Scientific's Plans to Present Data at ACC Under Review,2013-03-05 11:12:00-05:00,BSX,neutral
191094.0,Boston Scientific Shares Lower as Wells Fargo Warns Study May Not Have Met Goals; Stock Down ~0.6%,2013-03-05 10:27:00-05:00,BSX,positive
191095.0,"OrbusNeich Announces Patent Infringement Actions Against Boston Scientific in Germany, Netherlands ",2013-02-20 06:26:00-05:00,BSX,negative
191096.0,"Akamai, Murphy Oil and Other Stocks Insiders Are Buying",2013-02-16 13:57:00-05:00,BSX,neutral
191097.0,"13-F Alert: Leon Cooperman's Omega Advisors Dumps Apple, Buys Facebook ",2013-02-13 15:11:00-05:00,BSX,negative
191098.0,UPDATE: Jefferies Raises PT to $8.30 on Boston Scientific Corporation on Favorable 5-Year Outlook,2013-02-13 12:45:00-05:00,BSX,positive
191099.0,UPDATE: Stifel Nicolaus Raises PT to $9 on Boston Scientific Corporation Post Analyst Day,2013-02-13 10:33:00-05:00,BSX,neutral
191100.0,"UPDATE: Deutsche Bank Reiterates Hold Rating, Raises PT on Boston Scientific Corporation on Accelerating Growth",2013-02-13 09:09:00-05:00,BSX,positive
191101.0,"Stifel Nicolaus Maintains Buy on Boston Scientific Corporation, Raises PT to $9.00",2013-02-13 08:32:00-05:00,BSX,neutral
191102.0,"Deutsche Bank Maintains Hold on Boston Scientific Corporation, Raises PT to $7.20",2013-02-13 07:22:00-05:00,BSX,neutral
191103.0,"Jefferies Maintains Hold on Boston Scientific Corporation, Raises PT to $8.30",2013-02-13 07:17:00-05:00,BSX,neutral
191104.0,Strong Bullish Stocks to Watch next week,2013-02-04 09:49:00-05:00,BSX,positive
191105.0,UPDATE: Goldman Sachs Raises PT to $6.60 on Boston Scientific Following Q4 Takeaways,2013-01-30 13:35:00-05:00,BSX,neutral
191106.0,"UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Boston Scientific Corporation",2013-01-30 13:34:00-05:00,BSX,neutral
191107.0,"UPDATE: Bank of America Reiterates Neutral Rating, Raises PT on Boston Scientific Corporation",2013-01-30 12:43:00-05:00,BSX,neutral
191108.0,"Citigroup Maintains Buy on Boston Scientific Corporation, Raises PT to $8.20",2013-01-30 10:04:00-05:00,BSX,neutral
191109.0,"UPDATE: Jefferies Reiterates Hold Rating, Raises PT on Boston Scientific Corporation",2013-01-30 09:59:00-05:00,BSX,neutral
191110.0,"Goldman Sachs Maintains Sell on Boston Scientific Corporation, Raises PT to $6.60",2013-01-30 09:48:00-05:00,BSX,neutral
191111.0,"Bank of America Maintains Neutral on Boston Scientific Corporation, Raises PO to $7.50",2013-01-30 09:33:00-05:00,BSX,negative
191112.0,"BMO Capital Maintains Market Perform on Boston Scientific Corporation, Raises PT to $7.30",2013-01-30 08:27:00-05:00,BSX,neutral
191113.0,"Stifel Nicolaus Maintains Buy on Boston Scientific Corporation, Raises PT to $8.00",2013-01-30 08:04:00-05:00,BSX,neutral
191114.0,"Jefferies Maintains Hold on Boston Scientific Corporation, Raises PT to $7.60",2013-01-30 07:35:00-05:00,BSX,neutral
191115.0,"Mid-Morning Market Update: Markets Slightly Lower, Hess Continues its Rally",2013-01-29 10:38:00-05:00,BSX,negative
191116.0,"Boston Scientific Corporation Sees Q1 Sales $1.74B-1.82B vs $1.79B Est, Sees FY13 Sales $7.05B-7.35B vs $7.12B Est.",2013-01-29 07:42:00-05:00,BSX,neutral
191117.0,Boston Scientific Authorized Buyback for $1B in Common Shares,2013-01-29 07:40:00-05:00,BSX,positive
191118.0,Boston Scientific Corporation Reports Q4 EPS of $0.18 vs $0.11 Est; Revenue of $1.82B vs $1.78B Est,2013-01-29 07:07:00-05:00,BSX,neutral
191119.0,"US Stock Futures Slightly Lower Ahead Of Ford Earnings, Consumer Confidence Data",2013-01-29 05:59:00-05:00,BSX,positive
191120.0,"Earnings Scheduled For January 29, 2013",2013-01-29 03:39:00-05:00,BSX,neutral
191121.0,"UPDATE: J.P. Morgan Reiterates Neutral Rating, Raises PT on Boston Scientific Corporation",2013-01-28 13:18:00-05:00,BSX,neutral
191122.0,"JP Morgan Maintains Neutral on Boston Scientific Corporation, Raises PT to $7.00",2013-01-28 11:09:00-05:00,BSX,positive
191123.0,UPDATE: Stifel Nicolaus Raises PT to $6.51 on Boston Scientific Corporation S-ICD Checks  ,2013-01-16 13:25:00-05:00,BSX,neutral
191124.0,First Patient for Boston Scientific's ZERO AF Trial Treated,2013-01-16 11:32:00-05:00,BSX,neutral
191125.0,"Stifel Nicolaus Maintains Buy on Boston Scientific Corporation, Raises PT to $7.00",2013-01-16 08:31:00-05:00,BSX,neutral
191126.0,UPDATE: Credit Suisse Upgrades Boston Scientific to Outperform on Improving Top-Line  ,2013-01-15 12:32:00-05:00,BSX,positive
191127.0,"Credit Suisse Upgrades Boston Scientific Corporation to Outperform, Raises PT to $7.50",2013-01-15 08:33:00-05:00,BSX,positive
191128.0,A Peek Into The Market Before The Trading Starts,2013-01-15 07:17:00-05:00,BSX,neutral
191129.0,Benzinga's Top Upgrades,2013-01-15 07:05:00-05:00,BSX,positive
191130.0,Will the ObamaCare Excise Tax Kill the Medical Device Sector?,2013-01-08 16:00:00-05:00,BSX,negative
191131.0,"Deutsche Bank Maintains Hold on Boston Scientific Corporation, Raises PT to $6.70",2013-01-04 09:20:00-05:00,BSX,neutral
191132.0,Benzinga's Top Pre-Market Gainers,2012-12-26 08:08:00-05:00,BSX,positive
191133.0,Boston Scientific Commences Clinical Trial of Patients with INGEVITY Pacing Leads,2012-12-17 08:33:00-05:00,BSX,neutral
191134.0,Barclays Upgrades Boston Scientific Corporation to Overweight,2012-12-14 10:32:00-05:00,BSX,negative
191135.0,"Surprisingly, Politicians Could Boost Medical Device ETFs",2012-12-13 07:21:00-05:00,BSX,positive
191136.0,Boston Scientific Receives CE Mark for New Precision Spectra Spinal Cord Stimulator System ,2012-12-07 06:15:00-05:00,BSX,neutral
191137.0,Benzinga's Top Upgrades,2012-12-03 07:09:00-05:00,BSX,positive
191138.0,Benzinga's Top Upgrades,2012-12-03 07:07:00-05:00,BSX,positive
191139.0,Benzinga's Top Upgrades,2012-12-03 07:06:00-05:00,BSX,positive
191140.0,"Benzinga Market Primer, Monday, December 3",2012-12-03 06:56:00-05:00,BSX,neutral
191141.0,Benzinga's Top Downgrades,2012-11-27 09:02:00-05:00,BSX,positive
191142.0,"Bernstein Downgrades Boston Scientific from Outperform to Market Perform, Maintains PT at $6",2012-11-27 08:19:00-05:00,BSX,neutral
191143.0,UPDATE: Citigroup Upgrades Boston Scientific to Buy on Durata Withdrawal Impact  ,2012-11-26 08:08:00-05:00,BSX,neutral
191144.0,"Citigroup Upgrades Boston Scientific from Nuetral to Buy, Raises PT from $5.30 to $7.30",2012-11-26 08:04:00-05:00,BSX,neutral
191145.0,UPDATE: Stifel Nicolaus Initiates Boston Scientific Corporation at Buy on Steady Progress  ,2012-11-20 12:22:00-05:00,BSX,positive
191146.0,"Stifel Nicolaus Initiates Coverage on Boston Scientific at Buy, Announces PT of $6.50",2012-11-20 08:23:00-05:00,BSX,neutral
191147.0,"Benzinga's M&A Chatter for Thursday November 8, 2012",2012-11-08 19:04:00-05:00,BSX,neutral
191148.0,"Boston Scientific to Acquire Vessix Vascular With Upfront Payment of $125M, Milestone Payments up to $300M",2012-11-08 07:48:00-05:00,BSX,neutral
191149.0,"Benzinga Market Primer, Friday, October 26",2012-10-26 06:15:00-04:00,BSX,neutral
191150.0,Boston Scientific Says Epic Stent Continues Positive Clinical Outcomes,2012-10-23 08:14:00-04:00,BSX,positive
191151.0,"Jefferies & Company Maintains Boston Scientific at Hold, Raises PT from $5 to $6",2012-10-19 07:56:00-04:00,BSX,neutral
191152.0,"Earnings Scheduled For October 18, 2012",2012-10-18 03:22:00-04:00,BSX,neutral
191153.0,Earnings Expectations for the Week of October 15,2012-10-15 06:54:00-04:00,BSX,neutral
191154.0,First Patient Enrolled in Boston Scientific REPRISE II TAVR Clinical Trial ,2012-10-10 06:16:00-04:00,BSX,neutral
191155.0,Boston Scientific Buys Rhythmia Medical; Sees Immaterial in FY13 and FY14,2012-10-08 16:46:00-04:00,BSX,neutral
191156.0,UPDATE: Piper Jaffray Raises PT to $6 on Boston Scientific on Approcal of S-ICD System  ,2012-10-01 13:21:00-04:00,BSX,neutral
191157.0,"Piper Jaffray Maintains Boston Scientific at Neutral, Raises PT from $5.50 to $6",2012-10-01 07:53:00-04:00,BSX,neutral
191158.0,Boston Scientific Receives FDA Approval of First-in-Class S-ICD System for Patients at Risk of Sudden Cardiac Arrest ,2012-09-28 23:18:00-04:00,BSX,negative
191159.0,"UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, Lowers PO on Boston Scientific",2012-09-28 12:17:00-04:00,BSX,negative
191160.0,"Bank of America Maintains Boston Scientific at Neutral, Lowers PO from $8.50 to $6.30",2012-09-28 07:26:00-04:00,BSX,negative
191161.0,A Peek Into The Market Before The Trading Starts,2012-09-28 07:16:00-04:00,BSX,neutral
191162.0,Acacia Subsidiary Announces Settlement with Boston Scientific ,2012-09-28 06:12:00-04:00,BSX,neutral
191163.0,Boston Scientific Receives CE Mark for  Vercise  Deep Brain Stimulation System,2012-09-28 06:05:00-04:00,BSX,neutral
191164.0,Boston Scientific Launches Emerge PTCA Balloon Dilatation Catheter in the U.S. ,2012-09-27 08:38:00-04:00,BSX,neutral
191165.0,Boston Scientific Launches New Implantable Defibrillation Lead in Europe and Asia,2012-09-24 07:38:00-04:00,BSX,neutral
191166.0,Boston Scientific Launches New Implantable Defibrillation Lead In Europe And Asia ,2012-09-24 06:16:00-04:00,BSX,neutral
191167.0,Boston Scientific to Acquire BridgePoint Medical,2012-09-19 09:16:00-04:00,BSX,neutral
191168.0,Leerink Swann Downgrades Boston Scientific from Outperform to Market Perform,2012-09-18 10:03:00-04:00,BSX,neutral
191169.0,Boston Scientific Spikes Higher,2012-08-29 13:50:00-04:00,BSX,neutral
191170.0,"Boston Scientific Plans More Job Cuts, Will Separate Cardiac Divisions -Reuters",2012-08-29 13:46:00-04:00,BSX,negative
191171.0,A Peek Into The Market Before The Trading Starts,2012-08-27 07:22:00-04:00,BSX,neutral
191172.0,Boston Scientific WATCHMANÂ® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use ,2012-08-27 06:08:00-04:00,BSX,positive
191173.0,UPDATE: Jefferies Lowers PT on Boston Scientific Corp from $6 to $5,2012-07-27 11:35:00-04:00,BSX,negative
191174.0,"BMO Capital Markets Maintains Boston Scientific at Market Perform, Lowers PT from $6. to $5.50",2012-07-27 09:38:00-04:00,BSX,negative
191175.0,"Jefferies & Company Maintains Boston Scientific at Hold, Lowers PT from $6 to $5",2012-07-27 06:26:00-04:00,BSX,negative
191176.0,Boston Scientific Reports Q2 EPS $0.17 vs $0.10 Est; Revenues $1.83B vs $1.89B Est,2012-07-26 07:05:00-04:00,BSX,neutral
191177.0,UPDATE: Citigroup Reduces PT to $6 on Boston Scientific on Another Challenging Quarter  ,2012-07-23 10:12:00-04:00,BSX,positive
191178.0,"Citigroup Maintains Boston Scientific at Neutral, Lowers PT from $6.50 to $6",2012-07-23 06:23:00-04:00,BSX,negative
191179.0,Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting ,2012-07-18 08:30:00-04:00,BSX,positive
191180.0,Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device ,2012-07-02 08:31:00-04:00,BSX,neutral
191181.0,"Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying",2012-06-26 10:13:00-04:00,BSX,neutral
191182.0,Trading the Supreme Court's Obamacare Decision,2012-06-25 09:42:00-04:00,BSX,positive
191183.0,Supreme Court Decision Looms; How to Trade the Obamacare Ruling,2012-06-22 21:53:00-04:00,BSX,positive
191184.0,House Has Enough Votes for Medical Device Bill -Bloomberg,2012-06-07 17:00:00-04:00,BSX,neutral
191185.0,Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Elementâ¢ Plus Platinum Chromium Stent System ,2012-06-04 08:34:00-04:00,BSX,positive
191186.0,Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators ,2012-05-31 08:32:00-04:00,BSX,neutral
191187.0,Boston Scientific Announces Expanded Indication For CRE Wireguided Balloon Dilator ,2012-05-29 08:35:00-04:00,BSX,neutral
191188.0,FDA Fee Bill Gets Enough Support for Passage as Vote Continues -Bloomberg,2012-05-24 15:28:00-04:00,BSX,positive
191189.0,A Peek Into The Market Before The Trading Starts,2012-05-18 07:19:00-04:00,BSX,neutral
191190.0,Boston Scientific: PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study ,2012-05-18 06:32:00-04:00,BSX,positive
191191.0,Boston Scientific Announces FDA Approval and U.S. Launch of EPIC Vascular Stent,2012-05-17 17:16:00-04:00,BSX,positive
191192.0,Boston Scientific Announces Positive Data from Lotus Transcatheter Aortic Valve Trial,2012-05-15 12:46:00-04:00,BSX,positive
191193.0,Boston Scientific Announces Positive Data From Lotusâ¢ Transcatheter Aortic Valve Trial ,2012-05-15 11:00:00-04:00,BSX,positive
191194.0,Appaloosa Exited Stake in Boston Scientific,2012-05-14 16:41:00-04:00,BSX,neutral
191195.0,"UPDATE: Citigroup Reiterates Neutral Rating, Raises PT for Boston Scientific",2012-05-14 11:33:00-04:00,BSX,neutral
191196.0,Boston Scientific Announces CE Mark and European Launch of Innovaâ¢ Self-expanding Bare-metal Stent System ,2012-05-14 09:02:00-04:00,BSX,neutral
191197.0,Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering ,2012-05-14 08:32:00-04:00,BSX,neutral
191198.0,"Citigroup Maintains Boston Scientific at Neutral, Raises PT from $6.3 to $6.5",2012-05-14 07:52:00-04:00,BSX,neutral
191199.0,BSX: WATCHMANÂ® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation,2012-05-11 08:03:00-04:00,BSX,negative
191200.0,Boston Scientific Announces Schedule For EuroPCR 2012,2012-05-10 08:37:00-04:00,BSX,neutral
191201.0,Boston Scientific Announces FDA Approval and First U.S. Implant of New Devices To Treat Bradycardia ,2012-05-07 08:31:00-04:00,BSX,positive
191202.0,Boston Scientific Announces CE Mark and European Launch of Emerge PTCA Dilatation Catheter ,2012-04-24 08:30:00-04:00,BSX,neutral
191203.0,Boston Scientific's Cognis Defibrillator Linked to Death; Leerink Analyst Says Risk Minor -Bloomberg,2012-04-23 10:00:00-04:00,BSX,negative
191204.0,Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus Aortic Valve System ,2012-04-23 08:30:00-04:00,BSX,neutral
191205.0,"Deutsche Bank Maintains Boston Scientific at Hold, Raises PT from $6.5 to $6.75",2012-04-20 06:15:00-04:00,BSX,neutral
191206.0,Boston Scientific Sees First-Quarter Earnings Surge,2012-04-19 08:40:00-04:00,BSX,neutral
191207.0,Boston Scientific Reports Q1 EPS $0.15 vs $0.13 Est; Revenues $1.87B vs $1.86B Est,2012-04-19 07:57:00-04:00,BSX,neutral
191208.0,Boston Scientific Announces U.S. Launch of Z Flex-270 Steerable Sheath ,2012-04-11 08:32:00-04:00,BSX,neutral
191209.0,Boston Scientific Announces Launch of INGENIO Family of Pacemakers in Europe  ,2012-04-10 08:31:00-04:00,BSX,neutral
191210.0,Boston Scientific Marketing Backstop Gel in US,2012-04-02 08:35:00-04:00,BSX,neutral
191211.0,Boston Scientific: Alair Systems Meets CTAF Criteria,2012-03-27 08:33:00-04:00,BSX,neutral
191212.0,Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients,2012-03-26 08:36:00-04:00,BSX,negative
191213.0,Boston Scientific Begins U.S. and International Launch of WallFlex Biliary Transhepatic Stent System  ,2012-03-22 08:36:00-04:00,BSX,neutral
191214.0,"St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now",2012-03-21 07:20:00-04:00,BSX,positive
191215.0,Boston Scientific Reports Private Insurance Reimbursement for Alair BT System,2012-03-19 08:32:00-04:00,BSX,neutral
191216.0,Five Startup Tips from Sharing Spree CEO Ron Sapp,2012-03-16 13:22:00-04:00,BSX,positive
191217.0,"From Yesterday, Boston Scientific to Acquire Cameron Health for $150M",2012-03-09 07:34:00-05:00,BSX,neutral
191218.0,US Stock Futures Flat Ahead Of Jobs Data,2012-03-09 06:40:00-05:00,BSX,neutral
191219.0,Stocks To Watch For March 9,2012-03-09 04:25:00-05:00,BSX,neutral
191220.0,"Boston Scientific Will Acquire Cameron Health for $150M; Sees Deal Hurting 2012 EPS by $0.01; Will Fund Deal With Added Cash Flow, Sees Deal Breaking Even in 2013 on Adjusted Basis",2012-03-08 17:02:00-05:00,BSX,negative
191221.0,Boston Scientific Renews Agreement with Lumenis to Deliver Innovative Laser Products to Treat Urologic Conditions ,2012-03-08 08:31:00-05:00,BSX,positive
191222.0,"Option Alert: Boston Scientific January 2013 7.5 Call; Block Trade, 9,700 Contracts",2012-03-06 15:02:00-05:00,BSX,negative
191223.0,Boston Scientific Announces Launch of PROMUS Element Platinum Chromium Stent System in Japan  ,2012-03-01 08:33:00-05:00,BSX,neutral
191224.0,"Option Alert: Boston Scientific January 2013 Call; Block Trade, 2,200 Contracts",2012-02-23 11:15:00-05:00,BSX,negative
191225.0,Boston Scientific Announces First Implants of TELIGEN Implantable Defibrillator in China  ,2012-02-23 08:31:00-05:00,BSX,neutral
191226.0,Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients ,2012-02-22 17:01:00-05:00,BSX,neutral
191227.0,Boston Scientific WallFlex Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries ,2012-02-07 08:30:00-05:00,BSX,positive
191228.0,Boston Scientific Announces Global Launch of Expect 19 Flex Endoscopic Ultrasound Aspiration Needle ,2012-02-06 08:31:00-05:00,BSX,neutral
191229.0,"Benzinga's M&A Chatter for Friday February 3, 2012",2012-02-03 17:50:00-05:00,BSX,neutral
191230.0,"Option Alert: Heavy Volume in Boston Scientific February 7 Calls, 4,610 Contracts on Takeover Chatter",2012-02-03 10:42:00-05:00,BSX,positive
191231.0,Boston Scientific Spiking Higher on Takeover Chatter; KKR Rumored Buyer,2012-02-03 09:56:00-05:00,BSX,neutral
191232.0,Positive Rumors Circulate About Boston Scientific,2012-02-03 09:56:00-05:00,BSX,positive
191233.0,"Financial Breakfast: Morning News Summary for February 2, 2012",2012-02-02 07:27:00-05:00,BSX,neutral
191234.0,Boston Scientific Reports Q4EPS $0.13 vs $0.08 Est; Revenues $1.85B vs $1.91B Est	 			,2012-02-02 07:01:00-05:00,BSX,neutral
191235.0,Boston Scientific Announces First Implant and Market Launch of PROMUS Elementâ¢ Plus Stent System in Europe ,2012-02-01 08:32:00-05:00,BSX,neutral
191236.0,Top Performing Health Care Stocks in January,2012-02-01 06:32:00-05:00,BSX,positive
191237.0,Earnings Expectations for the Week of January 30,2012-01-29 09:53:00-05:00,BSX,neutral
191238.0,Boston Scientific Announces Favorable Ruling in Patent Infringement Case,2012-01-23 08:31:00-05:00,BSX,neutral
191239.0,Piper Jaffray Gives Insight to Medical Technology Industry Overview,2012-01-17 09:48:00-05:00,BSX,neutral
191240.0,From Earlier: Boston Scientific Epic Stent Demonstrates Positive Clinical Outcomes in Orion Trial  ,2012-01-17 07:10:00-05:00,BSX,positive
191241.0,Notable Call Options Activity in Boston Scientific,2012-01-10 15:42:00-05:00,BSX,neutral
191242.0,Boston Scientific's Alair Bronchial Thermoplasty System Achieves Important Reimbursement Milestones ,2012-01-04 07:33:00-05:00,BSX,positive
191243.0,Boston Scientific's Alair Bronchial Thermoplasty System Achieves Important Reimbursement Milestones,2012-01-04 07:31:00-05:00,BSX,positive
191244.0,Eight Healthcare Stocks Insiders Are Bullish About,2011-12-27 15:04:00-05:00,BSX,neutral
191245.0,Benzinga's Top Downgrades,2011-12-22 07:31:00-05:00,BSX,positive
191246.0,Mizuho Downgrades Boston Scientific to Neutral,2011-12-22 07:15:00-05:00,BSX,neutral
191247.0,Boston Scientific Hits 52-Week High of $5.14,2011-12-15 09:30:00-05:00,BSX,neutral
191248.0,Goldman Sachs Downgrades Boston Scientific to Sell from Neutral,2011-12-15 09:23:00-05:00,BSX,neutral
191249.0,Boston Scientific Hits 52-Week Low of $5.22,2011-12-14 10:31:00-05:00,BSX,negative
191250.0,Boston Scientific Receives FDA Approval for New Infinion 16 Percutaneous Lead for Precision Plus Spinal Cord Stimulator System ,2011-12-08 08:31:00-05:00,BSX,positive
191251.0,UPDATE: IRS Files $581M Deficiency Notice for Boston Scientific,2011-12-07 17:13:00-05:00,BSX,neutral
191252.0,IRS Files Deficiency Notice with Boston Scientific,2011-12-07 17:13:00-05:00,BSX,neutral
191253.0,Cooper Companies Earnings Preview: Double-Digit Revenue Growth Expected,2011-12-07 07:03:00-05:00,BSX,positive
191254.0,Boston Scientific Spiking Lower; May be Attributed to Barclay's Report,2011-12-02 14:36:00-05:00,BSX,negative
191255.0,Seven Stocks Insiders Are Buying,2011-12-02 14:12:00-05:00,BSX,neutral
191256.0,Boston Scientific Gets FDA Nod for Long-Lasting Implantable Cardiac Devices,2011-11-30 10:06:00-05:00,BSX,neutral
191257.0,Boston Scientific Announces FDA Approval and First Implant for New Devices to Treat Heart Failure and Sudden Cardiac Death,2011-11-30 08:31:00-05:00,BSX,negative
191258.0,Benzinga's Top Pre-Market Gainers,2011-11-25 07:38:00-05:00,BSX,positive
191259.0,"Stifel Nicolaus Reiterates Buy, $8 Target on Boston Scientific, Raises Estimates ",2011-11-23 11:23:00-05:00,BSX,neutral
191260.0,UPDATE: Citi Lowers PT to $5.70 on Boston Scientific ,2011-11-23 10:05:00-05:00,BSX,negative
191261.0,Jefferies Maintains Hold Rating and $6.50 PT on Boston Scientific ,2011-11-23 09:25:00-05:00,BSX,neutral
191262.0,Goldman Sachs Maintains Neutral Rating and $5.80 PT on Boston Scientific ,2011-11-23 09:14:00-05:00,BSX,neutral
191263.0,Citigroup Lowers PT on Boston Scientific to $5.70,2011-11-23 08:51:00-05:00,BSX,negative
191264.0,Benzinga's Top Pre-Market Gainers,2011-11-23 08:06:00-05:00,BSX,positive
191265.0,Morgan Stanley Reiterates Equal-Weight on Boston Scientific ,2011-11-23 07:54:00-05:00,BSX,neutral
191266.0,Bank of America Maintains Neutral Rating and $8.50 PT on Boston Scientific,2011-11-23 07:51:00-05:00,BSX,neutral
191267.0,Brean Murray Carret & Co Maintains Hold Rating on Boston Scientific ,2011-11-23 07:44:00-05:00,BSX,neutral
191268.0,"UPDATE: Piper Jaffray Reiterates Neutral, Ups Target to $7 on Boston Scientific ",2011-11-23 07:18:00-05:00,BSX,neutral
191269.0,Oppenheimer Reiterates Perform on Boston Scientific ,2011-11-23 07:00:00-05:00,BSX,neutral
191270.0,"FDA Approves PROMUS for Boston Scientific, Deutsche Bank Maintains Hold",2011-11-23 06:23:00-05:00,BSX,positive
191271.0,Piper Jaffray Lowers PT on Boston Scientific to $6,2011-11-23 05:54:00-05:00,BSX,negative
191272.0,Boston Scientific Hits 52-Week Low of $5.29,2011-11-21 10:51:00-05:00,BSX,negative
191273.0,"Medtronic Earnings Preview: Analysts Expect Flat EPS, Rising Revenue",2011-11-17 09:43:00-05:00,BSX,neutral
191274.0,Boston Scientific's WATCHMAN Device Implanted in First Patients in Latin America ,2011-11-16 08:30:00-05:00,BSX,neutral
191275.0,BofA/ML Reiterates Buy Rating on Blackstone Group,2011-11-14 13:12:00-05:00,BSX,neutral
191276.0,JP Morgan Lowers EPS Estimates on Boston Scientific ,2011-11-14 08:26:00-05:00,BSX,positive
191277.0,Morgan Stanley Maintains Equal-Weight Rating on Boston Scientific ,2011-11-14 06:52:00-05:00,BSX,neutral
191278.0,Boston Scientific SYNERGYâ¢ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Elementâ¢ Platinum Chromium Stent ,2011-11-11 14:32:00-05:00,BSX,positive
191279.0,Boston Scientific CRE Wireguided Balloon Dilator CE Marked for Expanded Indication ,2011-11-09 07:24:00-05:00,BSX,neutral
191280.0,"End-of-Day Market Summary for November 8, 2011",2011-11-08 16:14:00-05:00,BSX,neutral
191281.0,Boston Scientific Carotid WALLSTENT Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice,2011-11-08 14:57:00-05:00,BSX,positive
191282.0,Boston Scientific's PROMUS Element Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions ,2011-11-08 11:17:00-05:00,BSX,positive
191283.0,Boston Scientific Platinum Chromium IONâ¢ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program ,2011-11-08 11:00:00-05:00,BSX,positive
191284.0,Credit Suisse Initiating Coverage on Boston Scientific ,2011-11-03 09:06:00-04:00,BSX,positive
191285.0,Boston Scientific SpyGlass Direct Visualization System Demonstrates High Procedural Success Rate in Published Study ,2011-11-02 08:31:00-04:00,BSX,positive
191286.0,Celsion's Technical Breakout Appears to Have Upcoming News Wings,2011-11-01 00:54:00-04:00,BSX,neutral
191287.0,Notable Put Options Activity in Boston Scientific,2011-10-24 12:27:00-04:00,BSX,neutral
191288.0,Is Boston Scientific a Lucrative Pharma Investment?,2011-10-21 11:03:00-04:00,BSX,neutral
191289.0,Gabelli Has Hold on Boston Scientific,2011-10-21 08:54:00-04:00,BSX,neutral
191290.0,UPDATE: Piper Jaffray Lowers PT to $7 on Boston Scientific ,2011-10-21 08:27:00-04:00,BSX,negative
191291.0,Morgan Stanley Maintains Equal-Weight Rating on Boston Scientific  ,2011-10-21 08:03:00-04:00,BSX,neutral
191292.0,UPDATE: J.P. Morgan Lowers Price Target on Boston Scientific to $7,2011-10-21 07:57:00-04:00,BSX,negative
191293.0,Morgan Keegan Market Perform on Boston Scientific ,2011-10-21 07:48:00-04:00,BSX,neutral
191294.0,Earnings Roundup,2011-10-20 10:08:00-04:00,BSX,neutral
191295.0,UPDATE: Boston Scientific Reports Drop In Q3 Earnings,2011-10-20 09:33:00-04:00,BSX,negative
191296.0,Boston Scientific Tops Estimates Despite Profit Decline,2011-10-20 08:07:00-04:00,BSX,positive
191297.0,UPDATE: Boston Scientific Reports Drop In Q3 Earnings,2011-10-20 07:54:00-04:00,BSX,negative
191298.0,Boston Scientific Reports Q3 EPS $0.15 vs $0.09 Est; Revenues $1.87B vs $1.91B Est			,2011-10-20 07:47:00-04:00,BSX,neutral
191299.0,"Earnings Preview: Analysts Expect Boston Scientific's Revenue, Earnings to Dip",2011-10-19 16:13:00-04:00,BSX,neutral
191300.0,The Best of the Best From the Value Investing Congress,2011-10-19 15:22:00-04:00,BSX,positive
191301.0,Leon Cooperman's Top Ideas ,2011-10-18 09:40:00-04:00,BSX,positive
191302.0,Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlexÂ® Biliary RX Stent ,2011-10-18 08:32:00-04:00,BSX,positive
191303.0,Piper Jaffray Maintains Neutral Rating and $7.50 PT on Boston Scientific ,2011-10-18 07:53:00-04:00,BSX,neutral
191304.0,Notable Call Options Activity in Boston Scientific,2011-10-17 14:56:00-04:00,BSX,neutral
191305.0,Boston Scientific Launches Promus Element Stent System In China,2011-10-17 08:31:00-04:00,BSX,neutral
191306.0,Earnings Expectations for the Week of October 17,2011-10-16 09:36:00-04:00,BSX,neutral
191307.0,"Abbott Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-14 17:54:00-04:00,BSX,neutral
191308.0,"Edwards Lifesciences Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-14 17:50:00-04:00,BSX,negative
191309.0,"St. Jude Medical Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-14 17:50:00-04:00,BSX,neutral
191310.0,"Johnson & Johnson Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-14 10:19:00-04:00,BSX,negative
191311.0,Oppenheimer Publishes Industry Update on Large-Cap Medtech,2011-10-10 10:02:00-04:00,BSX,neutral
191312.0,Notable Call Options Activity in Boston Scientific,2011-10-07 11:12:00-04:00,BSX,neutral
191313.0,Boston Scientific Not Answering Phone to Comment on Takeover Chatter,2011-10-07 09:56:00-04:00,BSX,neutral
191314.0,Hearing Takeover Chatter in Boston Scientific ,2011-10-07 09:45:00-04:00,BSX,neutral
191315.0,Boston Scientific Begins Clinical Trial Enrollment for OMEGA Platinum Chromium Stent System ,2011-10-05 08:30:00-04:00,BSX,neutral
191316.0,Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial ,2011-09-29 17:00:00-04:00,BSX,neutral
191317.0,Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent ,2011-09-29 06:49:00-04:00,BSX,positive
191318.0,Block Trade Alert: 577K Shares of Boston Scientific Traded at $6.19,2011-09-27 10:40:00-04:00,BSX,positive
191319.0,Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair Bronchial Thermoplasty System ,2011-09-27 06:47:00-04:00,BSX,positive
191320.0,Boston Scientific Wins Ruling Dismissing Class Action Lawsuit; Was Accused of Inflating Share Price,2011-09-20 11:55:00-04:00,BSX,positive
191321.0,Boston Scientific Says Mahoney Will Get Sign-On Bonus of $1.5M,2011-09-19 17:10:00-04:00,BSX,positive
191322.0,Boston Scientific Launches Coyoteâ¢ Balloon Catheter,2011-09-19 08:30:00-04:00,BSX,neutral
191323.0,Top Ideas From Delivering Alpha,2011-09-15 11:41:00-04:00,BSX,positive
191324.0,"Piper Jaffray Maintains Boston Scientific Neutral, $7.50 PT",2011-09-14 07:58:00-04:00,BSX,neutral
191325.0,Oppenheimer Comments on Boston Scientific,2011-09-14 07:53:00-04:00,BSX,neutral
191326.0,Contrarian  09-13-2011,2011-09-13 19:27:00-04:00,BSX,neutral
191327.0,"Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan ",2011-09-13 17:00:00-04:00,BSX,neutral
191328.0,Boston Scientific Receives Notice of Delinquency From IRS; IRS Claiming $154M Net Assessment; Will File Petition To Tax Court to Contest,2011-09-12 17:14:00-04:00,BSX,neutral
191329.0,Block Trade Alert: 800K Shares of Boston Scientific Traded at $6.41,2011-09-07 11:54:00-04:00,BSX,positive
191330.0,MAKO Surgical and Urologix Hit New 52-Week Highs,2011-09-06 15:51:00-04:00,BSX,neutral
191331.0,Notable Put Options Activity in Boston Scientific,2011-09-02 14:08:00-04:00,BSX,neutral
191332.0,Block Trade Alert: 570K Shares of Boston Scientific at $6.36,2011-08-25 11:43:00-04:00,BSX,positive
191333.0,Benzinga's Top Downgrades,2011-08-24 07:49:00-04:00,BSX,positive
191334.0,"Morgan Keegan Downgrades Boston Scientific To Market Perform, Lowers PT To $7",2011-08-24 06:09:00-04:00,BSX,negative
191335.0,Benzinga's Top Pre-Market Gainers,2011-08-22 07:44:00-04:00,BSX,positive
191336.0,Can Support Hold?  08-11-2011,2011-08-15 15:08:00-04:00,BSX,positive
191337.0,Movin' On Up  08-11-2011,2011-08-15 15:05:00-04:00,BSX,neutral
191338.0,"Option Alert: Heavy Volume in Boston Scientific January 2012 7.5 Call; 14,000 Contracts",2011-08-11 09:52:00-04:00,BSX,positive
191339.0,Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case,2011-08-08 17:06:00-04:00,BSX,positive
191340.0,FDA Offical Will Speak Today on Device Report to Industry Lawyers,2011-08-04 11:11:00-04:00,BSX,neutral
191341.0,Morgan Keegan Reports Good Quarter For Boston Scientific,2011-07-29 09:32:00-04:00,BSX,positive
191342.0,UPDATE: Citi Lowers PT on Boston Scientific to $7.30,2011-07-29 08:08:00-04:00,BSX,negative
191343.0,J.P. Morgan Underweight On Boston Scientific Corporation,2011-07-29 07:37:00-04:00,BSX,neutral
191344.0,Morgan Stanley Comments on Performance at Boston Scientific,2011-07-29 07:11:00-04:00,BSX,neutral
191345.0,Citigroup Lowers PT on Boston Scientific To $7.30,2011-07-29 06:17:00-04:00,BSX,negative
191346.0,Thursday's S&P Sector Recap,2011-07-28 17:50:00-04:00,BSX,neutral
191347.0,"Boston Scientific Announces Elimination Of Up To 1,400 Jobs",2011-07-28 12:36:00-04:00,BSX,neutral
191348.0,Biggest Gainers of the Day,2011-07-28 10:27:00-04:00,BSX,neutral
191349.0,Boston Scientific Spiking Higher on Heavy Volume after $1B Buyback Announced Earlier This Morning,2011-07-28 09:47:00-04:00,BSX,neutral
191350.0,Boston Scientific Tops Wall Street Expectations,2011-07-28 09:09:00-04:00,BSX,positive
191351.0,"News Summary for July 28, 2011",2011-07-28 07:53:00-04:00,BSX,neutral
191352.0,A Peek Into The Market Before The Trading Starts,2011-07-28 07:22:00-04:00,BSX,neutral
191353.0,Boston Scientific Reports Q2 Prelim EPS $0.17 vs $0.09 Est; Revenues $1.98B vs $1.94B Est ,2011-07-28 07:02:00-04:00,BSX,neutral
191354.0,Boston Scientific Announces $1.0B Share Repurchase Program,2011-07-28 06:51:00-04:00,BSX,positive
191355.0,Earnings Scheduled For July 28,2011-07-28 05:02:00-04:00,BSX,neutral
191356.0,"Boston Scientific Announces Five-Year, $150 Million Investment in China to Accelerate Commercial Expansion",2011-07-27 08:41:00-04:00,BSX,neutral
191357.0,"Boston Scientific Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",2011-07-25 13:49:00-04:00,BSX,negative
191358.0,Markets Cautious - DC on Hot Seat over Weekend  07-22-2011,2011-07-22 18:54:00-04:00,BSX,negative
191359.0,"Vol Drops, Heat Still Up  07-22-2011",2011-07-22 15:05:00-04:00,BSX,neutral
191360.0,Calls Purchased on Boston Scientific,2011-07-22 10:36:00-04:00,BSX,neutral
191361.0,Earnings Preview: Edwards Lifesciences Revenue Expected to Rise,2011-07-18 14:55:00-04:00,BSX,neutral
191362.0,"Barclays Downgrades BSX, MDT",2011-07-18 07:44:00-04:00,BSX,neutral
191363.0,"Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-15 11:00:00-04:00,BSX,neutral
191364.0,"Earnings Preview: Johnson & Johnson EPS, Revenue Expected to Rise from Previous Quarter",2011-07-15 10:36:00-04:00,BSX,neutral
191365.0,"St. Jude Medical Earnings Preview: Analyts Expect Higher Earnings, Revenue from Prior Quarter",2011-07-15 10:15:00-04:00,BSX,neutral
191366.0,"Earnings Preview: Analysts Expect Abbott Laboratories Revenue, Earnings to Dip from Previous Quarter",2011-07-15 10:13:00-04:00,BSX,neutral
191367.0,"Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-13 12:44:00-04:00,BSX,neutral
191368.0,Boston Scientific Completes Clinical Trial Enrollment for Adapt Monorail Carotid Stent System ,2011-07-12 08:32:00-04:00,BSX,neutral
191369.0,Acacia Subsidiary Enters into Settlement Agreement with Boston Scientific Corporation   ,2011-07-12 07:06:00-04:00,BSX,positive
191370.0,Hottest and Coldest Sectors For the First Half of 2011,2011-07-05 02:49:00-04:00,BSX,neutral
191371.0,Time To Look At Boston Scientific?,2011-07-01 13:10:00-04:00,BSX,neutral
191372.0,Mad Money Lightning Round: Cramer Advises Investors To Buy Royal Dutch Shell,2011-07-01 00:22:00-04:00,BSX,negative
191373.0,Boston Scientific Announces U.S. and European Launch of Interlock - 35 Fibered IDC Occlusion System,2011-06-30 08:36:00-04:00,BSX,neutral
191374.0,Boston Scientific up Nearly 11% Pre-Market,2011-06-27 07:42:00-04:00,BSX,neutral
191375.0,Wednesday's S&P Sector Recap 6/22/11,2011-06-22 17:44:00-04:00,BSX,neutral
191376.0,Options Brief: Boston Scientific Corporation,2011-06-22 11:16:00-04:00,BSX,neutral
191377.0,Stifel Nicolaus Rating and Price Target Updates 6/22,2011-06-22 09:28:00-04:00,BSX,neutral
191378.0,"Stifel Nicolaus Upgrades BSX, FST To Buy",2011-06-22 08:01:00-04:00,BSX,neutral
191379.0,Bank of America Reiterates Neutral on Boston Scientific,2011-06-22 06:58:00-04:00,BSX,neutral
191380.0,Stocks and Sectors to Watch: S&P 500 Recap 6/20/11,2011-06-20 18:29:00-04:00,BSX,neutral
191381.0,Consumer Goods and Health Care Stocks Leading the Market,2011-06-20 13:09:00-04:00,BSX,positive
191382.0,FDA Announces Recall on Boston Scientific Innova Self-Expanding Stent System,2011-06-17 15:46:00-04:00,BSX,neutral
191383.0,"S&P Sector Update: Health Care Leading (1.3%), Basic Materials Lagging (2.5%)",2011-06-15 14:02:00-04:00,BSX,positive
191384.0,Boston Scientific Trading Higher As European Trial for Abdominal Stent Graft Begins,2011-06-15 09:25:00-04:00,BSX,neutral
191385.0,Health Care Sector Showing Strength,2011-06-13 13:28:00-04:00,BSX,positive
191386.0,Medtronic Is Shocking Under The Hood  (MDT),2011-06-08 19:23:00-04:00,BSX,negative
191387.0,Boston Scientific Wins Appeal In Stent Fight Against Johnson & Johnson -US Appeals Court,2011-06-07 11:21:00-04:00,BSX,positive
191388.0,Deutsche Bank Maintains Hold on Boston Scientific,2011-05-25 08:25:00-04:00,BSX,neutral
191389.0,Benzinga's Top Upgrades,2011-05-25 08:08:00-04:00,BSX,positive
191390.0,Boston Scientific Announces FDA Approval and U.S. Launch of PROMUSÂ® 2.25 mm Everolimus-Eluting Coronary Stent System,2011-05-25 07:01:00-04:00,BSX,positive
191391.0,"Goldman Sachs Upgrades Boston Scientific To Neutral, Raises PT To $7",2011-05-25 05:38:00-04:00,BSX,neutral
191392.0,Medtronic Earnings Preview: Modest Growth Seen for 4Q and FY 2011,2011-05-23 10:39:00-04:00,BSX,negative
191393.0,Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN Device,2011-05-18 08:01:00-04:00,BSX,positive
191394.0,Overall Trend is Intact  05-16-2011,2011-05-16 14:45:00-04:00,BSX,positive
191395.0,Boston Scientific Announces Long-term Safety and Effectiveness of Bronchial Thermoplasty Demonstrated in Treating Severe Asthma,2011-05-16 12:45:00-04:00,BSX,positive
191396.0,Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation ,2011-05-11 11:55:00-04:00,BSX,positive
191397.0,Boston Scientific Wins $19 Million Patent Damages From Cordis -Bloomberg (BSX),2011-05-11 11:16:00-04:00,BSX,positive
191398.0,Using the Euro as a Barometer  05-10-2011,2011-05-10 16:03:00-04:00,BSX,neutral
191399.0,Boston Scientific Plunges As CEO Retires (BSX),2011-05-10 13:45:00-04:00,BSX,neutral
191400.0,Boston Scientific Announces Retirement of Ray Elliott as President and CEO Effective End of 2011 (BSX),2011-05-10 10:48:00-04:00,BSX,positive
191401.0,Boston Scientific Begins U.S. and International Launch of Expect Endoscopic Ultrasound Aspiration Needle ,2011-05-09 08:31:00-04:00,BSX,neutral
191402.0,Boston Scientific Announces CE Mark Approval and First Use of Blazer Open-Irrigated Catheter in Europe ,2011-05-03 08:32:00-04:00,BSX,positive
191403.0,"Integrating Options into ""Sell in May & Go Away""  05-02-2011",2011-05-02 18:31:00-04:00,BSX,neutral
191404.0,Tornier N.V. Rallies on Alleged Johnson & Johnson Takeover (TRNX),2011-04-27 07:46:00-04:00,BSX,neutral
191405.0,"Trading on Johnson & Johnson's $21.3 Billion Purchase of Synthes (JNJ, MDT, BSX, TMO, IHI)",2011-04-27 06:14:00-04:00,BSX,neutral
191406.0,Boston Scientific Announces FDA Approval and U.S. Launch of ION Platinum Chromium Stent System  (BSX),2011-04-25 08:31:00-04:00,BSX,positive
191407.0,J.P. Morgan Raises PT On BSX To $8,2011-04-25 07:16:00-04:00,BSX,neutral
191408.0,Citi Revises Estimates On Boston Scientific,2011-04-25 07:03:00-04:00,BSX,neutral
191409.0,JP Morgan Raises PT on Boston Scientific To $8,2011-04-25 06:02:00-04:00,BSX,positive
191410.0,Boston Scientific Rises After Reporting Q1 Profit,2011-04-21 08:31:00-04:00,BSX,positive
191411.0,"J.P. Morgan Comments On BSX 1Q, Anticipates 8AM Call",2011-04-21 07:49:00-04:00,BSX,neutral
191412.0,Deutsche Bank Reports Reovery A Ways Off For Boston Scientific,2011-04-21 07:25:00-04:00,BSX,neutral
191413.0,Jefferies Maintains Hold on Boston Scientific (BSX),2011-04-21 07:25:00-04:00,BSX,neutral
191414.0,Boston Scientific Reports EPS $0.22 vs. $0.04 Estimate; Revenues $1.93B vs. $1.9B Estimate (BSX),2011-04-20 17:03:00-04:00,BSX,neutral
191415.0,Calls Purchased on Boston Scientific Corporation (BSX),2011-04-11 10:48:00-04:00,BSX,neutral
191416.0,Unconfirmed Rumors circulate that (JNJ) is in final stages to acquire (BSX) at $9.50 a share,2011-04-11 09:54:00-04:00,BSX,positive
191417.0,Boston Scientific Ticks Higher On Takeover Chatter (BSX),2011-04-11 09:40:00-04:00,BSX,neutral
191418.0,Boston Scientific Begins International Clinical Trial Enrollment for INNOVA Self-Expanding Bare-Metal Stent System ,2011-04-05 08:36:00-04:00,BSX,neutral
191419.0,Piper Jaffray On BSX Following Platinum Trial At ACC,2011-04-05 08:29:00-04:00,BSX,neutral
191420.0,Morgan Stanley On Boston Scientific's Promus Element,2011-04-05 07:34:00-04:00,BSX,neutral
191421.0,Semiconductors Get Lift  04-04-2011,2011-04-04 19:35:00-04:00,BSX,neutral
191422.0,Commodities Up on Strength of Emerging Markets  04-04-2011,2011-04-04 19:32:00-04:00,BSX,positive
191423.0,Boston Scientific's Promus Element Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial,2011-04-04 12:35:00-04:00,BSX,positive
191424.0,Traders Buying Protection on Boston Scientific (BSX),2011-04-04 11:59:00-04:00,BSX,neutral
191425.0,The Canary Chirped,2011-04-01 17:52:00-04:00,BSX,neutral
191426.0,Puts Purchased on Boston Scientific Corporation (BSX),2011-04-01 11:09:00-04:00,BSX,neutral
191427.0,BG Medicine Announces Research Agreement With Boston Scientific,2011-03-30 08:35:00-04:00,BSX,positive
191428.0,Boston Scientific Receives FDA Approval of New Clik Anchor for Precision Plus Spinal Cord Stimulator System,2011-03-24 08:37:00-04:00,BSX,positive
191429.0,Boston Scientific Receives FDA Approval of New Clik (BSX),2011-03-24 08:34:00-04:00,BSX,positive
191430.0,Options Brief: Boston Scientific Corporation (BSX),2011-03-11 15:10:00-05:00,BSX,neutral
191431.0,Boston Scientific Announces European Approval and Launch of OMEGA Platinum Chromium Stent System ,2011-03-07 08:35:00-05:00,BSX,positive
191432.0,Boston Scientific Ticks Higher On $10+ Buyout Rumor (BSX),2011-03-04 09:43:00-05:00,BSX,neutral
191433.0,Unconfirmed Rumors Circulate That (BSX) will be acquired at $12.50 a share,2011-03-04 09:43:00-05:00,BSX,positive
191434.0,"Benzinga's Top Upgrades (ESV, LVS, BSX, AONE)",2011-03-01 08:15:00-05:00,BSX,positive
191435.0,"John Paulson Adds Stakes In Health Care Companies, Oil Companies (APC, RIG, BAX)",2011-02-15 08:42:00-05:00,BSX,positive
191436.0,Earnings Scorecard: St. Jude - Analyst Blog,2011-02-03 10:01:00-05:00,BSX,neutral
191437.0,Earnings Scorecard: St. Jude - Analyst Blog,2011-02-03 09:30:00-05:00,BSX,neutral
191438.0,"Benzinga's Top Downgrades (LUV, BSX, APC, KBH)",2011-02-03 08:29:00-05:00,BSX,positive
191439.0,Deutsche Bank Maintains Hold On Boston Scientific (BSX),2011-02-03 07:24:00-05:00,BSX,neutral
191440.0,"Jefferies Remains On Boston Scientific Sidelines, Hold Rating (BSX)",2011-02-02 09:02:00-05:00,BSX,neutral
191441.0,Deutsche Bank Reduces Boston Scientific PT To $7.40 (BSX),2011-02-02 08:36:00-05:00,BSX,neutral
191442.0,Boston Scientific Beats - Analyst Blog,2011-02-02 08:35:00-05:00,BSX,neutral
191443.0,Boston Scientific Beats - Analyst Blog,2011-02-02 08:15:00-05:00,BSX,neutral
191444.0,Citi Leaves Boston Scientific Price Target Of $6.70 Unchanged (BSX),2011-02-02 07:44:00-05:00,BSX,neutral
191445.0,Deutsche Bank Lowers PT On Boston Scientific To $7.40,2011-02-02 07:29:00-05:00,BSX,negative
191446.0,Boston Scientic Reports Better Than Expected Earnings (BSX) ,2011-02-01 17:14:00-05:00,BSX,positive
191447.0,Boston Scientific Corporation Reports Q4 EPS of $.15 vs. $.10; Revenues $2.002B vs. $1.99B,2011-02-01 17:03:00-05:00,BSX,neutral
191448.0,"C.R. Bard's Mixed 4Q, Profit Zooms - Analyst Blog",2011-02-01 11:07:00-05:00,BSX,negative
191449.0,"C.R. Bard's Mixed 4Q, Profit Zooms - Analyst Blog",2011-02-01 10:45:00-05:00,BSX,negative
191450.0,Piper Jaffray Previews Boston Scientific's Q4 10 Earnings (BSX),2011-02-01 08:05:00-05:00,BSX,neutral
191451.0,"US Stock Futures Up As Investors Await Economic Data, Earnings Reports; Pfizer Results In Focus",2011-02-01 06:46:00-05:00,BSX,positive
191452.0,"Earnings Scheduled For February 1 (UPS, PFE, BIIB, ADM, COV, CE, MHP, LXK, BRCM, AFL, ERTS, BSX, WU)",2011-02-01 03:20:00-05:00,BSX,neutral
191453.0,Earnings Preview: Boston Scientific - Analyst Blog,2011-01-31 15:52:00-05:00,BSX,neutral
191454.0,Earnings Preview: Boston Scientific - Analyst Blog,2011-01-31 15:18:00-05:00,BSX,neutral
191455.0,Earnings Scorecard: Stryker - Analyst Blog,2011-01-31 15:01:00-05:00,BSX,neutral
191456.0,Earnings Scorecard: Stryker - Analyst Blog,2011-01-31 14:19:00-05:00,BSX,neutral
191457.0,Boston Scientific Announces FDA Approval of Renegade HI-FLO Fathom Pre-Loaded System ,2011-01-31 08:33:00-05:00,BSX,positive
191458.0,Boston Scientific Responds to DOJ Civil Lawsuit,2011-01-28 09:08:00-05:00,BSX,negative
191459.0,Hearing U.S. Government Sues Boston Scientific Corporation (BSX),2011-01-27 17:03:00-05:00,BSX,neutral
191460.0,St. Jude Beats on All Fronts  - Analyst Blog,2011-01-26 16:31:00-05:00,BSX,neutral
191461.0,St. Jude Beats on All Fronts  - Analyst Blog,2011-01-26 15:42:00-05:00,BSX,neutral
191462.0,Stryker Beats but Concerns Linger - Analyst Blog,2011-01-26 09:31:00-05:00,BSX,neutral
191463.0,Stryker Beats but Concerns Linger - Analyst Blog,2011-01-26 09:15:00-05:00,BSX,neutral
191464.0,BSX Evolves with EVOLVE Trial - Analyst Blog,2011-01-25 17:31:00-05:00,BSX,neutral
191465.0,BSX Evolves with EVOLVE Trial - Analyst Blog,2011-01-25 16:53:00-05:00,BSX,neutral
191466.0,Earnings Preview: St. Jude - Analyst Blog,2011-01-25 10:31:00-05:00,BSX,neutral
191467.0,Earnings Preview: St. Jude - Analyst Blog,2011-01-25 10:00:00-05:00,BSX,neutral
191468.0,Boston Scientific Targets Japan - Analyst Blog,2011-01-24 17:31:00-05:00,BSX,neutral
191469.0,Boston Scientific Targets Japan - Analyst Blog,2011-01-24 17:18:00-05:00,BSX,neutral
191470.0,Earnings Preview: Stryker - Analyst Blog,2011-01-24 12:01:00-05:00,BSX,neutral
191471.0,Earnings Preview: Stryker - Analyst Blog,2011-01-24 11:30:00-05:00,BSX,neutral
191472.0,510 (k) Reform: FDA's Blueprint - Analyst Blog,2011-01-21 15:31:00-05:00,BSX,neutral
191473.0,510 (k) Reform: FDA's Blueprint - Analyst Blog,2011-01-21 14:49:00-05:00,BSX,neutral
191474.0,BSX Gets Watchman with Atritech - Analyst Blog,2011-01-20 18:31:00-05:00,BSX,neutral
191475.0,BSX Gets Watchman with Atritech - Analyst Blog,2011-01-20 18:23:00-05:00,BSX,neutral
191476.0,BSDM's MTX-180 Debuts in Europe - Analyst Blog,2011-01-20 17:01:00-05:00,BSX,neutral
191477.0,BSDM's MTX-180 Debuts in Europe - Analyst Blog,2011-01-20 16:44:00-05:00,BSX,neutral
191478.0,Boston Scientific to Acquire Atritech for up to $375M,2011-01-19 08:36:00-05:00,BSX,neutral
191479.0,Market Longs Are Strong  01-18-2011,2011-01-18 18:22:00-05:00,BSX,positive
191480.0,Bad News Easily Absorbed  01-18-2011,2011-01-18 15:58:00-05:00,BSX,negative
191481.0,BSX Pins Hopes on Neuro (revised) - Analyst Blog,2011-01-18 12:01:00-05:00,BSX,positive
191482.0,BSX Pins Hopes on Neuro (revised) - Analyst Blog,2011-01-18 11:36:00-05:00,BSX,positive
191483.0,St Jude's New Ultrasound System - Analyst Blog,2011-01-17 16:31:00-05:00,BSX,neutral
191484.0,St Jude's New Ultrasound System - Analyst Blog,2011-01-17 16:15:00-05:00,BSX,neutral
191485.0,St. Jude's Prelim 4Q Sales Tops - Analyst Blog,2011-01-13 11:01:00-05:00,BSX,negative
191486.0,St. Jude's Prelim 4Q Sales Tops - Analyst Blog,2011-01-13 10:15:00-05:00,BSX,negative
191487.0,"AMMD Posts Prelim Sales, Reaffirms - Analyst Blog",2011-01-12 16:01:00-05:00,BSX,neutral
191488.0,"AMMD Posts Prelim Sales, Reaffirms - Analyst Blog",2011-01-12 15:34:00-05:00,BSX,neutral
191489.0,Stryker Rises on Buoyant View - Analyst Blog,2011-01-11 14:01:00-05:00,BSX,positive
191490.0,Stryker Rises on Buoyant View - Analyst Blog,2011-01-11 13:19:00-05:00,BSX,positive
191491.0,"Tuesday's Put/Call Ratio Leaders (ASNA, AON, BSX, HOG, IBN)",2011-01-11 12:10:00-05:00,BSX,neutral
191492.0,AngioDynamics Remains Neutral - Analyst Blog,2011-01-10 18:01:00-05:00,BSX,neutral
191493.0,AngioDynamics Remains Neutral - Analyst Blog,2011-01-10 17:40:00-05:00,BSX,neutral
191494.0,Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent,2011-01-10 08:34:00-05:00,BSX,neutral
191495.0,Stereotaxis' New Distribution Deal - Analyst Blog,2011-01-06 18:30:00-05:00,BSX,neutral
191496.0,Stereotaxis' New Distribution Deal - Analyst Blog,2011-01-06 18:07:00-05:00,BSX,neutral
191497.0,BSX Pins its Hope on Neuro - Analyst Blog,2011-01-06 09:03:00-05:00,BSX,positive
191498.0,BSX Pins its Hope on Neuro - Analyst Blog,2011-01-06 08:30:00-05:00,BSX,positive
191499.0,Boston Scientific Acquires Intelect Medical for $60M,2011-01-05 15:34:00-05:00,BSX,neutral
191500.0,Stryker Buys Boston Sci Unit  - Analyst Blog,2011-01-05 14:33:00-05:00,BSX,neutral
191501.0,Stryker Buys Boston Sci Unit  - Analyst Blog,2011-01-05 14:08:00-05:00,BSX,neutral
191502.0,AngioDynamics Posts a Mixed Bag - Analyst Blog,2011-01-05 12:33:00-05:00,BSX,neutral
191503.0,AngioDynamics Posts a Mixed Bag - Analyst Blog,2011-01-05 12:15:00-05:00,BSX,neutral
191504.0,BSX Completes Sadra Acquisition - Analyst Blog,2011-01-05 09:33:00-05:00,BSX,neutral
191505.0,BSX Completes Sadra Acquisition - Analyst Blog,2011-01-05 08:45:00-05:00,BSX,neutral
191506.0,Boston Scientific Acquires Sadra Medical for $193M,2011-01-04 16:14:00-05:00,BSX,neutral
191507.0,"Research in Motion: Targets, Estimates",2011-01-04 09:16:00-05:00,BSX,neutral
191508.0,Parsing Through ETFs For REITs' Extended Rally,2011-01-03 14:39:00-05:00,BSX,neutral
191509.0,Boston Scientific Sells Neurovascular Business ,2011-01-03 11:31:00-05:00,BSX,neutral
191510.0,J.P Morgan Downgrades Boston Scientific To Underweight From Neutral,2011-01-03 08:12:00-05:00,BSX,neutral
191511.0,JP Morgan Downgrades Boston Scientific To Underweight,2011-01-03 06:56:00-05:00,BSX,positive
191512.0,BSDM Setting up Sales Network - Analyst Blog,2010-12-23 18:03:00-05:00,BSX,neutral
191513.0,BSDM Setting up Sales Network - Analyst Blog,2010-12-23 17:45:00-05:00,BSX,neutral
191514.0,Good News for BSD Medical - Analyst Blog,2010-12-22 18:03:00-05:00,BSX,positive
191515.0,Good News for BSD Medical - Analyst Blog,2010-12-22 17:25:00-05:00,BSX,positive
191516.0,"Wednesday's Put/Call Ratio Leaders (CVBF, MNTA, JDSU, NG, BSX)",2010-12-22 12:48:00-05:00,BSX,neutral
191517.0,Options Brief: Boston Scientific Corporation (BSX),2010-12-22 11:12:00-05:00,BSX,neutral
191518.0,Boston Scientific: Where Will It Trade in 2011?,2010-12-21 11:29:00-05:00,BSX,neutral
191519.0,Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board ,2010-12-20 17:00:00-05:00,BSX,neutral
191520.0,"Boston Scientific Stock: Big, Bullish Breakout",2010-12-17 14:42:00-05:00,BSX,neutral
191521.0,C.R. Bard Initiates FY11 Guidance - Analyst Blog,2010-12-15 18:03:00-05:00,BSX,neutral
191522.0,C.R. Bard Initiates FY11 Guidance - Analyst Blog,2010-12-15 17:21:00-05:00,BSX,neutral
191523.0,Edwards Lifesciences Sees Growth  - Analyst Blog,2010-12-14 18:33:00-05:00,BSX,positive
191524.0,Edwards Lifesciences Sees Growth  - Analyst Blog,2010-12-14 17:51:00-05:00,BSX,positive
191525.0,Edwards Stays Neutral - Analyst Blog,2010-12-10 18:33:00-05:00,BSX,neutral
191526.0,Edwards Stays Neutral - Analyst Blog,2010-12-10 17:46:00-05:00,BSX,neutral
191527.0,Wells Fargo's EPS Revisions,2010-12-08 08:53:00-05:00,BSX,positive
191528.0,Earnings Scorecard: Medtronic - Analyst Blog,2010-12-08 02:03:00-05:00,BSX,neutral
191529.0,Earnings Scorecard: Medtronic - Analyst Blog,2010-12-07 15:24:00-05:00,BSX,neutral
191530.0,Medical Devices Industry Outlook - Dec. 2010 - Zacks Analyst Interviews,2010-12-06 17:30:00-05:00,BSX,neutral
191531.0,Medical Devices Industry Outlook - Dec. 2010 - Industry Outlook,2010-12-06 17:30:00-05:00,BSX,neutral
191532.0,Medical Devices Industry Outlook â Dec. 2010 - Industry Outlook,2010-12-06 17:30:00-05:00,BSX,neutral
191533.0,Medical Devices Industry Outlook â Dec. 2010 - Industry Outlook,2010-12-06 16:57:00-05:00,BSX,neutral
191534.0,Collins Stewart On Medical Devices & Hospital Supplies,2010-12-06 06:49:00-05:00,BSX,neutral
191535.0,Medical Devices Industry Outlook - Dec. 2010 - Zacks Analyst Interviews,2010-12-06 00:00:00-05:00,BSX,neutral
191536.0,Medical Devices Industry Outlook - Dec. 2010 - Industry Outlook,2010-12-06 00:00:00-05:00,BSX,neutral
191537.0,SurModics Cut to Underperform - Analyst Blog,2010-12-01 14:51:00-05:00,BSX,negative
191538.0,SurModics Cut to Underperform - Analyst Blog,2010-12-01 08:58:00-05:00,BSX,negative
191539.0,Piper Jaffray Encouraged After Meeting With Boston Scientific Management (BSX),2010-12-01 07:55:00-05:00,BSX,positive
191540.0,"Benzinga's After Hours Gainers (LNC, BSX, OCR, ES)",2010-11-26 15:24:00-05:00,BSX,neutral
191541.0,Earnings Preview: Medtronic - Analyst Blog,2010-11-22 11:00:00-05:00,BSX,neutral
191542.0,BSX to Acquire Sadra Medical - Analyst Blog,2010-11-22 10:06:00-05:00,BSX,neutral
191543.0,Oppenheimer Maintains Perform on Boston Scietific Corp. Following Analyst Day (BSX),2010-11-22 09:13:00-05:00,BSX,neutral
191544.0,Collins Stewart Reiterates Buy Rating on Boston Scientific (BSX),2010-11-22 09:13:00-05:00,BSX,neutral
191545.0,Goldman Sachs Maintains Its Sell Rating on Boston Scientific Corp. (BSX),2010-11-22 08:46:00-05:00,BSX,neutral
191546.0,J.P. Morgan Maintains Neutral Rating on Boston Scientific Corp. (BSX),2010-11-22 07:57:00-05:00,BSX,neutral
191547.0,Earnings Preview: Medtronic - Analyst Blog,2010-11-22 05:16:00-05:00,BSX,neutral
191548.0,BSX to Acquire Sadra Medical - Analyst Blog,2010-11-22 04:42:00-05:00,BSX,neutral
191549.0,St. Jude Wraps Up AGA Acquisition - Analyst Blog,2010-11-19 18:33:00-05:00,BSX,neutral
191550.0,St. Jude Wraps Up AGA Acquisition - Analyst Blog,2010-11-19 13:05:00-05:00,BSX,neutral
191551.0,Boston Scientific to Acquire Sadra Medical ,2010-11-19 12:02:00-05:00,BSX,neutral
191552.0,Domestic News Continues to Take Back Seat  11-17-2010,2010-11-17 15:40:00-05:00,BSX,neutral
191553.0,St. Jude & ZONARE in Imaging Tie-up - Analyst Blog,2010-11-17 12:33:00-05:00,BSX,neutral
191554.0,J.P. Morgan Reiterates Neutral Rating on Boston Scientific (BSX),2010-11-17 10:01:00-05:00,BSX,neutral
191555.0,St. Jude & ZONARE in Imaging Tie-up - Analyst Blog,2010-11-17 06:48:00-05:00,BSX,neutral
191556.0,Neutral on American Medical  - Analyst Blog,2010-11-16 17:39:00-05:00,BSX,neutral
191557.0,Gold & Silver Continue Move  11-09-2010,2010-11-09 13:42:00-05:00,BSX,neutral
191558.0,"Collins Stewart Initiates Coverages (BSX, MDT, STJ)",2010-11-04 10:24:00-04:00,BSX,neutral
191559.0,Priced Into the Market  11-01-2010,2010-11-01 15:05:00-04:00,BSX,neutral
191560.0,"Biotech /Pharma Market Movers; (NYSE:BSX), (NASDAQ:BPAX), (OTCBB: UVFT), (NASDAQ: CELG)",2010-10-28 14:14:00-04:00,BSX,neutral
191561.0,Boston Scientific Up In Pre-Market On Asset Sale (BSX),2010-10-28 08:17:00-04:00,BSX,positive
191562.0,Boston Scientific Completes Acquisition of Asthmatx for $193.5M,2010-10-26 17:01:00-04:00,BSX,neutral
191563.0,Boston Scientific Announces CE Mark Approval for WallFlexÂ® Biliary RX Stent ,2010-10-22 08:35:00-04:00,BSX,positive
191564.0,Boston Scientific Announces FDA Clearance for Advanix Biliary Stents,2010-10-21 08:36:00-04:00,BSX,neutral
191565.0,Boston Scientific Surpasses - Analyst Blog,2010-10-20 19:09:00-04:00,BSX,neutral
191566.0,"Zacks Analyst Blog Highlights: STJ,AGAM,BAC,MDT,BSX - Press Releases",2010-10-20 18:54:00-04:00,BSX,neutral
191567.0,"Market Roundup (EBAY, NFLX, STJ, BSX, UNH, RCRC, DAL, LCC, AMR)",2010-10-20 14:00:00-04:00,BSX,neutral
191568.0,Stocks Moving Sharply Higher Today,2010-10-20 12:29:00-04:00,BSX,neutral
191569.0,Boston Scientific Among Top Gainers Today (BSX),2010-10-20 11:16:00-04:00,BSX,positive
191570.0,Deutsche Bank Raises Boston Scientific Price Target,2010-10-20 11:15:00-04:00,BSX,neutral
191571.0,Boston Scientific Reports Earnings; Raises Guidance (BSX),2010-10-19 16:08:00-04:00,BSX,neutral
191572.0,"AAPL and Oil and 7.5% Levels, Oh My  ",2010-10-19 14:12:00-04:00,BSX,neutral
191573.0,Markets Well Off Lows ,2010-10-19 11:52:00-04:00,BSX,positive
191574.0,"Earnings Scheduled For October 19 (GS, BAC, KO, YHOO, UNH, JNPR, SLM, NYT, HOG, JNJ, ITW, EMC, LMT, GILD, BK, MICC, STT, WDC, BSX, MNI, OXY, BTU)",2010-10-19 04:46:00-04:00,BSX,neutral
191575.0,Earnings Preview: St. Jude - Analyst Blog,2010-10-18 14:45:00-04:00,BSX,neutral
191576.0,"Boston Scientific Chairman Sells 25,000 Shares of BSX",2010-10-04 16:26:00-04:00,BSX,positive
191577.0,Coverage Initiated For Boston Scientific At Hold,2010-09-29 08:06:00-04:00,BSX,neutral
191578.0,"Boston Scientific Corp. Chairman Sells 25,000 Shares of BSX",2010-09-22 17:04:00-04:00,BSX,positive
191579.0,Boston Scientific to Acquire Asthmatx - Analyst Blog,2010-09-21 19:03:00-04:00,BSX,neutral
191580.0,SPX Held Key Support 1139  09-21-2010,2010-09-21 18:38:00-04:00,BSX,positive
191581.0,St. Jude's Athena DBS Gets CE Mark - Analyst Blog,2010-09-21 18:21:00-04:00,BSX,neutral
191582.0,Waiting on the Fed  09-21-2010,2010-09-21 15:05:00-04:00,BSX,neutral
191583.0,Call Volume Growing on Boston Scientific (BSX),2010-09-21 12:01:00-04:00,BSX,positive
191584.0,FDA Labeling Seen As Positive For Boston Scientific,2010-09-17 10:20:00-04:00,BSX,positive
191585.0,Expanded Approval for BSX's CRT-Ds - Analyst Blog,2010-09-17 09:39:00-04:00,BSX,positive
191586.0,Two Top Selections for Contrarian Investors ,2010-09-16 10:05:00-04:00,BSX,positive
191587.0,"Cramer Likes JPMorgan Chase, Prefers Berkshire Hathaway  Over USG Corp",2010-09-16 07:14:00-04:00,BSX,positive
191588.0,"Mad Money Lightning Round: Cramer Sees JPM At $50 (BSX, MAT, HAS, NFLX, JPM, VOD ,USG)",2010-09-15 20:16:00-04:00,BSX,negative
191589.0,Morgan Stanley's Equity Morning Summary,2010-09-10 09:30:00-04:00,BSX,neutral
191590.0,Deutsche Bank Initiations For 9/10,2010-09-10 08:34:00-04:00,BSX,neutral
191591.0,Deutsche Bank Initiations For 9/10,2010-09-10 08:33:00-04:00,BSX,neutral
191592.0,AngioDynamics Q1 View Disappoints - Analyst Blog,2010-09-08 15:03:00-04:00,BSX,negative
191593.0,Earnings Scorecard: Medtronic - Analyst Blog,2010-09-03 16:36:00-04:00,BSX,neutral
191594.0,Stryker Buying Gaymar Industries - Analyst Blog,2010-08-26 13:09:00-04:00,BSX,neutral
191595.0,Medical Devices Industry Outlook - August 2010 - Industry Outlook,2010-08-24 19:15:00-04:00,BSX,neutral
191596.0,Earnings Preview: Medtronic  - Analyst Blog,2010-08-23 08:23:00-04:00,BSX,neutral
191597.0,Stryker Mulls Buying Boston Unit - Analyst Blog,2010-08-19 11:20:00-04:00,BSX,neutral
191598.0,American Medical Remains Neutral  - Analyst Blog,2010-08-16 15:46:00-04:00,BSX,neutral
191599.0,Good News for Boston Scientific  - Analyst Blog,2010-08-12 15:07:00-04:00,BSX,positive
191600.0,AMMD AdVance XP Gets CE Mark - Analyst Blog,2010-08-10 23:59:00-04:00,BSX,positive
191601.0,American Medical Beats by a Whisker - Analyst Blog,2010-08-04 15:29:00-04:00,BSX,neutral
191602.0,Earnings Scorecard: Boston Scientific - Analyst Blog,2010-08-03 16:45:00-04:00,BSX,neutral
191603.0,Left Behind By The Rally,2010-08-03 03:35:00-04:00,BSX,neutral
191604.0,"Volcano Beats, Raises Guidance - Analyst Blog",2010-08-02 13:39:00-04:00,BSX,neutral
191605.0,Boston Scientific Announces FDA Approval of New Leads for the Precision Plus Spinal Cord Stimulator System,2010-07-29 15:32:00-04:00,BSX,positive
191606.0,Puts Purchased on Boston Scientific (BSX),2010-07-23 14:48:00-04:00,BSX,neutral
191607.0,Piper Jaffray Reiterates Neutral Rating on Boston Scientific (BSX),2010-07-22 09:42:00-04:00,BSX,neutral
191608.0,Boston Scientific Estimates Updated For 2010 And Beyond,2010-07-22 08:52:00-04:00,BSX,neutral
191609.0,Boston Scientific Beats on Top and Bottom Line (BSX),2010-07-20 17:05:00-04:00,BSX,positive
191610.0,Piper Jaffray Reiterates Neutral Rating on Boston Scientific (BSX),2010-07-15 13:31:00-04:00,BSX,neutral
191611.0,Shorts Flee Strongest Stocks,2010-07-13 08:25:00-04:00,BSX,positive
191612.0,Boston Scientific Announces Patient Enrollment in New Trials,2010-07-08 08:43:00-04:00,BSX,neutral
191613.0,"Jim Cramer's Mad Money Lightning Round OT (MLNX, MRVL, INTC, BSX, FTR)",2010-06-14 19:46:00-04:00,BSX,negative
191614.0,"Company News for June 9, 2010 - Corporate Summary",2010-06-09 10:14:00-04:00,BSX,neutral
191615.0,Goldman Removes BSX From Conviction Sell List,2010-06-09 07:08:00-04:00,BSX,neutral
191616.0,Puts Purchased on Boston Scientific (BSX),2010-06-03 11:23:00-04:00,BSX,neutral
191617.0,Todayâs Best Market Rumors (6/1/2010),2010-06-01 08:52:00-04:00,BSX,positive
191618.0,"Top Day Trader Alerts (AIG, BP, EVVV, RSH, IRE, AIB, NBG)",2010-06-01 08:51:00-04:00,BSX,positive
191619.0,The Twitter-24/7 Wall St. Stock Market Report 5.28.2010 The Wisdom Of Crowds?,2010-06-01 08:39:00-04:00,BSX,positive
191620.0,Piper Jaffray Issues Positive Comments on Johnson and Johnson (JNJ),2010-05-26 15:06:00-04:00,BSX,positive
191621.0,"George Soros Cuts His Stake In GLD! (C, GLD, PFE, MO, BK, PBR, BSX, SU, KO, VZ, XOM)",2010-05-17 18:43:00-04:00,BSX,negative
191622.0,"Greenlight Capital's Newest 13-F (ABX, EMC, CIT, BJS, BSX, FBC, MSFT)",2010-05-17 17:24:00-04:00,BSX,neutral
191623.0,Boston Scientific Announces European Approval Of Stent System,2010-05-12 08:34:00-04:00,BSX,positive
191624.0,"Boston Scientific Bars Media From Its Annual Meeting (BSX, RISK)",2010-05-11 19:23:00-04:00,BSX,neutral
191625.0,Boston Scientific Announces FDA Approval For LATITUDE Patient Management System Upgrade,2010-05-11 08:53:00-04:00,BSX,positive
191626.0,Defibrillator Case Still Haunts Boston Scientific (BSX),2010-04-27 19:14:00-04:00,BSX,negative
191627.0,US Stock Futures Sink As Goldman Weighed,2010-04-27 09:16:00-04:00,BSX,neutral
191628.0,Boston Scientific Losing Ground In The After Hours After Lowering Guidance (BSX),2010-04-26 19:08:00-04:00,BSX,negative
191629.0,Boston Scientific (BSX) Reports First-Quarter Results,2010-04-26 17:37:00-04:00,BSX,neutral
191630.0,US Stock Futures Point To Bright Day At The Market,2010-04-26 09:21:00-04:00,BSX,positive
191631.0,"Johnson & Johnson Lowers Its Guidance (JNJ, BSX) ",2010-04-20 12:11:00-04:00,BSX,negative
191632.0,Johnson & Johnson Beats Q1 Forecasts With 29% Profit Growth; Lowers Guidance,2010-04-20 11:34:00-04:00,BSX,positive
191633.0,Johnson & Johnson (JNJ) Reports 29% Increase In First-Quarter Profit,2010-04-20 10:35:00-04:00,BSX,positive
191634.0,"Afternoon Market Update Goldman (NYSE: GS), Best Buy (NYSE: BBY), General Electric Co (NYSE: GE), Boston Scientific (NYSE: BSX)",2010-04-16 16:39:00-04:00,BSX,positive
191635.0,"Oracle To Buy Phase Forward (ORCL, PFWD, ANZ, BSX)",2010-04-16 14:54:00-04:00,BSX,neutral
191636.0,Boston Scientific Stock Reacts Positively To FDA Approval (BSX),2010-04-16 14:48:00-04:00,BSX,positive
191637.0,"St. Jude Medical Upgraded (STJ, BSX)",2010-04-12 08:07:00-04:00,BSX,neutral
191638.0,Piper Jaffray Maintains Neutral Rating On Boston Scientific Corporation (BSX),2010-04-09 13:46:00-04:00,BSX,neutral
191639.0,"Oracleâs Ellison Tops The List Of Highest Paid CEOs In 2009 (ORCL, BSX, OXY, HPQ, APC)",2010-04-05 09:43:00-04:00,BSX,positive
191640.0,Boston Scientific Corp. Deep In Debt (BSX),2010-04-05 09:00:00-04:00,BSX,negative
191641.0,Before Jumping Into A Single Health Care Stock Consider This ETF,2010-03-23 23:22:00-04:00,BSX,positive
191642.0,Investors Flock To Healthcare ETFs On Historic Reform,2010-03-22 16:13:00-04:00,BSX,neutral
191643.0,Boston Scientific Corporation (BSX) Options Active On Positive FDA Data,2010-03-16 14:10:00-04:00,BSX,positive
191644.0,Suspension Of ICDs And CRT-Ds Shipment Could Erode BSXâs Market Share ,2010-03-16 13:19:00-04:00,BSX,positive
191645.0,BSX Downgraded To Conviction Sell At Goldman,2010-03-16 11:05:00-04:00,BSX,neutral
191646.0,"Company News for March 16, 2010 - Corporate Summary",2010-03-16 10:00:00-04:00,BSX,neutral
191647.0,"Benzingaâs Top Pre-Market Losers (BSX, SQNM, UWBK, PSEC)",2010-03-16 08:23:00-04:00,BSX,negative
191648.0,Bullish Options Activity In Boston Scientific (BSX),2010-03-15 19:54:00-04:00,BSX,neutral
191649.0,"Fast Money Picks For March 16th (F, CNX, BSX, EXPD)",2010-03-15 18:40:00-04:00,BSX,neutral
191650.0,Boston Scientific Corp. Halts Sale Of ICDs (BSX),2010-03-15 16:13:00-04:00,BSX,neutral
191651.0,"Benzingaâs Top Downgrades (ATHR, ATPG, GMXR, BSX, AKAM)",2010-03-15 15:39:00-04:00,BSX,positive
191652.0,Boston Scientific Group (BSX) May Gain Support Only Around $6.14,2010-03-15 14:30:00-04:00,BSX,positive
191653.0,FDA Put Sales Of BSXâs ICD Products On Hold,2010-03-15 10:46:00-04:00,BSX,neutral
191654.0,"Benzingaâs Top Pre-Market Losers (CNX, BSX, ISPH, CYTX)",2010-03-15 09:32:00-04:00,BSX,negative
191655.0,Argus Downgrades Boston Scientific (BSX),2010-03-01 15:29:00-05:00,BSX,neutral
191656.0,"Healthcare Conference Update (JNJ, BSX, ATEC, BAX, ZOLL)",2010-02-22 17:22:00-05:00,BSX,neutral
191657.0,Benzinga's Market Movers,2010-02-17 14:36:00-05:00,BSX,neutral
191658.0,"Boston Scientific (BSX) Disappoints Investors, According To Barronâs ",2010-02-12 11:42:00-05:00,BSX,negative
191659.0,Boston Scientific Group (BSX) May Gain Support Only Around $6.14,2010-02-11 13:12:00-05:00,BSX,positive
191660.0,"Benzingaâs Top Downgrades (ELON, DF, BSX, SNI, SLAB)  ",2010-02-11 13:12:00-05:00,BSX,positive
191661.0,Deutsche Bank Lowers Boston Scientific (BSX) To Hold,2010-02-11 09:52:00-05:00,BSX,negative
191662.0,Boston Scientific Narrows Loss (BSX),2010-02-10 18:44:00-05:00,BSX,negative
191663.0,Don't Sweat a Big EPS Dip From Boston Scientific (BSX) - The Estimate is the Norm,2010-02-10 00:19:00-05:00,BSX,neutral
191664.0,"Mad Money Lightning Round: Cramer Says It's Time To Buy Apple, BNI",2010-02-02 07:53:00-05:00,BSX,negative
191665.0,"Fast Money Picks For February 2nd (DELL, AKAM, BSX, CEPH)",2010-02-01 18:23:00-05:00,BSX,neutral
191666.0,"Benzinga's Top Pre-Market Gainers (XOM, JNJ, ALV, MDU, JPM, GCI)",2010-02-01 08:31:00-05:00,BSX,positive
191667.0,"Domestic Cardiac Cath Lab Survey (BSX, MDT)",2010-01-25 14:34:00-05:00,BSX,neutral
191668.0,"Benzingaâs Top Downgrades (BSX, NI, BBI, MS)",2010-01-21 09:08:00-05:00,BSX,positive
191669.0,Large Calendar Spread in Boston Scientific ,2010-01-20 13:41:00-05:00,BSX,neutral
191670.0,Johnson & Johnson Suing Boston Scientific Over Stents,2010-01-20 08:41:00-05:00,BSX,negative
191671.0,Boston Scientific (BSX) To Shift Resources Beyond Stents,2010-01-13 10:06:00-05:00,BSX,neutral
191672.0,Boston Scientific to Rise?,2010-01-07 15:53:00-05:00,BSX,neutral
191673.0,BSX To Launch Xience/Promus In Japan In 1Q10,2009-12-30 10:23:00-05:00,BSX,neutral
191674.0,"Benzingaâs News Roundup (BG, AZN, QCOR, BSX, CVX, MOS, PFE)",2009-12-24 09:03:00-05:00,BSX,neutral
191675.0,"Fast Money Picks For December 14th (CHD, LLL, BSX, DHR)",2009-12-11 20:25:00-05:00,BSX,neutral
191676.0,"10 Stocks To Shine In 2010 (C, NYT, LVLT, KBH, LLY)",2009-12-08 08:40:00-05:00,BSX,neutral
191677.0,Boston Scientific Calls Active,2009-11-27 10:45:00-05:00,BSX,positive
191678.0,"Fast Money Picks For November 25th (F, ABT, BSX, BRCD)",2009-11-24 18:47:00-05:00,BSX,neutral
191679.0,An ETF Play For Medtronic's Earnings (IHI),2009-11-23 20:55:00-05:00,BSX,positive
191680.0,"Bernstein Neutral On Medtronic With Slowing ICD Market (MDT, STJ, BSX)",2009-11-16 09:11:00-05:00,BSX,neutral
191681.0,"House Health Care Bill Will Tax Wealthy (ANPI, BSX, MDT, STJ)",2009-10-29 18:32:00-04:00,BSX,positive
191682.0,"Biggest Losers (MI, GAP, BSX, STT, ZION)",2009-10-20 10:50:00-04:00,BSX,negative
191683.0,Notable Positive Earnings Surprises,2009-10-20 08:59:00-04:00,BSX,positive
191684.0,Boston Scientific Corp (BSX) to Pay $716.3M to Johnson& Johnson (JNJ),2009-09-30 07:22:00-04:00,BSX,negative
191685.0,Boston Scientific (BSX) Achieves Positive Results in Implants Registry,2009-09-01 07:05:00-04:00,BSX,positive
191686.0,Boston Scientific (BSX) Adds New Leading Electrophysiologist to its Medical Team,2009-08-31 06:23:00-04:00,BSX,neutral
191687.0,"TheFortuneFinancial.com Free Market Research on BSX, ARW, CVG, WY, TS and CRL",2009-08-07 06:47:00-04:00,BSX,positive
